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THE PROTEIN-FOLDING PROBLEMProteins have evolved to become some of the most important components in living cells. Not only do proteins confer stability through the cytoskeleton, provide immune responses, and control gene expression, they are also essential for cellular homeostasis through catalysis of metabolic reactions and transport of the resulting products. The ability of proteins to perform such a wide range of functions and re-
actions stems from folding their amino acid sequences into three-dimensional (3D) structures. Every protein consists of a linear chain of amino acid residues with a spe-
cific sequence. This peptide sequence is referred to as the protein’s primary struc-
ture, which folds into secondary structure elements such as α-helices, β-strands and 
loops. In most proteins these elements fold into a specific, often tightly packed and globular, 3D conformation, which is referred to as the tertiary structure or the native structure. Some proteins, so called multi-domain proteins, are composed of multiple chains of amino acid residues and the resulting tertiary structures must come to-
gether in a quaternary structure for correct functionality.How proteins are able to form such a wide variety of complex 3D-structures from 
differing amino acid sequences and how similar sequences can fold to dissimilar 
structures have been long-standing questions in the field of protein folding (1-5). Two principles of protein folding have been essential for trying to understand these 
difficult questions. The first principle is Anfinsen’s thermodynamic hypothesis, which states that, at least for small globular proteins, the native structure is only 
determined by the amino acid sequence (1). The native structure is a unique, stable 
conformation that has the lowest free energy in the protein’s relevant physiological environment. All possible conformations arising from a single amino acid chain can be visualized in a folding funnel (2,6). This funnel depicts the free energy of fold-ing (z-axis) as a function of conformational entropy (x,y-plane). Starting from the unfolded state of a protein (i.e., high entropy and free energy), the chain of amino acid residues randomly searches for the native state, which is the lowest point in the energy landscape for protein folding (Fig. 1A, (1)). This search highlights the second 
principle that governs protein folding, namely Levinthal’s paradox. Calculating the time it would take for a 100-residue protein to randomly search all possible con-formations, Levinthal concluded that it would take longer than the lifetime of the universe (7,8). However, most small proteins fold to their native structure within milliseconds or even microseconds. The paradox can be resolved if the conforma-tional search is not random, but involves intermediates in which local interactions 
form that determine the subsequent folding of the polypeptide chain (7,8). Due to 
formation of intra-chain contacts, the conformational freedom and the peptide’s free energy is lowered. As a result, a pathway emerges in the folding landscape that di-rects and thus accelerates the folding reaction (Fig. 1B). 
The starting point for folding (i.e., the unfolded state) is not just one defined state. Instead, it comprises a conformational ensemble of rapidly interconverting unfolded structures. Thus, there is not just one “correct” pathway to the native state, but folding can start from any conformation within the unfolded state. This phenom-enon can be represented in an idealized funnel, as depicted in Fig. 1C, where folding routes from any unfolded conformation to the native structure are direct and kinet-ically identical. Though such landscapes promote unrestricted folding, most pro-teins have to pass through local energetic minima on their way to their native fold. 
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Figure 1 Visualisation of various types of folding landscapes, also called folding funnels. A, the classic Levinthal “golf course”, wherein the search for the native state is random. B, because of formation of folding intermediates, a “pathway” emerges. C, an idealized funnel, in which all possible starting conformations lead to the native state. D, kinetic traps and energy barriers lead to a “rugged” landscape.This causes the folding funnel to become rugged (Fig. 1D), producing kinetic traps and barriers that folding proteins must overcome to reach the native state. Such traps and barriers are associated with the formation of intermediate folding species, which can be either on- or off-pathway to the native structure. While on-pathway intermediates reside on a productive folding route, off-pathway intermediates have non-native contacts between amino acid residues and need to (partially) unfold be-fore they can resume a productive folding route. Due to the high-energy barrier be-tween the off-pathway intermediate and the native state, the folding protein can 
become trapped in the off-pathway state, which can subsequently lead to aggrega-tion with similarly trapped molecules. By studying the formation and behaviour of intermediates, we may comprehend the principles underlying protein folding.A particular type of intermediate is the molten globule (MG), which can be ei-
ther on- or off-pathway to the native state. MGs were first described for the protein 
α-lactalbumin (9-11). They are characterized by a substantial amount of secondary structure, yet without the tight side-chain packing and burial of hydrophobic sur-faces associated with tertiary protein structure. Furthermore, while MGs possess a 
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Introductionloosely packed core, they are relatively compact compared to native protein (typical radius increase of around 10 to 30 %) (11,12). Under mildly denaturing conditions 
MGs can be found for various proteins, such as α-lactalbumin, apomyoglobin and cy-tochrome c (13-18). Detailed structural characterization of molten globular proteins is challenging, since MGs often consist of transient structures that possess inherent 
flexibility and these states are hardly populated compared to native or unfolded pro-tein.
THE PROCESS OF PROTEIN PRODUCTION AND FOLDING IN VIVO
In vitro folding experiments most often use the full-length protein sequence to 
probe the folding landscape. This does not reflect the situation in vivo, as proteins may already fold during their translation from mRNA by the ribosome, so-called cotranslational folding. Translation of proteins (described in detail in (19)) starts with the positioning of two ribosomal subunits (i.e., the 30S and the 50S subunit in case of bacteria) along mRNA with help from initiation factor proteins (Fig. 2A). On the mRNA, the start codon for methionine recognises the anti-codon of fMet-tRNA (tRNA charged with a formyl-methionine). Within the peptidyl transferase center (PTC) of the ribosome, where amino acids become covalently attached to one another, there are three sites for tRNAs: the amino-acyl (A), the peptidyl (P) and the exit (E) site. Elongation factor Tu (EF-Tu) brings a charged tRNA to the A-site (Fig. 2B), where the anti-codon of this tRNA binds to the corresponding codon of mRNA. The P-site already holds tRNA at-tached to the growing nascent chain (i.e., fMet-tRNA when translation starts). Upon C-terminal formation of a peptide bond between the amino acid attached to the tRNA in the A-site and the nascent chain, this chain is transferred to the tRNA in the 
A-site. Subsequently, translocase EF-G binds to the ribosome and shifts tRNAs from A- and P-sites to P- and E-sites, respectively. In addition, mRNA shifts downstream in relation to the ribosome, and provides the next mRNA codon in the now unoccupied A-site (Fig. 2C and D). Finally, tRNA in the E-site exits the ribosomal complex and a new round of translation starts. This repetitive process continues until a stop codon is reached.Upon emergence of the nascent chain from the ribosomal exit tunnel, cellular 
proteins can start to interact with it. Some of the first proteins that interact with the nascent chain are processing proteins such as peptide deformylase (PDF), which removes the formyl group of N-terminal formyl-methionine. Another processing protein is methionine aminopeptidase (MAP), which hydrolyses the N-terminal me-thionine in case of more than 50 % of nascent chains (Fig. 2E) (20). Chaperones such as Trigger Factor (Fig. 2F) and the DnaK/DnaJ (Fig. 2G) complex may already bind to the nascent chain, either preventing aggregation by holding the nascent chain in an unfolded state, or stimulating folding towards the native state. These chaperones 
can bind to the nascent chain on their own or they can bind sequentially, thereby passing the nascent chain on from one chaperone to the other. Often chaperones interact with numerous co-chaperones, many of which have not yet been studied extensively. Chaperones can affect proteins during or after translation and may be 
confined to specific environments such as the ER, periplasmic space or the Golgi apparatus. Other processes that can happen during translation are further processing of the 
12
Chapter 1nascent chain through glycosylation, phosphorylation, etcetera, and translocation of the nascent chain into membranes, such as the cell membrane or in eukaryotes the ER. Upon reaching the stop codon, which cannot be recognized or bound by tRNA, release factor protein (RF) binds and disassembles the ribosomal complex (Fig. 2G 
and H). Subsequently, the nascent chain releases and diffuses out of the ribosome through the exit tunnel (Fig. 2I). Once in the cytoplasm a protein may either fold by itself or with help from chaperones such as the DnaK/DnaJ or GroEL/GroES com-plexes (Fig. 2J).
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Figure 2 Simplified scheme of protein translation in vivo. 
A-D, the process of translation involves ribosomes (brown), 
mRNA and tRNA’s (black), and transcription factor Ef-Tu and EF-G. E-F, upon emergence of the nascent chain (bold black line) from the ribosomal exit tunnel processing fac-tors such as PDF and MAP and chaperones such as trigger factor and DnaK/DnaJ interact with the polypeptide. G-H, after translation termination a release factor breaks the bond between tRNA and nascent chain. I-J, the ribosomal subunits dissociate and the nascent chain diffuses into the cellular environment where it can fold on its own or with the help of chaperones like GroES/GroEL.
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DIFFERENCES BETWEEN FOLDING IN VIVO AND IN VITROWhile in vitro folding studies have contributed much to the understanding of protein folding, their results cannot be transplanted indiscriminatingly to the fold-ing of proteins in vivo. Four major differences between folding in vivo and in vitro are: presence of chaperones; macromolecular crowding; the use of denaturants such as GuHCl in in vitro experiments and cotranslational folding. As explained above, the circumstances under which proteins are introduced in in vivo or in vitro experiments 
(i.e., full-length sequence versus growing polypeptide) differ considerably. Though 
in some cases chemically or sequentially truncated versions of proteins have been studied for their folding behaviour (21-24), these experiments do not take into ac-count the other major differences between in vivo and in vitro circumstances. As the lifetimes of proteins in cells can range from minutes to years (25) there is ample time for multiple folding rounds for fully synthesized protein.During these folding and unfolding cycles in vivo, chaperone proteins may aid the unfolded or misfolded proteins to achieve their correct fold. Irreversibly misfolded 
proteins can be targeted for degradation by the proteasome or may be sequestered 
in inclusion bodies. Chaperones can be purified and their effect on folding can be studied in vitro. However, the effect of the entirety of all proteins in the chaperone 
network is difficult to test adequately in vitro, as it numbers in the hundredfold for eukaryotes (26).Another major difference is the amount of crowding in the cellular environment versus a diluted buffer. Estimated concentrations of proteins and other macromol-ecules range between 300 to 400 g/L (27). These macromolecules are extremely varied with regard to their biophysical properties, spanning the entire spectrum of size, charge and hydrophobicity. In studies on macromolecular crowding effects in 
vitro, often only one type of crowder is used (28).Finally, the use of GuHCl and urea to denature proteins in vitro and subsequently study their folding is something that is hardly relevant in a cellular context. To trans-
plant findings from such experiments to understand protein folding in vivo is diffi-cult. Of more relevance for this are in vitro experiments that unfold proteins through 
changes in temperature or pH. However, also with these techniques it is important to not stray too much from the physiologically relevant conditions, as these would not occur in the cell.
TECHNIQUES TO STUDY PROTEIN FOLDING IN VIVOOne of the greatest challenges to study protein folding in vivo is differentiating be-tween the signals of the protein of interest and those of other proteins in the cellular 
environment. By using sophisticated and very specific labelling techniques it is pos-
sible to distinguish certain proteins from those of the cellular bulk. These techniques 
can be used for in-cell NMR (29-31) or fluorescence (32-34) studies of already trans-lated and folded proteins. Studying cotranslational folding in vivo is even more diffi-cult, as the ribosome itself contains more than 50 proteins in E. coli, a number that increases up to 80 in eukaryotes (35). In addition, chaperones such as Trigger factor and DnaK, but also enzymes such as PDF, MAP and other modifying enzymes inter-act (transiently) with the nascent chain (20). All these factors complicate characteri-zation of folding pathways of nascent chains in vivo. Therefore, most high-resolution 
cotranslational folding studies employ purified ribosomal nascent chain complexes 
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(RNCs) or purified transcription/translation systems. These systems consist of the 
minimal constituents required for successful translation, such as for example tRNAs, aminoacetylases, and transcription factors. Sometimes transcription is performed in 
vitro and purified mRNAs are added to the translation system, though transcription/translation can also be achieved in a one-pot reaction series.Investigation of most RNCs involves complete ribosomes, containing both a small and a large subunit (i.e., 30S and 50S in case of E. coli), to which a nascent chain is 
tethered through a stalling mechanism. Purification of these RNCs is relatively easy, 
either by ultracentrifugation or through attachment of an affinity tag to the N-ter-
minus of the nascent chain followed by an affinity chromatography step (36,37). Depending on the stalling mechanism used, RNCs can have lifetimes of up to 1 or 2 days (38). These lifetimes attests to the relative strength of the stalling mechanism 
and makes purified RNCs suitable for biophysical and biochemical research. Var-ious ways exist to stall translation, ranging from truncated mRNAs lacking a stop 
codon to naturally occurring stalling sequences such as TnaC or SecM (39). Stalling 
sequences can work in a variety of ways, using effector molecules (TnaC) or by al-tering the geometry of the ribosome at the PTC (SecM) (40). One of the most widely 
used stalling sequences is derived from the SecM protein, which is essential for cor-rect incorporation of the SecA protein into membranes (39).
Folding of RNCs can be probed either at equilibrium or, as described recently, in real time (i.e., during the process of translation) (41). Studies of cotranslational folding in real time do not employ stalling mechanisms, as this would halt the trans-
lation reaction. Techniques to probe folding states of RNCs include NMR (38,42,43), Förster Resonance Energy Transfer (FRET) (41,44,45), force-induced unfolding/refolding by optical tweezers (46) and proteolytic digestion (47). To be able to dis-tinguish the nascent chain from ribosomal proteins by NMR spectroscopy, NMR-sen-sitive isotopes needed for labelling the nascent chain are added upon induction of translation. This procedure ensures that ribosomes themselves are not labelled and thus do not drown out the signal of the nascent chain (38,48). Similarly, to selective-
ly probe nascent chain folding by FRET requires the necessary fluorescent labels to be added cotranslationally. In contrast, conventional labelling reactions, such as maleimide labelling of cysteines, would also label the 30 cysteines present in E. coli ribosomal proteins (41,44). In summary, the methods used to follow nascent chain 
folding are quite challenging.Up to now, cotranslational folding studies have elucidated the timing of several 
steps during protein production, though there is much that still needs clarification. 
Folding of α-helices in the ribosomal exit tunnel has been observed for several pro-
teins. A 29-residue zinc finger domain protein was shown to bind its metal cofactor Zn2+ while it still resides in the ribosomal exit tunnel (49). Upon emerging from this tunnel various proteins interact with the nascent chain in processes that are precise-ly coordinated. The proteins PDF and MAP were shown to interact with the nascent chain as soon as it emerges from the exit tunnel (20). These proteins are superseded by Trigger factor after approximately 100 amino acids have been translated (50). 
When the entire amino acid sequence is available outside the exit tunnel, various 
proteins can achieve their native fold. These proteins range from all α-proteins, such 
as globins (44,51), calmodulin (52) and HemK (41), all β-proteins like GFP (53), 
Dom5 (48), tailspike protein (37,54) and SH3 (38,47), to α/β proteins such as lu-ciferase (55), CFTR NBD1 (56) and barnase (57). The ribosome itself also affects 
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Introductionprotein folding, as shown for T4 lysozyme (46), an immunoglobin-like domain (58), and for the N-terminal domain of HemK (41). Presence of non-native intermediates during nascent chain folding has been detected for a few proteins, including GFP and the N-terminal domain of HemK (41,53). The conformations of these intermediates could not be determined, except that for most proteins probed they seem to be rath-er compact. In case of SH3, addition of Trigger factor actually unfolded the folding intermediate observed, possibly to prevent misfolding of the nascent chain and sub-
sequent aggregation (47). The real-time folding events of the N-terminal domain of HemK showed that it forms a non-native state in the exit tunnel and rearranges itself into native-like structure upon emerging from the ribosome (41). While important steps have been made to probe cotranslational folding, the folding of nascent poly-peptides with complex native structure remains largely unexplored. 
ELUCIDATING COTRANSLATIONAL FOLDING OF FLAVODOXIN
One such complex structure is the α-β parallel native-state topology. We aim to clarify how nascent proteins with such a topology fold cotranslationally. We choose 
to follow nascent chain folding of the α-β parallel protein flavodoxin, which is well known for producing an off-pathway MG during its folding in vitro. This choice en-
ables us to probe the influence the ribosome and the intracellular environment have on (mis)folding of nascent chains.
Flavodoxins are small monomeric flavoproteins that contain a non-covalently bound FMN cofactor. Flavodoxins act as low-potential one-electron carriers and 
adopt a α-β parallel fold, with a central β-sheet surrounded by α-helices (Fig. 3). 
This fold is often called the flavodoxin-like fold, but it is not constricted to flavodox-
ins only, as proteins unrelated in sequence or function, such as chemotactic proteins 
also adopt this fold (59). The flavodoxin-like topology is considered to be one the 
most ancient protein folds (60). While the flavodoxin protein itself is absent from higher kingdoms of life such as plants and animals (61), it is present in bacteria and 
many algal species (62). Furthermore, flavodoxin-like folds are found as domains in many crucial multi-domain eukaryotic pro-teins such as cytochrome P450 reductase (63) and nitrogen oxide synthase (64).The obligate aerobic bacterium Azotobacter 
vinelandii contains three flavodoxins, of which 
flavodoxin II is most abundant under nitrogen 
fixating conditions (65). The folding of flavo-doxin II from A. vinelandii (65,66) has been studied extensively. Un- and re-folding of both the apo- and the holo-form of this protein have been probed, using GuHCl as denaturant (67-
74). It has been shown that apoflavodoxin folds autonomously to its native state, after which it 
binds FMN as the last step in flavodoxin forma-tion (Fig. 4). The 3D structures of natively fold-
ed apoflavodoxin and flavodoxin are almost 
identical, except for considerable flexibility 
in the flavin-binding region of apoflavodoxin (75,76).
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Figure 3 Schematic picture of the 
flavodoxin-like topology, which 
consists of a central β-sheet 
(squares) involving 5 β-strands 
and is surrounded by 5 α-helices (circles).
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The folding landscape of kinetic apoflavodoxin folding involves two intermedi-ates and is described by the following scheme:
Intermediate Ion is an obligatory, high-energy on-pathway species, which is 
non-molten globular and rapidly converts to native apoflavodoxin (67). Due to its 
instability it is not observed during denaturant-dependent equilibrium folding. In contrast, the off-pathway intermediate MGoff is a molten globule that is relatively stable and needs to unfold extensively before productive folding to the native state 
can resume (71,77). Of all folding apoflavodoxin molecules approximately 90 % first 
misfolds to this MG (67). Its off-pathway nature is due to docking of non-native α-he-
lices, thereby preventing formation of the central β-sheet of native flavodoxin (Fig. 4) (70,71,78). Formation of off-pathway folding intermediates seems to be typical for 
proteins with a flavodoxin-like fold, as they have also been observed for Anabaena 
apoflavodoxin and chemotactic protein (59,79-81). MGoff aggregates severely at ele-vated protein concentrations or in the presence of macromolecular crowders (77). 
While formation of native apoflavodoxin is highly cooperative, MGoff folds non-coop-eratively (71). In vitro, the folding of the C-terminal part of MGoff precedes the folding of the N-terminal part and the MG gradually compacts due to progressive extension of its ordered core (74).
MG
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U N
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MGoff Apo HoloFMN
IonU
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Figure 4 Folding of flavodoxin proceeds from the unfolded state to either native apoflavo-doxin (Apo) or to an off-pathway MG (MGoff). Binding of FMN to native apoflavodoxin forms 
flavodoxin (Holo). Structures of Apo and Holo are shown as cartoon renderings of PDB entry 
1YOB (83), with α-helices in green and β-strands in red. FMN is shown in yellow. The car-toon rendering of MGoff is a model for the known secondary structure elements within the 
off-pathway MG. α-helices in MGoff that are also found in native apoflavodoxin are coloured green, non-native helices in MGoff are coloured blue and the structured part of MGoff that is 
neither α-helix nor β-strand is coloured orange (82). This model does not represent the rela-tive positioning of these secondary structure elements within MGoff, because this positioning is currently unknown.
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In flavodoxin variant F44Y, in which phenylalanine at position 44 is substituted for a tyrosine, MGoff can be induced in the absence of denaturant by lowering the ionic strength (82). This mutation de facto introduces an oxygen atom into a hydro-
phobic pocket of apoflavodoxin and destabilizes its native state (78,82). F44Y apo-
flavodoxin is thus an interesting candidate to study formation of off-pathway MGs in 
vivo, as substantial population of MGoff occurs at physiologically relevant conditions.
To study cotranslational folding of flavodoxin, we prepared RNCs of flavodoxin variants C69A (in which cysteine at position 69 is substituted for an alanine) and 
F44Y. The native states of both protein variants are similar to native WT flavodoxin 
(75,82). Besides examining the folding of nascent chain in which the entire apoflavo-doxin domain is exposed outside the ribosome, we also prepared C-terminally short-
ened RNCs of C69A apoflavodoxin. The latter enables us to assess distinct stages 
during cotranslational folding of flavodoxin. The construct used for RNC production 
consists of several components (Fig. 5) (38,57): a triple Strep-tag for purification purpose; a Smt3-domain with a C-terminal Ulp1-protease cleavage site to produce 
authentic N-termini for RNCs; the flavodoxin sequence; a TEV-protease site located 
C-terminally of the flavodoxin sequence to enable release of the nascent chain from 
the ribosome; a linker that spans the ribosomal exit tunnel; and the SecM sequence, which stalls the nascent chain to the ribosome.
OUTLINE OF THIS THESISThe main focus of this thesis is the investigation of how A. vinelandii flavodoxin folds during its translation by the ribosome.
This flavodoxin is notorious for forming an off-pathway MG during folding and 
this intermediate can be populated extensively in flavodoxin variant F44Y. Lower-ing ionic strength facilitates this population, thus the F44Y variant is an excellent candidate for exploring cotranslational folding. Various methods exist to reveal the presence of MGs, including the use of extrinsic dyes, circular dichroism and intrinsic 
tryptophan fluorescence. However, these methodologies are unsuitable for studying cotranslational MG formation, as RNCs not only contain the emerging polypeptide, but also more than 50 ribosomal proteins. Thus, detection of MG formation on the 
ribosome is particularly difficult. 
A
Smt3 FLD SecM
3x StrepII TEV
FL-10
-5
44 2721179 97 aa
Smt3 FLD SecM
3x StrepII TEV
F44Y
B
Figure 5 The constructs used for production of 
RNCs of flavodoxin. All constructs contain a triple N-terminal StrepII-tag (orange), an Smt3-domain 
(green) fused to flavodoxin (yellow), a recogni-tion site for TEV protease (blue) and a linker that spans the ribosomal exit tunnel and concludes 
with the SecM stalling sequence (magenta). All 
constructs contain the C69A mutation in the fla-vodoxin gene. A, construct used to produce C-ter-minally shortened RNCs. Through deletion of 5 
or 10 residues at the C-terminus of flavodoxin, respectively, 2 constructs are obtained that pro-
duce stalled nascent proteins of specified length. 
B, construct used to produce F44Y RNCs.
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Chapter 2 describes detection of MG formation in vitro through a combination 
of cofactor binding kinetics and polarized time-resolved tryptophan fluorescence 
spectroscopy. We exploit the fact that while the cofactor FMN is fluorescent in solu-
tion, upon binding to apoflavodoxin its fluorescence becomes severely quenched. The off-pathway MG needs to unfold before productive folding and FMN only binds 
to natively folded apoflavodoxin. Thus, whenever MGoff is present in an apoflavo-doxin sample the corresponding FMN binding rate ought to be delayed. We show that FMN binding kinetics indeed allows us to follow the presence of MGoff under physiological conditions. Interestingly, in combination with polarized time-resolved 
fluorescence spectroscopy, the binding kinetics reveals the presence of another, si-multaneously occurring MG. We present proof that the two concurrent MGs of F44Y 
apoflavodoxin are kinetically distinct, with one species being on-pathway and the other being off-pathway. Presence of this on-pathway MG would explain why ap-
proximately 10 % of folding apoflavodoxin molecules directly follows the productive folding route, as opposed to the 90 % that misfold to MGoff.In Chapter 3 we present the first insights into cotranslational folding of flavodox-
in. We address the binding of flavin mononucleotide (FMN) to nascent flavodoxin, by generating ribosome-arrested nascent chains that expose either the entire protein or C-terminally truncated segments outside the exit tunnel. We used constructs for 
flavodoxin that lack zero, five or ten amino acid residues at the C-terminus of stalled polypeptide (Fig. 5A). This procedure allows us to mimic the late stages of protein 
translation and enables the elucidation of the phase at which nascent apoflavodoxin is capable of binding FMN. Chapter 3 demonstrates that sequestering of only five 
C-terminal amino acids of flavodoxin within the ribosome already forces the poly-peptide chain in a non-native conformation, which is incapable of binding FMN. In 
contrast, released protein that lacks the five C-terminal residues of flavodoxin can 
bind FMN. We show that because the ribosome affects protein folding, apoflavodox-in cannot bind FMN during its translation. Chapter 3 also proofs that in E. coli FMN 
is limiting for saturation of this flavoprotein on time-scales vastly exceeding those of 
flavodoxin synthesis (hours versus seconds). We show in Chapter 3 that binding of 
cofactor to released protein is the last step in production of this flavoprotein in the cell. Finally, Chapter 3 reveals that once apoflavodoxin is entirely synthesized and 
exposed outside the ribosome to which it is stalled by an artificial linker containing 
the SecM sequence, the protein is natively folded and capable of binding FMN. For 
multi-domain proteins that contain a flavodoxin-like fold as subdomain, our work suggests that incorporation of cofactor probably occurs cotranslationally once this fold has fully emerged from the ribosome.
Chapter 4 reports on the existence of MGs during translation, which is a phe-
nomenon that has not been investigated to date. We utilize apoflavodoxin variant F44Y to probe this phenomenon, as extensive population of MGoff occurs with this variant at physiological ionic strength. Chapter 4 shows that ascertaining the bind-ing rate of FMN as a function of ionic strength can be used as a tool to determine the presence of the off-pathway MG on the ribosome. Application of this methodology to 
F44Y apoflavodoxin RNCs reveals that at physiological ionic strength the ribosome 
restrains molten globule formation in stalled nascent flavodoxin and forces the na-
scent chain towards the native state. Confinement of MG formation during transla-tion is an important observation that emphasizes differences between folding in vivo and in vitro.
19
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The folding properties of various bacterial flavodoxins and other proteins with 
flavodoxin-like topologies such as CheY have been extensively studied in vitro. This research of the past two decades is reviewed in Chapter 5. The common theme of the folding of these proteins is the occurrence of a misfolded intermediate, which for several proteins is molten globular. These intermediates arise due to topological 
frustration in the folding pathway, as an α-helix forms much quicker than a parallel 
β-sheet. While the misfolded intermediate seems to be a conserved feature of the 
flavodoxin-like architecture, the productive transition states of the various proteins 
differ significantly from one another. The final part of the review bridges the knowl-edge on in vitro folding of proteins with a flavodoxin-like topology with information obtained on the cotranslational folding of A. vinelandii flavodoxin.The main insights obtained during the research that lead to this thesis are dis-cussed in Chapter 6, as well as directions for future research and possible applica-tions in biotechnology or pharmaceutics.
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Concurrent presence of on- and off- pathway molten globules under physiological conditions
Proteins fold along routes on which intermediates form that can be on- or off-path-way to the native structure. An important type of intermediate is the molten glob-ule (MG), which is characterized by a substantial amount of secondary structure, yet without the tertiary side-chain packing of natively folded protein. The protein 
flavodoxin has an architecture that can be traced back to the universal ancestor of 
the three kingdoms of life. Proteins with a flavodoxin-like architecture tend to tem-porarily misfold during unassisted folding to their native state and as a result they form intermediates. Several of these intermediate species are MGs, with the MG of 
flavodoxin from Azotobacter vinelandii as a particular example. Without the use of denaturants or lowering of pH, this MG is induced in the F44Y variant of A. vinelandii 
apoflavodoxin at physiological ionic strength. Here, using a combination of cofactor 
binding kinetics and polarized time-resolved tryptophan fluorescence spectroscopy, 
we show that two MG species of F44Y apoflavodoxin co-exist. Besides the misfolded, off-pathway MG described previously, we discovered an on-pathway MG. Thus, dis-tinct, simultaneously present MGs that reside on folding routes of decidedly differ-
ent nature (i.e., on- and off-pathway) exist during apoflavodoxin folding. Detection of the presence of concurrent MGs enables future exploration of how the cellular 
environment, like involvement of chaperones, influences their formation.
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INTRODUCTIONProteins that fold from their unfolded to native structure often pass through intermediate folding states (i.e., local minima in free energy), which are partially structured species (1-4). These intermediates can either reside on productive fold-ing pathways (on-pathway species) or form dead-ends within the folding funnel (off-pathway species) (5). On-pathway intermediates pre-dominantly contain na-tive-like interactions in their structured parts. In contrast, off-pathway species have 
significant non-native, misfolded structure and are trapped in the corresponding en-ergetic minima. To return to the productive folding ensemble, these trapped species 
have to overcome significant energy barriers.
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Figure 1 Cartoon drawings of folding species of A. vinelandii flavodoxin (PDB entry 1YOB (28)). A, Topology of the flavodoxin-like fold. α-Helices are represented as circles and β-strands 
as squares. B, flavodoxin, with the FMN cofactor coloured yellow. C, native apoflavodoxin (i.e., 
flavodoxin without FMN), which is structurally identical to flavodoxin except for disorder (not 
shown) in the flavin-binding region (74). D, Model for MGoff, which highlights the four tran-siently structured. Helical parts also present in native protein are shown and regions that 
adopt α-helical structure not found in native protein are coloured blue; the orange element 
is structured, yet is neither α-helix nor β-strand (38). These regions dock non-natively and 
form the core of apoflavodoxin’s MGoff (38-41). The cartoon shows the structural elements of MGoff, but their relative positioning is unknown. Residues F44, A69, W74, W128 and W167 are represented as sticks and are labelled. Residue F44 is shown in blue, A69 is coloured magenta and the tryptophans are highlighted in red.
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Concurrent presence of on- and off- pathway molten globules under physiological conditions
A specific type of folding intermediate is the molten globule (MG). MGs contain secondary structure but lack the tight tertiary packing of natively folded proteins. Furthermore, MGs are relatively compact (typical radius increase compared to na-tive protein of about 10 to 30 %), possess a loosely packed hydrophobic core and expose hydrophobic patches to the solvent (6,7). MGs are prone to aggregation and 
consequently are implicated in various diseases (8) Several proteins form MGs in vi-
tro, including α-lactalbumin, apomyoglobin and cytochrome c (9-16). The MGs of the latter proteins contain native-like secondary structure and packing, causing them to be on-pathway to the native state. In contrast, off-pathway MGs contain non-native secondary structure and/or packing. Nowadays, many proteins are thought to fold via MGs (17-23) and these intermediates are for example necessary during inser-tion of proteins into membranes or during translocation (24-26). Because of their importance in protein folding, considerable effort has been put into determining the structural properties of MGs. Investigating the characteristics of MGs is complicated 
by their generally low presence at equilibrium, their conformational heterogeneity, their often transient nature, and their tendency to aggregate (27) To research their folding properties, MGs are induced by for example lowering pH or through addition of denaturant. However, it remains a challenge to extrapolate the insights gained in such studies to physiologically relevant conditions.
Flavodoxins are monomeric, single domain flavoproteins that are involved in 
electron transfer. To shuttle electrons, flavodoxins contain a non-covalently bound 
flavin mononucleotide (FMN). The native protein has an α/β parallel topology, with 
five α-helices surrounding a central parallel β-sheet (Fig. 1A) and is the archetype 
for the αβα sandwich class (28,29). Flavodoxins from Anabaena, A. vinelandii, (Fig. 1B) and Desulfovibrio desulfuricans tend to form off-pathway intermediates during their unassisted folding in vitro to their functionally active forms (20,30-32). Several of these species are MGs. Off-pathway intermediate formation is also characteristic 
for the folding of CheY-like proteins, which share the flavodoxin-like fold (33,34). A MG that has been extensively studied is the off-pathway MG (MGoff) of the 179-resi-
due flavodoxin from A. vinelandii (32,35-43). Characterisation of how A. vinelandii flavodoxin kinetically folds in vitro shows that two parallel folding routes are accessible (32,44). These routes, of which one is on- and the other off-pathway, are visualized in the energy landscape of Fig. 2. This landscape depicts a funnel to the native state and a trough in which a misfolded intermediate temporarily resides. Folding in the funnel and trough are described by schemes 1 and 2, respectively:
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Chapter 2Scheme 1 represents the approximately 10 % of unfolded molecules (U; rim of the funnel towards native protein) that directly follow the productive folding route 
to native apoflavodoxin (N(Apo); bottom of funnel). On this path, intermediate Ion is an 
obligatory, high-energy on-pathway species that rapidly converts to native apofla-
vodoxin (i.e., flavodoxin without FMN; Fig. 1C) (32). Ion is native-like and resides in a moat in the funnel towards native protein. Due to its instability, Ion is not observed 
during denaturant-dependent equilibrium folding of the protein. This productive folding of 10 % of unfolded molecules happens on the microsecond timescale. Sub-
sequently, flavodoxin (N(Holo); not depicted in Fig. 2) forms upon binding of FMN to 
native apoflavodoxin.
Around 90 % of unfolded molecules (U*; the outer edge of the off-pathway trough) temporarily misfold within milliseconds and form the off-pathway interme-diate MGoff (scheme 2). This relatively stable species is also detected during dena-
turant-dependent equilibrium folding and is molten globular. MGoff is positioned at the bottom of the off-pathway trough (Fig. 2) (32,35,42). MGoff needs to unfold sub-
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Figure 2 Schematic folding energy landscape of A. vinelandii apoflavodoxin. Free energy is shown vertically and the reaction coordinate is horizontally. Unfolded protein structures re-side at the rim of each folding funnel. The left funnel shows the on-pathway route to native protein (N(Apo)), on which an on-pathway intermediate (Ion) resides. The trough on the right 
displays formation of apoflavodoxin’s off-pathway MG (MGoff). This molten globular species 
folds gradually, as exemplified by the presence of shallow moats. Only native apoflavodoxin binds FMN, which leads to considerable stabilisation of the protein and deepening of the cor-responding funnel (not shown). In reality, the ratio of the circumferences of the rims of the 
on- and off-pathway funnels is about 1 to 9. This ratio reflects that 10 % of unfolded molecules 
directly follow the productive folding route to native apoflavodoxin, whereas 90 % of unfold-ed molecules misfold and temporarily form MGoff (32). Apoflavodoxin is in 100 mM potassium pyrophosphate, pH 6.0, at 25 °C.
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Concurrent presence of on- and off- pathway molten globules under physiological conditionsstantially (i.e., to U*) before folding to the native state takes place. This productive folding occurs within microseconds and again involves Ion. Thus, all folding apofla-vodoxin molecules, whether they reside on productive or non-productive pathways, ultimately pass through Ion before reaching the native state.
Unfolded apoflavodoxin is not a featureless statistical coil, but instead contains four transiently ordered regions. Three of these regions are α-helices, whereas the fourth adopts non-native structure that is neither α-helix nor β-strand (Fig. 1D) 
(38). During folding, these structured elements interact and can subsequently form the ordered core of MGoff (38,40). This propensity to interact is visualized in Fig. 2 and in scheme 2 by U*. Non-native docking of the α-helices in MGoff prevents forma-
tion of the parallel β-sheet of native apoflavodoxin (38,40,41,45). Thus, the source for MGoff formation is situated in the unfolded state. The off-pathway intermediate has a drastically different architecture compared with native protein: it is largely 
α-helical and contains no β-sheet (39) and is slightly expanded compared to native 
apoflavodoxin (36). This α-helical MG acts as a trap and needs to unfold significantly 
in order to embark on a route to native α-β parallel protein.
While formation of native apoflavodoxin is highly cooperative (32,43,46,47), con-version of unfolded protein into MGoff is a non-cooperative, gradual process that si-
multaneously involves separate regions within apoflavodoxin (40,43). This suggests an energy landscape of MG folding with many barriers (visualised by shallow moats in the off-pathway trough of Fig. 2). Ultimately, after folding, the helical off-pathway 
MG of apoflavodoxin is almost entirely structured (40,43).Unfolding of MGoff happens within seconds (32) and is symbolized, for use in the analysis of the data obtained in this study, in the following scheme:
   Scheme 3
Note that the productive on-pathway intermediate Ion has not been included in this and following schemes, because its rapid transformation to native protein cannot be detected on the timescale of the cofactor binding kinetics and polarized 
time-resolved tryptophan fluorescence experiments described in this paper.
Most of our knowledge of apoflavodoxin’s MGoff stems from studies that use de-
naturant. In case of apoflavodoxin variant F44Y, in which phenylalanine at position 44 is substituted for a tyrosine, the protein switches from natively folded to MGoff upon decreasing ionic strength to physiological values (i.e., from 100 to 10 mM po-
tassium pyrophosphate (KPPi), which is equivalent to 75 to 345 mM NaCl) (39). The tyrosine introduces an extra oxygen atom into a hydrophobic pocket of native apo-
flavodoxin, causing considerable destabilization (39,41). F44Y protein allows char-
acterization of apoflavodoxin’s MGoff under physiologically relevant conditions. In this study we characterize the behaviour of MGoff by exploiting the quenching of FMN 
fluorescence upon binding to apoflavodoxin (48,49). FMN binding to apoflavodoxin 
involves a very specific combination and geometry of hydrogen bonds and aromat-
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ic interactions (50). Therefore, binding of FMN only occurs to native apoflavodoxin 
and is the last step in folding of flavodoxin (44). This binding is diffusion-limited. As MGoff needs to unfold before native apoflavodoxin can form, in presence of this inter-
mediate the rate of cofactor binding and accompanied FMN fluorescence quenching 
slows down compared to the situation where only natively folded apoflavodoxin is 
present. Thus, the rate of FMN fluorescence quenching ought to track the unfolding of MGoff.Here we show that FMN binding kinetics, in combination with polarized time-re-
solved fluorescence spectroscopy, reveals, besides MGoff, the presence of another, 
simultaneously occurring MG. This concurrent MG of F44Y apoflavodoxin is kineti-cally distinct from MGoff and is on-pathway to native protein. 
MATERIAL AND METHODS
Protein expression and purification. To avoid covalent dimerization of puri-
fied A. vinelandii (apo)flavodoxin, the single cysteine at position 69 was substitut-ed by an alanine (46). The properties of variant C69A are largely similar to that of 
wild-type (apo)flavodoxin (46,51). An additional F44Y replacement was introduced 
(39), and this protein variant is referred to as F44Y (apo)flavodoxin. Each construct (i.e., C69A or F44Y) was transformed in Escherichia coli (strain TG2) and purified as described previously (46). Apoprotein was prepared according to established pro-
tocols (52). Holo- and apoproteins were flash-frozen in liquid nitrogen and stored in KPPi buffer, pH 6.0, at -80 °C.
FMN binding. To assess the binding rates of cofactor to apoflavodoxin, FMN flu-
orescence was followed in time. Flavin fluorescence was recorded on a Cary Eclipse 
spectrofluorimeter (Varian) at 25 °C. Upon freezing and subsequent thawing of F44Y apoprotein a fraction of the protein deteriorates into soluble molecules that are in-capable of binding FMN. As these molecules cannot be easily separated from FMN 
binding competent apoflavodoxin, determination of the concentration of cofactor binding competent apoprotein was achieved by titrating the protein solution with FMN (Sigma). Protein samples of 50 to 140 nM cofactor-binding competent mole-cules were prepared in KPPi at pH 6.0. Final concentration of FMN was 25 nM. FMN 
fluorescence of the apoflavodoxin samples was measured in stirred fluorescence 
cuvettes during five minutes, before and after manual addition of FMN at the same 
KPPi concentration as the corresponding protein solution. C69A apoflavodoxin sam-
ples were made in 100, 70, 40 and 10 mM KPPi and F44Y apoflavodoxin samples were prepared in 100, 90, 80, 70, 60, 50, 40, 30, 20, and 10 mM KPPi, respectively. Excitation was at 450 nm and emission was monitored at 540 nm. Excitation and emission slits were set to bandwidths of 10 and 20 nm, respectively, and PMT volt-age was 970 V. The averaging time of the measurement was 0.1 s. The time between 
adding FMN and the start of fluorescence detection was approximately 2 s. Back-
ground correction was performed by subtracting the fluorescence at 540 nm before 
addition of FMN from the fluorescence data obtained after addition of FMN.
Analysis of FMN binding rates. Analysis of cofactor binding data was done in IGOR Pro (version 6.37). Fluorescence traces (Flu) resulting from predominantly 
native apoflavodoxin (N(Apo); i.e., all C69A traces and traces of F44Y in 100, 90 and 80 mM KPPi, respectively) were analysed according to the following scheme and 
equations:
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Traces resulting from MG (i.e., when F44Y apoflavodoxin is in 10 to 70 mM KPPi) 
were analysed with the following scheme and equations, including equations 2 to 4:
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CMG, CN(Apo), CFMN, CN(Holo), are the initial concentrations of MG, native apoflavodoxin, 
FMN and flavodoxin, respectively. CMG and CN(Apo) are determined by 
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 the initial ratio between native apoflavo-doxin and MG. 
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and 
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are the rate constants for conversion of MG 
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to native apoflavodoxin and conversion of native apoflavodoxin to MG, respectively and 
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equals 
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. kon is the second-order rate constant for 
association of FMN to native apoflavodoxin (M-1s-1) and koff is the first-order rate constant for dissociation of FMN (s-1). koff and KD have been determined previously (50) and kon can be determined because KD equals koff/kon. FFMN and FHolo are the con-
version factors from amount of molecules to fluorescence of FMN and flavodoxin, respectively. Before analysis, data were normalized.
Time-resolved fluorescence anisotropy. C69A and F44Y apoflavodoxin con-
centration was 2 μM. F44Y apoprotein was freshly prepared to avoid the cold de-naturation described above. The KPPi concentrations were as used for the FMN 
binding experiments. Time-resolved fluorescence anisotropy was determined using time-correlated single photon counting, as described (37,53). Excitation was at 300 nm. Repetition rate of the excitation pulses was 3.8 MHz with a pulse duration of less than 0.2 ps and pulse energies at the pJ level, and samples were in 1 ml 10 mm 
path length quartz cuvettes at 25 °C. Use was made of a Schott UV-DIL 348.8 nm (∆λ = 5.4 nm) interference filter to detect the fluorescence photons. Decay curves were collected in 4096 channels of a multi-channel analyser using a channel time 
spacing of 5.0 ps. Ten repeated sequences of 10 s duration of parallel (I||(t)) and of perpendicularly (I⊥(t)) polarized fluorescence emission were acquired. Background 
fluorescence emission was determined under identical conditions. For deconvolu-tion purposes, the dynamic instrumental response function was recorded using a freshly made solution of p-terphenyl in a mixture of 50/50 (v/v) cyclohexane and CCl4 (54,55).
Total fluorescence decay
I(t) = I||(t) + 2 I⊥(t)      Eq. 7
was analysed using a sum of discrete exponentials with lifetimes τi and ampli-
tudes αi:
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  Eq. 8
E(t) is the instrumental response function and ⊗ denotes a convolution product. 
Time-dependent fluorescence anisotropy
r(t) = (I||(t) – I⊥(t))/ I(t)      Eq. 9
was analysed from parallel and perpendicular intensity components (37).
Analysis of time-resolved fluorescence anisotropy. Decay of fluorescence an-
isotropy of apoflavodoxin is caused by exchange of excited-state energy between two tryptophan residues by the Förster mechanism and by overall protein rotation and is described by (37,56,57):
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  Eq. 10
with φT the correlation time of resonance energy transfer, φr the rotational cor-
relation time of the protein. Both βT and βr depend on the intra- and intermolecular angles between absorption and emission transition moments.Reversible energy transfer happens between a pair of identical, isoenergetic chromophores (i.e., tryptophans). In this case φT is given by:
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  Eq. 11
with kT the rate constant for energy transfer, which is given by the Förster equa-tion (58):
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  Eq. 12
with κ2 the orientation factor for the transition dipole moments of the trypto-phans involved, n the refractive index of the medium between donor and acceptor 
(59) (for native apoflavodoxin n=1.6) (60), kr the radiative rate constant (ns-1) (61), J the integrated spectral overlap of acceptor (tryptophan) absorbance and donor 
(tryptophan) fluorescence emission (M-1cm3), and R the distance (nm) between do-nor and acceptor.Unidirectional energy transfer happens if excited-state energy of one tryptophan is lower than that of the other and thereby the lowest excited-state acts as acceptor of resonance energy transfer. In this situation φT is given by:
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Steady-state fluorescence anisotropy. Polarized time-resolved fluorescence data 
are related to steady-state fluorescence anisotropy  according to the following rela-tion (62):
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  Eq. 14
in which I(t) is the total fluorescence decay and r(t) the time-dependent fluores-cence anisotropy.
This equation can be rewritten into the well-known Perrin equation:
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  Eq. 15
in which r(0) is fluorescence anisotropy at t=0, <τ> is the average fluorescence 
lifetime, and <φ> is a harmonic mean correlation time characteristic for the particu-
lar flu rescence depolarization process.
RESULTS
FMN binding follows formation of apoflavodoxin’s off-pathway MG. As dis-cussed, FMN binding kinetics ought to track the presence of apoflavodoxin’s off-path-way MG under physiologically relevant conditions. To proof the latter, we mixed 
FMN with either native apoflavodoxin or MG and analysed cofactor binding using 
Schemes 4 and 5, respectively. As the pseudo-first-order rate constant for FMN bind-
ing is on the order of μM-1s-1 (44,50) low concentrations of both apoflavodoxin and 
FMN are required to enable tracking of cofactor binding on the seconds timescale 
after manual addition of FMN. The major fluorescence contribution to the binding 
curves reflects the decrease in free FMN due to FMN binding to apoflavodoxin. The 
minor fluorescence component to the binding curves tracks the increasing number 
of flavodoxin molecules, as freshly generated flavodoxin is slightly fluorescent (50). 
Thus, the FMN fluorescence trace obtained after titrating native apoflavodoxin with 
FMN is complex, is not simply biphasic, and needs to be analysed by using equations 
1 to 4 (Fig. 3A-C, Tables 1 and 2). The FMN fluorescence trace resulting from molten 
globular apoflavodoxin is also multi-faceted and requires analysis with equations 2 to 6 (Fig. 3D). 
In case of C69A apoflavodoxin, the protein is native in 10 and 100 mM KPPi (39). 
Indeed, FMN fluorescence shows that binding of the cofactor to C69A flavodoxin is independent of salt in this concentration range (Fig. 3A,B). In contrast, the FMN 
fluorescence traces of F44Y apoflavodoxin at both salt concentrations differ consid-
erably (Fig. 3C,D). F44Y apoflavodoxin in 100 mM KPPi is predominantly natively folded (39) and hence Fig. 3C shows that it has a similar FMN binding curve as native 
C69A apoflavodoxin (Fig. 3A,B). In 10 mM KPPi however, F44Y apoflavodoxin pre-
dominantly adopts the off-pathway MG conformation, which first needs to unfold 
before native apoflavodoxin can form (Scheme 5) (39). FMN only binds to native 
apoflavodoxin and under the conditions used this binding happens much faster than the time it takes to unfold the off-pathway MG. As a result, under the latter condition, 
FMN fluorescence decreases much slower (Fig. 3D) than observed for this protein in 100 mM KPPi (Fig. 3C). This change in FMN binding rate allows us to track the unfolding of MGoff.Previously, it was shown that the rate constants for FMN binding to native apo-
flavodoxin and FMN release from flavodoxin (i.e., kon and koff, respectively) are affect-ed by ionic strength (63,64). We checked whether this phenomenon occurs in the rather narrow KPPi concentration range of 10 to 100 mM. A superposition of the 
FMN binding traces obtained for native C69A apoflavodoxin at 100 and 10 mM KPPi, respectively, shows no ionic strength dependence (Fig. 4A). Fitting of these FMN 
binding curves with equations 1 to 4 resulted in koff and kon values of 9.6510-5 s-1 and 
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Figure 3 Quenching of FMN fluorescence upon binding of the cofactor to C69A and F44Y apo-
flavodoxin in 100 or 10 mM KPPi, respectively. Shown are the normalized FMN fluorescence 
(grey), the fits of the data (black) and the corresponding residuals. Table 1 and 2 list the pa-
rameters of the fits. A, C69A apoflavodoxin in 100 mM KPPi. B, C69A apoflavodoxin in 10 mM KPPi. Protein and FMN concentrations are 140 and 25 nM, respectively. C, F44Y apoflavodoxin in 100 mM KPPi. D, F44Y apoflavodoxin in 10 mM KPPi. Protein and FMN concentrations are 
71 and 25 nM, respectively. (A-C) are analysed with differential equations 1 to 4. (D) is ana-
lysed with differential equations 2 to 6. The pH is 6.0 and temperature is 25 °C.
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Table 1 Parameters that describe the binding of FMN to C69A and F44Y apoflavodoxin.
For explanation of parameters see main text. C69A apoflavodoxin is in 100 mM KPPi and is native.a Values at t = 0 s.b Initial fluorescence of normalized FMN binding trace
* Parameter fixed# Parameters for traces of F44Y apoflavodoxin containing predominantly native protein (i.e., 
the protein is in 100, 90 or 80 mM KPPi), as analysed with equations 1 to 4$ Parameters for traces of F44Y apoflavodoxin containing predominantly MG (i.e., the protein 
is in 10 to 70 mM KPPi), as analysed with equations 2 to 6.
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Figure 4 Dependence of the rate of FMN binding to C69A 
and F44Y apoflavodoxin on KPPi concentration. Shown are 
normalized FMN fluorescence 
traces acquired at various salt concentrations. A, superposi-tion of FMN binding curves of 
C69A apoflavodoxin in 100 and 10 mM KPPi, respectively. B, superposition of FMN binding 
curves of F44Y apoflavodoxin at various KPPi concentrations. 
Concentrations of C69A apofla-
vodoxin, F44Y apoflavodoxin and FMN are 140, 71 and 25 nM, respectively.
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3.45105 M-1s-1, respectively (Table 1). We fixed these rates during further analysis of FMN binding data. Tables 1 and 2 summarize the parameters that describe the 
binding of FMN to C69A and F44Y apoflavodoxin at various KPPi concentrations. 
Whereas FMN binding to native apoflavodoxin is independent of KPPi concentra-tion in the range we use, Fig. 4B shows that the rate of FMN binding to F44Y apopro-tein changes most noticeably upon lowering KPPi concentration from 50 to 10 mM KPPi. The FMN binding rate thus depends on the ratio of the initial concentrations of MG and native protein in the sample. This ratio relates to the rates for folding (i.e. ) and unfolding (i.e. ) of the off-pathway MG. These latter rates must therefore 
depend on ionic strength and can be derived using equations 2 to 6. To be able to fit 
the FMN binding data of F44Y apoflavodoxin at low KPPi concentration with these 
equations, one needs to know the ratio of MG to native protein. To obtain this ratio, 
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we use the average fluorescence lifetime as derived from time-resolved tryptophan 
fluorescence anisotropy, as presented in the next sections.
Time-resolved tryptophan fluorescence anisotropy. This methodology can be used to establish relative distances and orientations between pairs of tryptophans. 
It measures depolarization of fluorescence emission of tryptophans, which is caused by molecular rotation due to Brownian motion and/or by energy transfer to a mol-
ecule/residue with a different orientation (see Eq. 10). The time-resolved fluores-
cence anisotropy decays of native and molten globular apoflavodoxin are shown in 
Fig. 5. The traces of C69A apoflavodoxin in 10 and 100 mM KPPi and of F44Y apofla-vodoxin in 100 mM KPPi are similar (Fig. 5A-C), as at these salt concentrations the 
samples contain natively folded apoprotein (37,39). In contrast, F44Y apoflavodoxin 
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Figure 5 Time-resolved tryptophan fluorescence anisotropy (grey) and associated fits (black) 
for C69A and F44Y apoflavodoxin in 100 or 10 mM KPPi, respectively. Decays are fitted to 
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. The data of C69A apoflavodoxin in 
100 and 10 mM KPPi are globally fitted, with linked parameters for ϕT1, ϕT2 and ϕr, and fixed 
ϕT1. A, C69A apoflavodoxin in 100 mM KPPi with ϕT1= 0.04 ns (fixed) (βT1= 0.09), ϕT2= 2.89 
ns (βT2= 0.07) and ϕr= 12.02 ns (βr= 0.04), χ2 = 1.34. B, C69A apoflavodoxin in 10 mM KPPi 
with ϕT1= 0.04 ns (fixed) (βT1= 0.08), ϕT2= 2.89 ns (βT2= 0.07) and ϕr= 12.02 ns (βr= 0.04), χ2 
= 1.34. The data of F44Y apoflavodoxin in 100 and 10 mM KPPi are globally fitted, with linked 
parameters for ϕT2 and ϕr, and fixed ϕT1 for F44Y apoflavodoxin in 100 mM KPPi. C, F44Y 
apoflavodoxin in 100 mM KPPi with ϕT1= 0.07 ns (fixed) (βT1= 0.05), ϕT2 = 2.61 ns (βT2= 0.07) 
and ϕr= 12.65 ns (βr= 0.06), χ2 = 1.30. D, F44Y apoflavodoxin in 10 mM KPPi with ϕT1= 0.84 
ns, (βT1= 0.04), ϕT2= 2.61 ns (βT2= 0.04) and ϕr= 12.65 ns (βr= 0.13), χ2 = 1.30.
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molecules are predominantly MG. Examples of the analysis of fluorescence and an-
isotropy decays are shown in Fig. S1 and S2. In addition, we verified that the steady-
state anisotropies derived from time-resolved fluorescence anisotropy data overlap with previously published ones (Fig. S3) (39).
In native protein, the three tryptophans of apoflavodoxin (i.e., W74, W128 and W167) are positioned and oriented in such a manner that they yield a surprisingly low steady-state anisotropy of 0.04 (32), instead of a commonly expected value of 0.1 to 0.2 (37). This low value is due to Förster resonance energy transfer (FRET) 
between tryptophans. In native apoflavodoxin two major energy transfers can be de-tected, i.e., from W167 to W128 and from W74 to W167, with W128 acting as a sink for FRET (37). As a result of the sink, uni-directional FRET with a 0.04 ns transfer 
correlation time ϕT1 occurs from W167 to W128 (Fig. 5A,B).
Upon going from native F44Y apoflavodoxin to off-pathway MG, the steady-state 
fluorescence anisotropy increases from 0.04 to 0.08 (39). This increase is due to two phenomena. Firstly, a change in solvent accessibility of tryptophans shortens the av-
erage fluorescence lifetime thereby increasing steady-state fluorescence anisotropy 
(Eq. 15). Secondly, the fast rotation correlation time  increases by a factor of about ten (i.e., from 0.07 to 0.84 ns, Fig. 5C,D), which is caused by a change in the position-ing and/or orientation of the W167/W128 FRET pair, which decreases FRET and 
increases fluorescence anisotropy (eq. 10).
Average fluorescence lifetime reveals the fraction of natively folded F44Y 
apoflavodoxin. To determine the fraction of natively folded F44Y apoflavodoxin at various KPPi concentrations, and thereby establish the ratio of MG to native protein, 
we use the change in average fluorescence lifetime upon formation of molten glob-
ular apoflavodoxin molecules. This lifetime can be derived from the time-resolved 
fluorescence anisotropy data by using the following equation:
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  Eq. 16
in which τi are the fluorescence lifetimes and αi are the corresponding ampli-
tudes (Eq. 8), with the sum of α’s equaling one. The average fluorescence lifetime 
decreases as the MG state becomes populated, because in the MG of apoflavodoxin 
the tryptophans are solvent exposed, causing quenching of tryptophan fluorescence.
o correlate the average fluorescence lifetime with the relative fraction of native 
apoflavodoxin molecules, one requires  values for the presence of 100 and 0 % native 
apoprotein, respectively. The  for C69A apoflavodoxin (i.e., 4.13 ± 0.01 ns) is used as 
reference for the presence of 100 % native apoflavodoxin molecules. To obtain the 
reference value for the presence of 0 % native apoflavodoxin molecules (i.e., 100 % 
MG) we extrapolated the average fluorescence lifetime of F44Y apoflavodoxin as a 
function of KPPi concentration to 0 mM KPPi (i.e., 3.02 ± 0.04 ns). For extrapolation 
we used a sigmoidal fit, because the equilibrium (un)folding of the off-pathway MG 
of apoflavodoxin has a sigmoidal transition (43).
Table 3 and Fig. 6 (red squares) showv the calculated fraction of natively fold-
ed F44Y apoflavodoxin molecules as a function of KPPi concentration. For protein in 100 mM KPPi the fraction of natively folded molecules is calculated to be about 
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Chapter 261 %, whereas at 10 mM KPPi this fraction decreases to approximately 5 %. These numbers are consistent with previous estimations of about 88 and 2 % of native 
F44Y apoflavodoxin in 100 and 10 mM KPPi, respectively (39).
A folding intermediate concurrent with the off-pathway MG exists at physi-
ological ionic strength. FMN only binds to native apoflavodoxin and under the con-ditions used this binding happens much faster than the time it takes to unfold the 
off-pathway MG. Using the ratio of MG to native apoflavodoxin derived from the av-
erage fluorescence lifetime (Table 3; Fig. 6), we fitted the FMN binding curves of 
F44Y apoflavodoxin in 10 to 70 mM KPPi (Fig. 4) to equations 2 to 6. Fixing the ratio 
between MG and native apo in these equations allows one to determine 
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and 
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, i.e., the rates for folding and unfolding of the MG, respectively. Initial guesses for these rates were obtained from a COPASI 4.16 (build 104) model, based 
on equations 2 to 6 and values for koff and kon of 9.6510-5 s-1 and 3.45105 M-1s-1, re-spectively (Table 1). As stated, we derived that the fraction of native apoprotein mol-
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* Extrapolated value from a sigmoidal fit of the dependence of <τ> values of F44Y apoflavo-doxin on KPPi concentration.
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Figure 6 Comparison of the percentage of F44Y apoprotein molecules that bind FMN swiftly 
with the fraction of natively folded apoflavodoxin molecules. The average fluorescence life-
time has been used to derive the fraction natively folded apoflavodoxin molecules (red), see main text. The corresponding fraction molten globular apoprotein is shown in purple. The 
percentage of molecules that bind FMN rapidly (blue) is derived from fitting equations 1 to 6 to FMN binding traces (i.e., based on the determination of the ratio between MG and native 
apoflavodoxin). The corresponding percentage of molecules that bind FMN slowly (i.e., relat-
ed to the presence of the off-pathway MG of apoflavodoxin) is shown in green. To calculate the percentage of apoprotein molecules that rapidly bind FMN the average of two independent data sets is used, and error bars show the standard deviations.
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ecules in case of F44Y apoflavodoxin in 10 mM KPPi is approximately 5 %. When 
constraining the fit of the corresponding FMN binding curve to a ration of native 
apoflavodoxin to MG of 0.047 ratio, no adequate fit of the data could be obtained (Fig. 7A). Fitting of this FMN binding curve with no constraints to the fraction of 
native apoflavodoxin shows that approximately 20 % of protein molecules bind FMN rapidly (Fig. 7B). For KPPi concentrations between 10 and 70 mM, the percentage of molecules that binds FMN swiftly is consistently higher than anticipated from the amount of 
native apoflavodoxin molecules derived from the average fluorescence lifetime (Fig. 
6; compare blue and red squares respectively). For KPPi concentrations of 80 mM 
and above, it is not possible to fit the FMN binding data taking an off-pathway MG 
fraction into account, and hence these data sets are fitted considering only native 
apoflavodoxin (equations 1 to 4). The FMN binding data show that the fraction of molecules that binds FMN swiftly is on average 30 % higher than anticipated from 
the amount of native apoflavodoxin molecules derived from the  values (Fig. 6).
To explain the discrepancy, we propose that besides MGoff another folding inter-
mediate of F44Y apoflavodoxin co-exists at equilibrium. The latter intermediate is 
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Figure 7 The FMN binding trace of F44Y apoflavodoxin in 10 mM KPPi cannot be properly 
fitted upon taking into account the percentage of native apoflavodoxin molecules as derived 
from tryptophan fluorescence anisotropy. Depicted are normalized FMN fluorescence (grey), 
fits of the data (black) and corresponding residuals. Shown is the FMN binding curve of 25 nM 
FMN that is added to 71 nM F44Y apoflavodoxin in 10 mM KPPi. A, data fitted with a ratio of 
native apoflavodoxin to MG of 0.047, which corresponds to 5 % natively folded protein. B, data 
fitted with a ratio of native apoflavodoxin to MG of 0.306, which corresponds to 20 % natively 
folded protein. All other fitting parameters are fixed (see Table 1 and 2).
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present at KPPi concentrations ranging from 10 to 100 mM, which is equivalent to 75 to 345 mM NaCl (i.e., similar to physiological ionic strengths). This intermedi-
ate interconverts rapidly with native apoflavodoxin, as opposed to the non-native, misfolded off-pathway MG. This newly discovered intermediate is most probably 
on-pathway during productive folding of apoflavodoxin.
DISCUSSION
The discovered on-pathway intermediate of apoflavodoxin is molten glob-
ular. Virtually all F44Y apoflavodoxin molecules in 10 mM KPPi are molten globular 
as Fig. 6 (purple squares) implies. About 20 % of the molecules is on-pathway inter-
mediate (blue squares) and the remaining 80 % of protein molecules form the well-
known off-pathway MG of apoflavodoxin (green squares). The structural features of 
F44Y apoflavodoxin under these conditions have been probed by thermal denatur-
ation, tryptophan fluorescence, far-UV circular dichroism and steady-state trypto-
phan fluorescence anisotropy (39) and hydrogen/deuterium exchange (41). These 
techniques show that the protein is flexible with solvent-exposed tryptophans, and is molten globular, which thus also applies for the on-pathway intermediate discov-ered here. The aforementioned methodologies are unsuitable to further structurally characterize the on-pathway MG (MGon), because these techniques cannot distin-guish the structural features of two simultaneously occurring MGs. As MGon rapidly 
interconverts with native apoflavodoxin, it most likely has structural features of na-
tive apoprotein and possibly possesses its anti-parallel β-sheet.
Hence, to accurately fit the FMN binding data we would need to introduce addi-
tional terms in the differential equations used to describe the folding behaviour of MGon. Furthermore, it is unknown whether MGon is on route between MGoff and native 
apoflavodoxin, as shown in Scheme 6:
MG
off
MG
on
N
(Apo)
N
(Holo)
FMN
FMN   Scheme 6or whether these three folding species are interconnected like in Scheme 7:
MG
on
MG
off
N
(Apo)
N
(Holo)
FMN
FMN    Scheme 7
The first scenario would require taking into account two additional rate con-
stants, whereas the second scenario would require four extra ones. As these rate 
constants are unknown, it would be impossible to verify their accuracy when fitted.
MG on-pathway to native apoflavodoxin. During folding of apoflavodoxin ap-
proximately 90 % of molecules first form MGoff, which subsequently unfolds and 
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folding apoflavodoxin molecules directly follow the productive folding route (Fig. 2) (32). Using single-molecule FRET we demonstrated that all folding molecules 
convert into MG protein before native apoflavodoxin is formed (43). Our current 
findings show that molten globular apoflavodoxin contains a minor fraction of mol-
ecules that interconvert rapidly to native apoflavodoxin. This fraction is comparable to the 10 % of molecules in kinetic refolding experiments that directly follow the productive folding route. Therefore, we hypothesize that these molecules are the on-pathway MG discovered in this study.
Observations of distinct MGs at equilibrium under physiological condi-
tions. Investigation of MGs is important to improve our understanding of protein folding and aggregation and hence considerable effort has been put into the study of MGs of various proteins. A handful of these studies demonstrated existence of distinct MGs under (semi-)physiological conditions.
In case of α-lactalbumins, MGs can be formed either by acid denaturation or by removal of Ca2+ ions. Each method results in MGs that share many secondary struc-ture elements, yet they do exhibit differences in their respective overall structure. These MG species seem to have native-like topology (15,16). Other proteins that form multiple MGs are cytochrome c and apomyoglobin. Interestingly, each of these 
proteins forms two distinct MGs at equilibrium in acidic conditions, with the ratio between both MGs dictated by salt concentration. For cytochrome c the two MGs 
form at pH 2 and have a highly native α-helical content (11,13). Apomyoglobin forms 
two MGs at pH 4. These MGs have near-native α-helical content (12,14). The MGs of 
all aforementioned proteins are on-pathway and are situated sequentially on one route towards native protein. Barstar however, forms two on-pathway MGs that are not on the same folding pathway to native protein (65). To our knowledge, the study 
we present here is the first description of the existence of distinct, simultaneously present MGs that reside on folding routes of decidedly different nature (i.e., on- and off-pathway).
Formation of MGs in a cellular context. Several chaperones, such as α-crys-
tallin and GroEL, have been shown to interact with MGs. α-Crystallin distinguishes 
between MG states of α-lactalbumin, and preferentially interacts with MGs on route to aggregation and precipitation (66). GroEL, sometimes in combination with GroES, recognizes MGs and may stimulate their productive folding, though the exact mecha-nisms by which it does this are still not completely understood (67-69). In addition, the ribosome seems to have a protein folding activity through Domain V rRNA (70). This folding activity has been shown to promote productive folding from denatured 
and MG states (71-73). As both MGs of F44Y apoflavodoxin arise under physiological conditions, these MGs are promising candidates for the investigation of how a cell deals with their potential intracellular formation. 
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Figure S1. Total fluorescence decay (grey) and associated fit (black) obtained for 2 
μM F44Y apoflavodoxin in 100 mM KPPi, pH 6.0, 25 °C. The excitation wavelength 
is 300 nm and the emission is measured at 348.8 nm. To achieve an optimal fit to 
the experimental data a sum of three exponential terms (N=3) is required. The op-timized lifetimes and relative amplitudes (percentage in parentheses) obtained are: 
τ1 = 0.114 ns (5 %), τ2 = 1.496 ns (21 %) and τ3 = 4.545 ns (74 %), the goodness-of-fit 
parameter χ2 = 1. The average fluorescence lifetime is determined to be 3.69 ns. To 
illustrate the quality of the fit the weighted residuals and autocorrelation function of the residuals are shown as well.
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Figure S2. Fluorescence anisotropy decay (grey) and associated fit (black) obtained 
for 2 μM F44Y apoflavodoxin in 100 mM KPPi, pH 6.0, 25 °C. The excitation wave-length is 300 nm and the emission is measured at 348.8 nm. The optimized param-
eters are:  0.07 ns (fixed) (0.05),  2.61 ns  (0.07) and  12.65 ns  (0.06), the goodness-
of-fit parameter χ2 = 1.30. To illustrate the quality of the fit the weighted residuals and autocorrelation function of the residuals are shown as well.
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Figure S3. Steady-state tryptophan fluorescence anisotropy (R) shows that when 
KPPi concentration is decreased, F44Y apoflavodoxin forms a MG. Comparison be-
tween steady-state fluorescence anisotropy as measured by Nabuurs et al. on a Flu-
orolog 3.2.2 fluorometer (blue circles (39)) and values derived in this study from time-resolved anisotropy measurements using a time-correlated single photon counting device (green diamonds). As the anisotropies are recorded on set-ups with differences in excitation/emission wavelengths, the absolute anisotropy values dif-fer. Upon correcting time-resolved data for this difference in offset (red triangles), both data sets overlap.
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Figure S4. Tryptophan fluorescence emission of F44Y apoflavodoxin decreases with 
decreasing salt concentration, whereas it remains the same for C69A apoflavodoxin. The emission spectra obtained at 100 mM KPPi (blue) and 10 mM KPPi (red) are normalized to the emission obtained at 100 mM KPPi. A, the emission spectrum of 
C69A apoflavodoxin at 10 mM KPPi is identical to the corresponding spectrum at 100 mM KPPi. The tryptophans remain in a similar micro-environment and are not solvent exposed. B, A similar decrease in salt concentration in case of F44Y apofla-
vodoxin leads to a reduction in fluorescence emission. This observation is due to formation of MGs at low salt concentration. The tryptophans in these species are 
exposed to the solvent and have increased flexibility as compared to native apofla-
vodoxin. Concentrations of C69A and F44Y apoflavodoxin are 11.2 μM and 5.7 μM, respectively. Spectra are recorded at 25 °C. 
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Stalled flavodoxin binds its cofactor while fully exposed outside the ribosome
Correct folding of proteins is crucial for cellular homeostasis. More than thirty per-cent of proteins contain one or more cofactors, but the impact of these cofactors on cotranslational folding remains largely unknown. Here, we address the binding 
of flavin mononucleotide (FMN) to nascent flavodoxin, by generating ribosome-ar-rested nascent chains that expose either the entire protein or C-terminally truncat-
ed segments thereof. The native α/β parallel fold of flavodoxin is among the most ancestral and widely distributed folds in nature and exploring its cotranslational folding is thus highly relevant. In Escherichia coli (strain BL21(DE3) Δtig::kan) FMN 
turns out to be limiting for saturation of this flavoprotein on time-scales vastly ex-
ceeding those of flavodoxin synthesis. Because the ribosome affects protein folding, 
apoflavodoxin cannot bind FMN during its translation. As a result, binding of cofac-
tor to released protein is the last step in production of this flavoprotein in the cell. 
We show that once apoflavodoxin is entirely synthesized and exposed outside the 
ribosome to which it is stalled by an artificial linker containing the SecM sequence, the protein is natively folded and capable of binding FMN. 
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INTRODUCTIONProteins belong to the most important elements of a living cell. For example, they confer stability in the form of the cytoskeleton, act as biological catalysts and trans-porters, provide immune protection, and are essential in cellular homeostasis (1). An important aspect of homeostasis is proteostasis, which not only encompasses the amount and distribution of proteins, but their correct folding as well (2). Protein folding has been extensively studied in vitro and for some proteins folding energy landscapes have been derived. Nowadays, focus has shifted to understanding how proteins fold in vivo, which includes folding while a protein is synthesized by the ribosome. Whereas ribosomal structures have been elucidated in atomic detail (see e.g. (3-5)), relatively little is known about the conformational events polypeptide chains undergo while they are produced.Several differences between in vitro and in vivo conditions may affect protein folding, such as the dissimilarity between the dilute environment of the test tube and the highly crowded condition in cells (6). In addition, a large fraction of cellu-lar proteins comprise chaperones, which prevent aggregation of newly synthesized proteins (1). Moreover, the vectorial nature of polypeptide synthesis by the ribo-some can open up entirely new folding pathways.Folding can already begin cotranslationally, with only part of the polypeptide 
chain synthesized, and has been investigated for protein folds like all α (7-9), all β 
(10-13) and α/β (14-17). Some proteins seem to fold only when they are entirely ex-posed outside the ribosome (12) or when they are released (18). During synthesis, other proteins can form folding intermediates (8,9,11,13,17,19), and protein sub-
domains may properly fold while the remainder of the nascent sequence does not (14,16). In addition, the ribosome itself can in principle also modulate nascent chain folding (20).Few nascent proteins investigated contain a cofactor in their native state. This under-representation is undesirable, considering that at least thirty percent of pro-teins have such a moiety (21). Cofactors range from metal ions to complexes like 
hemes, and organic moieties such as flavins. Heme has been suggested to bind to nascent globin (7), which may imply that the protein folds cotranslationally. Fla-vin adenine dinucleotide (FAD) was proposed to covalently attach to nascent 6-hy-
droxy-D-nicotine oxidase (22), but its cotranslational flavinylation is now judged unlikely (23).
Most cofactors bind non-covalently, and in case of flavoproteins ninety percent 
bind flavin in this way (24). Flavoproteins make up to three and a half percent of 
genes in certain genomes and fulfil many important roles (24). To reveal whether 
flavin can bind to nascent apo-protein, in this study we utilize a 179-residue flavo-doxin from Azotobacter vinelandii. Flavodoxin is involved in electron transport in the nitrate reduction cycle. For this purpose it uses a non-covalently, but tightly bound 
flavin mononucleotide (FMN) (25). The protein consists of five α-helices sandwich-
ing a central parallel β-sheet, which is an α/β parallel topology (26). Approximately 
twenty-five percent of proteins share this topology, according to SCOP classification in the Protein Data Bank (PDB). The flavodoxin-like fold is among the most ancestral 
folds (27) and is considered to be an archetype for the entire class of αβα sandwich-
es. Though flavodoxin is absent from plants and animals (28), it is found in most algal 
lineages (29) and the flavodoxin-like fold is part of many multi-domain eukaryotic 
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In vitro folding of full-length, isolated flavodoxin involves two intermediates: an 
on-pathway one, which is quickly converted into natively folded apo-protein, and a molten globule species (32-35). This species is off the productive folding pathway and needs to unfold to embark on a route to native protein (36). The molten globule consists of a loosely packed core and solvent exposed hydrophobic side chains (37-
39). For many proteins with an α/β-parallel topology, formation of an off-pathway 
intermediate seems to be a characteristic feature (40). FMN binds to the flavin-bind-
ing site of native apoflavodoxin. Besides affecting this pocket, cofactor incorporation 
also influences thermodynamic stabilities of residues faraway from the binding site (25).
Here, we report properties of nascent flavodoxin. We prepare ribosome-nascent chain complexes (RNCs) that expose either the entire protein or C-terminally trun-
cated segments of flavodoxin outside the exit tunnel. Use is made of constructs for 
flavodoxin that lack zero, five or ten amino acid residues at the C-terminus of the stalled polypeptide. This procedure allows the mimicking of late periods during protein translation and enables the elucidation of the stage at which nascent apo-
flavodoxin is capable of binding FMN. Translational stalling is made possible by at-
taching a sequence derived from E. coli SecM to the C-terminus of a nascent protein (41,42). The RNCs are isolated from E. coli strain BL21(DE3) Δtig::kan, which lacks chaperone Trigger factor. We address FMN binding to nascent flavodoxin by titrating RNCs with FMN or by treating them with trichloroacetic acid (TCA). It turns out that 
because the ribosome influences protein folding, FMN cannot bind to apoflavodoxin during translation.
MATERIALS AND METHODS
Engineering RNCs. The construct for arrested, nascent protein, containing a tri-ple N-terminal StrepII-tag linked to a Smt3 domain, a multiple cloning site (MCS), a TEV-site, a linker and a SecM stalling motif (Fig. 1A), was a kind gift of Professor 
Elke Deuerling (University of Konstanz, Germany) (12). Ulp1 protease specifically recognises Smt3 and cleaves the polypeptide down-stream of Smt3, thereby produc-
ing nascent flavodoxin chains with Ala-1 as authentic N-terminus, if required. The recognition site for TEV protease enables future release on demand of nascent poly-
peptide. After the gene for flavodoxin was cloned into the MCS, two deletion vari-ants of nascent protein were produced by using the method described in (43). These 
variants are shortened at the C-terminus by five or ten amino acids, respectively. To 
avoid covalent protein dimerization, the single cysteine at position 69 of flavodoxin was replaced by an alanine in all constructs (44). Plasmids were transformed in E. 
coli strain BL21(DE3) Δtig::kan for expression of RNCs.
Expression and purification of RNCs. Based on the protocol described in (12), 
we developed the following procedure. Cells were grown O/N in 50 ml Terrific Broth 
(TB) with 100 μg/ml ampicillin at 37 °C while shaking at 140 rpm. Cells were then pelleted at 5,000 g for 10 min at 4 °C, re-suspended in 3 l of fresh TB containing 100 
μg/ml ampicillin and grown until an OD600 of 0.8. For full-length construct, cells were pelleted at 11,000 g for 15 min at 4 °C. The pellet was re-suspended in 1 l of minimal 
(M9) medium with 100 μg/ml ampicillin and shaken for 1 h at 37 °C at 140 rpm. Induction by 1 mM IPTG lasted 2.5 hours. After reaching an OD600 of 0.8, shortened 
constructs were induced by 1 mM IPTG for 1h in TB. Cells were subsequently pel-
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leted at 11,000 g for 15 min at 4 °C and frozen in liquid nitrogen.Frozen cells were thawed and re-suspended in buffer I (50 mM HEPES-KOH, 100 mM potassium acetate, 15 mM magnesium acetate, 1 mM dithiothreitol (DTT), pH 7.4) with added protease inhibitor cocktail (Roche) and lysed by French Press. After 
centrifugation at 40,000 g for 30 min at 4 °C, supernatant was filtered using a 0.22 
μm filter (EMD Millipore) and loaded onto a Strep-Tactin sepharose (IBA GmbH) 
column, pre-equilibrated with buffer I. RNCs and released protein were eluted with buffer I containing 2.5 mM desthiobiotin (IBA GmbH). Eluate was concentrated with 
a 10-kDa spin filter (EMD Millipore) at 5,500 g and loaded onto a Superdex75 col-umn to separate RNCs from released constructs. Both fractions were concentrated, 
frozen in liquid nitrogen and stored at -80 °C.
Samples of each purification step were analysed by Coomassie-stained SDS-PAGE 
or Western blotting using either flavodoxin antibody raised in rabbits (Eurogen-tec) followed by anti-rabbit HRP-IG (Eurogentec) or StrepMAB classic (IBA GmbH) against the N-terminal StrepII-tag.To determine whether binding of FMN releases nascent chains and thus results 
in a different Superdex75 profile, the above purification protocol was used with one 
modification. The filtered cell extract was split in two and 50 μM FMN (Sigma) was added to one half. Both samples were incubated on ice for 1 hour.
FMN titration and TCA precipitation. To determine the extent of FMN occupa-
tion of RNCs and released constructs, samples were made after Superdex75 purifica-
tion that contain 0.5 to 1 μM of RNC or 2 to 3 μM of released protein in buffer I. Sam-ples were then split in two, of which one half was titrated with FMN to determine its 
FMN-binding capacity using flavin fluorescence. The other half was precipitated by adding 3 % (w/v) TCA to establish the total amount of FMN bound to protein. Pre-
cipitate was spun down for 10 min at 4 °C at 21,000 g and flavin fluorescence of the 
supernatant was subsequently measured. A 3 μM solution of FMN in 3 % (w/v) TCA in buffer I was used as reference.
Flavin fluorescence was measured on a Cary Eclipse spectrophotometer (Vari-an). Excitation was at 450 nm, with emission recorded between 460 and 625 nm. Each sample was scanned 5 times and the average was used for calculations. Exci-tation and emission slits were set to a bandwidth of 5 nm. For RNCs the PMT voltage was 900 V, whereas released protein was measured at 800 V.
Preparations of (truncated) apoflavodoxin variants. For production of apo-proteins, the constructs were loaded onto a Superdex75 column containing 6 M guanidine hydrochloride (GuHCl; Fluka) in its upper 20 % volume. As a result, 
holo-protein unfolds and releases FMN. Upon elution with buffer, apoflavodoxin and 
FMN separate. Due to migration into buffer without denaturant, apoflavodoxin au-tonomously folds to native protein on-column, as its unfolding is reversible (45). 
RESULTS
Production and purification of RNCs. To assess cofactor binding during 
translation, we generated stalled nascent chains of flavodoxin. The corresponding 
constructs (Fig. 1A) enable the tracking of nascent flavodoxin folding outside the 
ribosome at sequential stages of elongation. Nascent protein lacking none, five or 
ten C-terminal amino acids of flavodoxin, termed FL, -5 and -10 respectively, was 
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Figure 1 Schematic representation of the construct for production of arrested, nascent fla-
vodoxin and assessment of full-length and truncated RNCs of flavodoxin. A, The gene for pro-duction of RNCs consists of a triple N-terminal StrepII-tag (orange), an Smt3 domain (green) 
fused to flavodoxin (yellow), a recognition site for TEV protease (blue) and a flexible hinge 
(i.e., GSGASGGAS) connected to a linker, which contains the SecM stalling sequence (magenta) and spans the ribosomal exit tunnel. Through deletion of 5 or 10 residues at the C-terminus 
of flavodoxin, respectively, 2 constructs are obtained that produce stalled nascent proteins of 
specified length. B, Cartoon model of native flavodoxin (PDB ID 1YOB (26)) with FMN colour-
ed yellow. Flavodoxin’s C-terminal 10 residues are highlighted in red. C, After induction in 
E. coli in M9 minimal medium, cell lysis, and elution from a Strep-Tactin column, samples 
were loaded onto a Superdex75 column. The Superdex75 elution profile of FLRNC and FLP, shows absorbance at 260 (red line) and 280 nm (blue line). RNCs elute in the void volume, whereas released protein is retarded, thus achieving separation of both species. D, Coomassie stained SDS-PAGE. Lanes marked “Strep” show the mixture of RNCs and released proteins eluted from a Strep-Tactin sepharose column. Lanes marked “RNC” display nascent protein eluted from a Superdex75 column and illustrate the pattern typical for ribosomal proteins. Lanes marked “free” show released protein (FL) and Smt3-domain with StrepII-tag attached (Smt3). This domain is a degradation product of released protein. In (D) and (E), the position of nascent chain attached to tRNA is labelled (*) and the position of nascent chain without tRNA is marked (**). The position of StrepII-tag attached to Smt3-domain is labelled (***). E, 
Western blots of RNCs and released proteins, with antibodies against flavodoxin (α-FLD) or 
the N-terminal StrepII-tag (α-strep). The 60-kDa band observed in the RNC samples blotted 
with α-FLD is due to ribosomal protein that reacts with α-FLD.
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Stalled flavodoxin binds its cofactor while fully exposed outside the ribosome
produced. The removed residues are part of the C-terminal α-helix of flavodoxin, 
which packs onto the central β-sheet of native protein (Fig. 1B). Expression of these constructs in E. coli and subsequent purification (see Materials and Methods) suc-ceeded.
The SecM sequence allows for relatively tight stalling of nascent chains (41). However, some release of SecM-stalled nascent chains has been documented both 
during production (17,46) and from purified RNCs (12,47). The mechanism that overcomes stalling in a cell is not yet known. It has been suggested that physical 
force plays a role (41,48,49). We observe for all flavodoxin constructs that release of stalled nascent protein happens during production in E. coli. As a result, Strep-Tac-tin column eluates contain RNCs (i.e., FLRNC, -5RNC, -10RNC, respectively) and released protein (i.e., FLP, -5P, -10P, respectively). To separate RNCs from released protein, we employ size-exclusion chromatography (Fig. 1C). The absorbance ratio A260/A280 en-
ables distinction between RNCs and released flavodoxin, as this ratio is ~2 for RNCs, while A260/A280 is <1 for released protein. Fig. 1D shows assessment of the obtained fractions after Strep-Tactin and Superdex75 column chromatography by Coomassie stained SDS-PAGE. The lanes marked “Strep” display ribosomal protein bands aris-ing from RNCs and surplus released protein, i.e., FLP, -5P or a 18-kDa band containing the StrepII-tag attached to Smt3, labelled (***). This 18-kDa band is an in vivo deg-
radation product of released protein, and its identity is confirmed by blots probed 
with antibodies against the StrepII-tag (Fig. 1E). As the quantity of released protein is many times more than the number of ribosomes in a cell, release of nascent chains 
likely occurs during their production and not during their purification. Co-elution of released nascent chains with RNCs was excluded (see Fig. S1 and S2). The lanes marked “RNC” show the typical pattern for ribosomal proteins and the presence of 
nascent protein, some of which is attached to tRNA. Fig. 1D confirms successful sep-aration of RNCs from released protein for all three constructs. Fig. 1E displays West-
ern blot bands detected with antibodies against StrepII-tag or flavodoxin. The lanes 
marked “α-FLD” show the presence of flavodoxin in the fractions containing RNCs or released proteins. As mentioned, some nascent chains are coupled to tRNA, which results in observation of two bands approximately 15 kDa apart in the lanes con-
taining RNCs. Because a polyclonal antibody is used to detect flavodoxin, we observe 
differences in affinity for the constructs used. Highest affinity is observed for FL, 
and affinity decreases in the order of -5 to -10. The lanes marked “α-Strep” display a similar pattern for RNCs, showing nascent chain with or without tRNA.
Intracellular release of stalled nascent protein depends on growth condi-
tion and chain length. Production of protein in E. coli at 37 °C in nutrient rich (i.e., TB) or in minimal medium (i.e., M9) leads to similar amounts of FLRNC. However, release of stalled nascent chains is much lower for cells grown in minimal medium (Fig. 2A and B). A similar decrease in release of stalled nascent chains is observed when RNC production in E. coli takes place in nutrient rich medium at 20 °C (Fig. 2C and D). These observations suggest that the more favourable the growth condi-tions are for E. coli, the less effective SecM stalling becomes. To compensate for low-er synthesis rates during less favourable growth conditions, induction times were increased from 1 hour (for TB at 37 °C) to 2.5 hours (for M9 at 37 °C or TB at 20 °C). 
Another factor that influences the efficiency of ribosomal stalling could be the length of the nascent chain. Fig. 3A shows observations for FL construct. It is esti-mated that about 350 times more FLP than FLRNC is present, based on absorbance at 
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Chapter 3280 and 260 nm, respectively. Absorbance at 450 nm reveals that part of FLP con-tains FMN. In case of -5 construct we observe less released nascent chains as com-pared to released FL construct (Fig. 3B). The ratio of -5P to -5RNC is about 90. In case of -10 construct, we detect no released protein (i.e., -10P) (Fig. 3C). The -5 and -10 
purifications all show separate elution of StrepII-tag attached to Smt3 domain, as 
verified by Western blotting with antibodies against StrepII-tag. Thus, both nascent chains are rather unstable, because intracellular proteases can cleave off the tagged N-terminal parts of these constructs. This degradation might happen while the pro-tein chain is attached to the ribosome and/or after its release. As we obtain similar amounts of FLRNC, -5RNC and -10RNC, which must have a StrepII-tag coupled to the na-
scent chain during the first step of purification, degradation likely happens mostly after release of the stalled nascent chain. However, as can be seen in Fig. 1D, the 
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Stalled flavodoxin binds its cofactor while fully exposed outside the ribosomeintensity of the nascent chain in the -10RNC lane (at approximately 40 kDa) is lower than the intensities corresponding to ribosomal proteins, indicating that some deg-
radation of -10 nascent chain happens during subsequent Superdex75 purification. 
After purification we observe no further degradation of nascent chains and released proteins during our experiments, which last only several hours at room tempera-ture. Clearly, the shorter the chain length of the C-terminus of nascent flavodoxin is, the more destabilized the protein becomes.
Released FLp and -5p contain FMN and are natively folded. Because we sep-arate RNCs from released protein, a comparison of their cofactor binding capacities 
can be made. First, we focus on released flavodoxin constructs. FLP and -5P both show absorbance at 450 nm (Fig. 3A and B), indicating that FMN is bound. Binding of FMN 
to native apoflavodoxin occurs primarily through a very specific combination and geometry of hydrogen bonds and aromatic interactions (25,50). Thus, FMN-contain-ing FLP and -5P must be natively folded.To assess remaining FMN binding capacity, we titrated released protein from 
several purification batches of E. coli with FMN (Fig. 4A). Due to quenching of the 
fluorescence of FMN upon binding to protein, the slope of fluorescence arising from bound FMN is less steep than the slope from free FMN. This characteristic demon-strates FMN binding. Both FLp and -5p were evaluated, whereas -10P was not, because of degradation by proteases in E. coli. In case of FLP, FMN binding varies strongly be-
tween batches. Quantification of the amount of bound FMN, derived by precipitating FLP with TCA and measuring fluorescence of released FMN, also shows considerable variation between batches. FMN content of FLP ranges between 40 to 100 % of pro-tein population. FMN synthesis is strictly regulated in E. coli and is only activated 
when needed. To make FMN, the enzyme riboflavin kinase converts riboflavin into FMN. Because most of the ribosomes in cells producing stalled nascent chains are 
occupied, we assume that they synthesize less riboflavin kinase and thus less FMN is made. Small variations during growth may lead to alterations in the amount of 
riboflavin kinase and thus FMN. As the amount of protein we produce is relatively small, in terms of percentage, variation between batches can be large. Apparently, a 
significant fraction of apo-FLP resists intracellular proteolysis. Of the -5P molecules 90 – 100 % contain FMN according to TCA precipitation. As a result, FMN titration of -5P shows no additional binding of flavin (Fig. 4A). 
The question arises why a higher proportion of -5P is observed to be in the holo form than is the case for FLP. We note that the apo form of -5P is more susceptible to degradation than apo-FLP, which is in agreement with our observation that site-di-
rected mutagenesis of apoflavodoxin decreases the stabilities of the corresponding 
native apo-proteins (38,45,51,52). In addition, flexibility of the flavin-binding site in 
flavodoxin is much lower than in apoflavodoxin and holo-protein is much more sta-
ble than apo-protein (25,53,54). As a result, contrary to apoflavodoxin, flavodoxin is hardly degraded by proteases, as trypsin digestion corroborates (Fig. 4C). For FLP it is possible to prepare apo-protein, using GuHCl unfolding of the construct and its 
subsequent refolding on a Superdex75 column (see Materials and Methods). Apo-FLP shows the same degradation pattern as apoflavodoxin (Fig. 4C). The apo form of -5P could not be generated due to aggregation of the sample during refolding, an indication of -5p’s instability. A -5P mimic was created by N-terminally moving the 
original stop codon of flavodoxin, generating a -5P without StrepII-tag, Smt3-domain 
and SecM sequence. Upon overexpression, this -5P mimic is sequestered into the in-
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soluble part of cell lysate or degraded by proteases (see Fig. S3), whereas flavodoxin is soluble and stable. This observation is another indication of the instability of -5P. During production of stalled nascent chains the accompanying apo -5P is degraded by proteases, whereas holo -5p is protected. Observation of the elution of the isolated StrepII-tag attached to Smt3 supports this scenario (Fig. 3B). As a result, in case of -5P 90 – 100 % of purified, released nascent chains contain FMN and are properly folded.
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In E. coli (strain BL21(DE3) Δtig::kan) nascent flavodoxin does not bind FMN. In contrast to FLP and -5P, FLRNC and -5RNC show no fluorescence of free FMN after TCA precipitation. As none of the ribosomal proteins contain FMN or FAD as cofactor, we conclude that during an induction period of up to 2.5 hours, and under the growth 
conditions used, nascent flavodoxin does not bind FMN during production in E. coli.
To reveal whether RNCs of flavodoxin have intrinsic FMN-binding capacity, we 
titrated them with FMN. Upon binding, FMN fluorescence is quenched, resulting in 
a difference in fluorescence intensity between free and bound FMN. The altering 
slope in the fluorescence titration data of FLRNC (Fig. 4B) shows that FMN binds to FLRNC. Non-native folding states, like for example unfolded and molten globular apo-
flavodoxin, do not show a change in slope of the titration data and thus they do not 
bind FMN (50). The titration data of Fig. 4B thus demonstrate that flavodoxin can obtain its native fold while fully exposed outside the ribosome. Folding to native 
apoflavodoxin can occur in vivo as well as in vitro, and consequently FMN binding also happens in both conditions. It is unlikely that FMN titration induces structural 
rearrangements that permit FMN binding in stalled or released apoflavodoxin and 
its C-terminally truncated variants. Only natively folded apoflavodoxin is capable of 
binding FMN, because it provides the required combination and geometry of hy-drogen bonds and aromatic interactions (25). As FMN titration of -5RNC shows, in-
complete flavodoxin polypeptide that emerges from the ribosomal exit tunnel does not incorporate FMN (Fig. 4B). The corresponding released product (i.e., -5P) does 
bind FMN (Fig. 4A). Docking of the C-terminal α-helix of flavodoxin onto the core 
of the protein is required for binding of FMN, as several residues of this α-helix are 
involved (25). Thus, upon dissociation from the ribosome, the C-terminal α-helix forms within -5P, with possibly some residues of the TEV linker involved (Fig. 1A), 
enabling subsequent binding of FMN. FMN incorporation is also seen in the -5P mim-
ic (which has no StrepII-tag, Smt3 and SecM sequence) though to a lesser degree (see Fig. S4). The difference in FMN binding capacities of -5RNC and -5P reveals that 
the ribosome affects nascent flavodoxin folding and cofactor binding.
The C-terminally fused SecM sequence, which is used as the stalling sequence, 
does not constrain native folding of apoflavodoxin, because it is well inside the ribo-
somal exit tunnel and relatively distant from the apoflavodoxin sequence (Fig. 1A). 
Using similar constructs, it has been shown that the presence of the SecM sequence does not affect nascent SH3 domain and barnase, because they fold properly when fully exposed outside the ribosome (12,15). Indeed, full-length ribosome-attached 
apoflavodoxin folds natively and binds FMN, as demonstrated above. 
Binding of FMN does not release FL protein from the ribosome. As FLRNC can 
bind FMN the question arises whether FMN binding overcomes stalling. Incorpo-
ration of FMN stabilizes flavodoxin by about 7 kcal/mol (50) and this drop in free 
energy might suffice to dissociate SecM from the ribosome.
To test this hypothesis, 50 μM of FMN has been added to cell extract obtained through lysis of E. coli cells expressing FL construct. This FMN concentration is 
about 20 times the total concentration of released protein and RNCs. Subsequent 
purification of FLRNC and FLP happens according to protocol. If FMN binding would release stalled nascent chains, the ratio of released protein versus RNC should in-crease. However, no such increase is observed within experimental error (Fig. 5A 
and B). Incubation of purified FLRNC with excess FMN for 24 hours shows some re-lease of stalled nascent chain, but no more than without FMN. Clearly, binding of 
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Chapter 3FMN does not dissociate FL protein from the ribosome.
DISCUSSIONWhereas the understanding of folding of isolated proteins in a test tube is consid-erable, knowledge about how polypeptides fold while they are synthesized by the ri-
bosome is largely lacking. As the α/β parallel architecture of flavodoxin is a common 
structural design in nature, and the flavodoxin-like fold is a subdomain in various multi-domain proteins, elucidating its nascent chain folding is highly relevant.
Synthesis of the 179-residue flavodoxin lasts about 9 seconds in E. coli under optimal conditions, because the translation rate is about 20 amino acid residues per second (55). Our data imply that, during an induction period of up to 2.5 hours, FMN in E. coli (strain BL21(DE3) Δtig::kan) is limiting for saturating apoflavodoxin, because FLP and FLRNC can still bind additional FMN (Fig. 4A and B). However, we cannot exclude that the  presence of chaperones may affect folding of full-length ri-
bosome-attached  apoflavodoxin in E. coli (strain BL21(DE3) Δtig::kan), which could 
adversely influence FMN binding. We note minute, sub-stoichiometric amounts of 
chaperones DnaK and GroEL/ES with mass spectrometry in purified samples of 
RNCs and released proteins. Apoflavodoxin molecules that are unable to incorpo-rate FMN explain why we previously observed less over-production in E. coli (strain 
TG2) of protein variants of flavodoxin (like e.g. F44Y, W128F, W167F and W128F/W167F (38,56)) compared to wild-type protein. During the 12 to 20 hours lasting over-production of these protein variants, cells have to produce a large amount of 
FMN to satisfy the requirements for cofactor. As FMN synthesis is relatively slow, it takes much longer to assemble all the protein in holo form than the time in which 
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Stalled flavodoxin binds its cofactor while fully exposed outside the ribosomethe maximum of apo-protein is synthesized (57). Due to amino acid residue replace-
ment, F44Y, W128F, W167F or W128F/W167F apoflavodoxin variants are desta-bilized compared to wild-type protein (38,45,51,52). Thus, these apo-proteins are 
more efficiently degraded by intracellular proteases before they can take advantage 
of the stabilization conferred through binding of FMN. For larger flavoproteins the timely incorporation of cofactor and thus stabilization of the protein may be even 
more important, as larger (multi-domain) proteins often do not refold efficiently once they have been unfolded (58).Our study demonstrates that the ribosome affects cofactor binding during birth 
of flavodoxin, because translation emulators like -5RNC cannot bind FMN (Fig. 6). The corresponding released protein construct (i.e., -5P) is shown to contain FMN. As a 
result, non-covalent binding of cofactor to released apoflavodoxin is the last step 
in production of this flavoprotein in the cell. Full-length, isolated chains of proteins with an α-β parallel native-state topology tend to temporarily misfold during unas-sisted folding in vitro to their functionally active forms. This folding defect causes the presence of molten globules, which are prone to aggregation (32,37,40). Whether 
the ribosome modulates formation of molten globules of nascent flavodoxin awaits further investigation.
Protease Protease
A CB
Figure 6 Proposed model for cotranslational flavodoxin folding and cofactor binding. Flavo-doxin and Smt3-domain (PDB ID 1L2N) are coloured red/green and blue, respectively. FMN is shown in yellow. A, Full-length RNCs can fold while stalled to the ribosome (coloured brown) and are capable of binding FMN. However, most nascent chains release as apoFLP, which sub-
sequently bind FMN. B, -5RNC does not acquire flavodoxin’s native fold while stalled to the ribosome. After release, either -5P does not fold properly and is degraded by proteases, re-
sulting in purification of only the Smt3 domain. Or, -5P folds properly and binds FMN, which protects it against proteolytic degradation. C, -10RNC does not fold properly while stalled to the ribosome. Released -10P is degraded by proteases, and as a result only the Smt3 domain 
is purified.
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Using a linker with a SecM stalling sequence, we have shown that flavodox-in is natively folded while fully exposed outside the ribosome and that it can bind FMN (Fig. 6). Separate domains of multi-domain proteins are expected to fold in-dependently of each other during translation (14). For multi-domain proteins that 
contain a flavodoxin-like fold as subdomain, our work suggests that incorporation of cofactor probably occurs cotranslationally once this fold has fully emerged from the ribosome. This concept contributes to understanding proteostasis during trans-lation of cofactor containing, multi-domain proteins. Incorporation of cofactors would hamper proteolytic degradation of nascent chains, due to increased stabili-ty conferred by cofactor binding. Especially in eukaryotes, where protein synthesis is much slower than in prokaryotes (i.e., 3 instead of 20 amino acids per second 
(59)), such impediment of proteolysis could increase protein production efficiency. 
Indeed, for several flavoproteins involved in diseases, a beneficial effect has been 
observed when the respective flavin was supplemented (60).
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SUPPLEMENTARY INFORMATION
MATERIALS AND METHODS
RNase A degradation of RNCs. FLRNC was produced and purified according to Material and Methods section 2.2. After use of the Superdex75 column to separate FLRNC from FLP, the FLRNC-containing fractions were concentrated and incubated with 
RNAse A (50 μg/ml) and 25 mM EDTA for 1 hour at 37 °C. The resulting sample was 
spun down for 10 minutes at 18000 RCF and the supernatant was subsequently run on a Superdex75 column while fractions were collected during the run. The frac-
tions were characterized using a 15% SDS-PAGE gel and subsequently blotted with 
anti-flavodoxin.
Elution of ribosomes versus released nascent chains. To verify the elution patterns of ribosomes versus FLP, first empty ribosomes (purchased from New En-
gland Biolabs (NEB)) were run on a Superdex75 column. Subsequently FLP (purified in the experiment described above) was mixed with the empty ribosomes and this 
mixture was run over the Superdex75 column. Lastly purified FLP was run over the same Superdex75 column.
Expression of terminally truncated variants of flavodoxin without fusion 
to the Smt3-domain and the stalling sequence. The pUC18 plasmid containing 
the flavodoxin gene was used to construct two protein variants, 1-174 and 1-169, in which the stop codon has been moved N-terminally. These protein variants mimic the -5P (1-174) and -10P (1-169) molecules, respectively, but lack the StrepII-tag, 
Smt3-domain and SecM sequence. Both protein variants (named -5 and -10, respec-
tively), along with full-length flavodoxin (FL) and empty vector pUC18 (pUC) were expressed in E. coli (strain TG2) grown on TB or minimal medium. Half of the cor-responding cultures were induced with IPTG for a period of 16 hours. Gel samples were taken before and after induction. The cells in these samples were lysed and separated into supernatant and pellet fractions by centrifugation. Supernatant and pellet samples were analysed by running them on a 15% SDS-PAGE gel and subse-
quent blotting with anti-flavodoxin.
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Figure S1 Disruption of FLRNC by RNase A results in elution of nascent FL at relative volume of FLP. Shown are Superdex75 elution profiles, with all absorbance traces normalized relative to the maximum absorbance at 260 nm. Absorbance at 450 nm tracks FMN incorporation. Elution volumes are normalized to the total column vol-ume Vt. A, FLRNC incubated for 1 hour with RNase A. Due to degradation of rRNA, the RNC peak has vanished, resulting in several smaller peaks corresponding to ribo-somal proteins and rRNA. B, Expansion of (A) reveals the presence of a peak with ab-sorbance at 450 nm, which elutes at the same relative volume as FLP. Dashed vertical lines designate collected fractions during the run. C, Collected fractions are analysed 
by Western blot probed with anti-flavodoxin. Fractions corresponding to the peak with absorbance at 450 nm indeed contain FLP.
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Figure S2 FLP does not co-elute with intact, empty ribosomes. Shown are Super-
dex75 elution profiles, with all absorbance traces normalized relative to the maxi-mum absorbance at 260 nm of empty ribosomes. Absorbance at 450 nm tracks FMN incorporation. Elution volumes are normalized to the total column volume Vt. A, Empty ribosomes (purchased from NEB). B, Mixture of empty ribosomes and puri-
fied FLP. C, Purified FLP.
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Figure S3 Expression of terminally truncated variants of flavodoxin. Shown are 
Western blots probed with anti-flavodoxin. Three variants of flavodoxin were pro-
duced. The first one is full-length protein (FL). In the other two variants the regular stop codon has been moved N-terminally to create protein variants 1-174 (-5) and 
1-169 (-10). As a control, the empty vector containing no flavodoxin gene (pUC) was also tested. All four constructs were transformed into E. coli (strain TG2) and grown either in nutrient-rich medium (TB) or minimal medium (MM). Samples were taken before induction (0), after induction for 16 hours (ONi) or after growth for 16 hours 
without induction (ONu). Subsequently, cells of the samples were lysed and both supernatant (Sup) and pellet (Pel) fractions were analysed on Western blot. Due to a leaky promoter in the vector, protein is produced in un-induced samples. For 
full-length flavodoxin, protein is found in supernatant and pellet fractions of cells grown on both TB and MM medium. -5 and -10 are detected only in the pellet of cells grown on TB medium. Due to lower expression of the -5 and -10 protein in cells grown on MM medium compared to on TB medium, the protease machinery is able 
to degrade all produced protein in the first situation, but not in the second one. As 
expected, the empty vector does not show production of flavodoxin, though there is 
some cross-reactivity of the flavodoxin antibody with E. coli proteins in the fractions.
FL TB -10 MM-10 TB pUC TB-5 TBFL MM
Figure S4 FMN content of overexpressed flavodoxin is reflected in the colouring of 
pelleted cells. Three variants of flavodoxin (FL, -5 and -10) and a vector containing 
no flavodoxin gene (pUC) were transformed in E. coli (strain TG2) and grown and 
induced for 16 hours. Subsequently, cells were pelleted and checked for their colour. 
Expression of FL in TB results in a blue-greenish colour due to the semiquinone form of FMN. TB and MM denote the medium in which the cells were induced, i.e., nutrient-rich (TB) or minimal medium (MM). FL and -5 induced in TB show a darker blue-greenish coloured cell pellet than -10 (which is incapable of binding FMN) or 
pUC (which does not express flavodoxin), indicating binding of FMN. FL has a darker coloured cell pellet than -5, signifying higher FMN content. Due to lower growth in MM medium, the cell pellet in these samples is not large enough for the colour change between FL and -10 to be visible.
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The ribosome restrains molten globule formation in stalled nascent flavodoxin 
Folding of proteins usually involves intermediates, of which an important type is the molten globule (MG). MGs are ensembles of interconverting conformers that contain (non-)native secondary structure and lack the tightly packed tertiary structure of 
natively folded globular proteins. Whereas MGs of various purified proteins have been probed to date, no data is available on their presence and/or effect during pro-tein synthesis. To study whether MGs arise during translation, we use ribosome-na-
scent chain (RNC) complexes of the electron-transfer protein flavodoxin. Full-length, 
isolated flavodoxin, which contains a non-covalently bound flavin mononucleotide 
(FMN) as cofactor, acquires its native α/β parallel topology via a folding mechanism that contains an off-pathway intermediate with molten globular characteristics. Ex-
tensive population of this MG state occurs at physiological ionic strength for apofla-vodoxin variant F44Y, in which a phenylalanine at position 44 is changed to a tyro-sine. Here, we show for the first time that ascertaining the binding rate of FMN as a function of ionic strength can be used as a tool to determine the presence of the 
off-pathway MG on the ribosome. Application of this methodology to F44Y apoflavo-
doxin RNCs shows that at physiological ionic strength the ribosome influences for-mation of the off-pathway MG and forces the nascent chain towards the native state.
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INTRODUCTIONProteins need to fold into their correct native conformations to perform their functions. Folding progresses from unfolded to natively folded protein and often in-volves intermediates (1,2). Some of these intermediates are dead-ends within the folding funnel (i.e., local minima in free energy) and must therefore (partially) un-fold before the productive folding pathway can be followed (3). Molten globules are 
a specific type of folding intermediates, which contain secondary structure elements but lack the tight tertiary packing found in natively folded proteins. Molten globular intermediates can reside on or off the folding pathway to native protein. MGs are 
prone to aggregation and consequently are implicated in various diseases (4).
Since the first description of MGs (5) much research has focused on determin-ing conditions at which MGs form. Several proteins form these intermediates under mildly alkaline or acidic conditions (6-9). Nowadays, many proteins are thought to fold via MG intermediates (10-13). For example, it has been postulated that the oc-currence of MG species is necessary during insertion of proteins into membranes or through membrane pores (14-16). Such insertions often happen cotranslationally, i.e., while the ribosome synthesizes the protein concerned. It has been shown that proteins can fold cotranslationally and sample intermediate folding states (17-23), which might include MGs.
Determining proteins’ ability to form cotranslational MGs would be a step-ping-stone in elucidating protein folding in the cell, and potentially contributes to understanding the initiation of protein aggregation. Characterization of MGs is 
complicated by their often transient nature, generally low presence at equilibrium, conformational heterogeneity and tendency to aggregate (24). The presence of MGs 
can be revealed through use of extrinsic dyes, such as thioflavin T (ThT), as these 
dyes become highly fluorescent upon binding to exposed hydrophobic residues (25). Other methods for MG detection include circular dichroism and intrinsic tryptophan 
fluorescence (26-28). However, these methodologies are unsuitable for studying cotranslational MG formation, as ribosome-nascent chain complexes (RNCs) not only contain the emerging polypeptide, but also more than 50 ribosomal proteins. 
Thus, detection of MG formation on the ribosome is notoriously difficult.
To investigate whether nascent chains form MGs, we utilize a 179-residue fla-vodoxin from Azotobacter vinelandii. Flavodoxin contains a non-covalently bound 
flavin mononucleotide (FMN) as cofactor and is involved in electron transport in the 
nitrate reduction cycle. The native protein consists of five α-helices sandwiching a 
central parallel β-sheet, which is an α/β parallel topology (Fig. 1A) (29). According 
to SCOP classifications in the Protein Data Bank (PDB), approximately twenty five 
percent of proteins share this topology. The flavodoxin-like fold is an ancestral fold 
(30) and is archetypal for the class of αβα sandwiches. It has been well established 
that proteins with a flavodoxin-like architecture fold in vitro through involvement of an off-pathway intermediate (11,31-37). Upon folding, the large majority of unfold-
ed flavodoxin molecules temporarily misfold. This misfolding yields an off-pathway MG that is prone to aggregation (38). In contrast to native protein, this MG contains 
no β-sheet and is helical (Fig. 1B) (33,39,40). Under steady-state conditions the MG 
is in equilibrium with native apoflavodoxin. Before formation of native apoflavodox-in can occur the MG has to (partially) unfold. This unfolding is the rate-limiting step 
in folding of native apoflavodoxin. The cofactor FMN only binds to the flavin-binding 
site of natively folded apoflavodoxin (41). This binding can be followed in time by 
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Figure 1 Differences between flavodoxin’s native and MG structure and the construct used for RNC production. A, cartoon drawing of native flavodoxin (PDB entry 1YOB (29)) with FMN coloured yellow. Residue F44 (blue) is shown in stick representation. B, cartoon drawing of the 
four transiently structured regions of the off-pathway MG, which include α-helices (coloured 
blue) and structure that is neither α-helix nor β-strand (coloured orange) (33). These regions 
dock non-natively and form the core of apoflavodoxin’s MG (33,35,39,40). The cartoon is a representation of structural elements in the MG, not of their packing. C, the construct for RNC production contains a triple N-terminal StrepII-tag (orange), an Smt3-domain (green) fused 
to flavodoxin (yellow), a recognition site for TEV protease (blue) and a linker that spans the 
ribosomal exit tunnel and concludes with the SecM stalling sequence (magenta).
fluorescence spectroscopy, as FMN’s fluorescence becomes severely quenched upon 
binding to native apoflavodoxin (42,43).
Upon mixing FMN with apoflavodoxin under conditions where MG is present, 
cofactor binding and accompanied fluorescence quenching should be delayed, as 
the MG needs to unfold before native apoflavodoxin can form. This delayed FMN 
quenching is used in this study to reveal whether the ribosome modulates forma-
tion of molten globular apoflavodoxin. Previously, we demonstrated that once apo-
flavodoxin has been entirely synthesized and is exposed outside the ribosome, the protein is natively folded and capable of binding FMN (44). To demonstrate whether MGs form during translation, we take advantage of the following folding character-
istic of flavodoxin variant F44Y (39): the apo-form of this variant switches from na-tively folded to the off-pathway MG upon decreasing ionic strength to physiological values (39,40). Due to the higher thermodynamic stability of the holo-form of this 
protein, once apoflavodoxin binds FMN this topological switching no longer occurs 
(45). We prepared stalled RNC complexes that expose the entire F44Y flavodoxin protein outside the ribosomal exit tunnel. The translational stalling of the ribosomes is caused by an Escherichia coli SecM derived peptide (46,47), which we attached 
at the C-terminus of flavodoxin. After purification of F44Y apoflavodoxin RNCs, we 
determined the corresponding FMN binding rates and thus the influence of the ribo-some on MG formation.
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MATERIAL AND METHODS
Protein expression and purification. To avoid covalent dimerization of pu-
rified A. vinelandii (apo)flavodoxin, the single cysteine at position 69 was substi-
tuted by an alanine (50). The C69A variant is similar to wild-type (apo)flavodoxin (49,50). An additional F44Y mutation was introduced (39), and this protein variant 
is referred to as F44Y (apo)flavodoxin. Both constructs were transformed in Esch-
erichia coli (strain TG2) and purified as described previously (50). Apoprotein was prepared according to established protocols (44). Apoprotein concentrations were 
determined by titration with known amounts of FMN. Purified proteins in 100 mM 
potassium pyrophosphate (KPPi) buffer, pH 6.0, were flash frozen in liquid nitrogen and stored at -80 °C.
Due to cold denaturation, some F44Y apoflavodoxin deteriorates into soluble molecules that are incapable of binding FMN upon thawing. These molecules cannot 
be separated from FMN binding competent apoflavodoxin, thus the latter concentra-tion was determined by titration with FMN in 100 mM KPPi, pH 6.0. Also, as much as 
possible, freshly prepared F44Y apoflavodoxin was used in experiments.
Influence of temperature on full-length, isolated protein. Thermal unfolding 
of F44Y apoflavodoxin was probed by ThT fluorescence using a Cary Eclipse spectro-photometer (Varian). Excitation was at 445 nm and emission was measured at 485 nm. Temperature was increased from 15 to 45 °C at a rate of 1 °C/min. The excitation and emission slits were set to bandwidths of 5 and 10 nm, respectively, and the PMT 
voltage was 900 V. 3.3 μM of F44Y apoflavodoxin and 56 μM of ThT (Sigma) were used in 10 or 100 mM KPPi, pH 6.0. 
Engineering RNC variants. Plasmids for RNC production contain a sequence coding for a triple N-terminal StrepII-tag, an Smt3 domain, a TEV-site, a linker and a 
SecM stalling motif (Fig. 1C). The flavodoxin sequence (C69A or F44Y) was inserted in the multiple cloning site (MCS) present between the TEV-site and the linker. Ulp1 
protease specifically recognises the Smt3 domain and cleaves down-stream this do-
main, thereby producing nascent flavodoxin chains with Ala-1 as authentic N-ter-
minus, if required. The recognition site for TEV protease enables release of nascent protein from the ribosome. The plasmid was a kind gift of Professor Elke Deuerling (University of Konstanz, Germany) (56).
Expression and purification of RNCs in vivo and in vitro. Plasmids were transformed in E. coli strain BL21(DE3) Δtig::kan for expression of RNCs in vivo. All RNC variants were prepared as described previously (44). After growth of E. coli 
in Terrific Broth (TB) medium, cells were transferred to minimal (M9) medium 
for expression of RNCs at either 37 or 15 °C for 1 hour. RNCs were purified using 
Strep-Tactin Sepharose (IBA GmbH) chromatography and subsequent size-exclusion 
(Superdex75) chromatography. RNCs and released protein chains were purified and stored in buffer I (50 mM HEPES-KOH, 100 mM potassium acetate, 15 mM magne-
sium acetate, 1 mM dithiothreitol (DTT), pH 7.4). After purification, the apo-form of 
released protein chains of F44Y flavodoxin was prepared in 100 mM KPPi, pH 6.0 as described in (44).For in vitro expression of RNCs, the PURExpress® Δ (aa, tRNA) In Vitro Protein Synthesis kit from New England Biolabs was used. Instructions of the manufactur-
er were followed. After mixing the kit’s components with the F44Y flavodoxin con-taining RNC plasmid, the reaction was allowed to proceed for 2 hours at 37 °C. To 
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The ribosome restrains molten globule formation in stalled nascent flavodoxin purify RNCs produced in vitro, the reaction mixture was loaded onto a Strep-Tactin sepharose column and eluted as previously described in buffer I (44). Eluted RNCs 
were concentrated with a 10-kDa spin filter (EMD Millipore) at 5,500 g. Concentrat-
ed samples were frozen in liquid nitrogen and stored at -80 °C.
Samples of each purification step were analysed by Coomassie-stained SDS-PAGE 
or Western blotting using either flavodoxin antibody raised in rabbits (Eurogen-tec) followed by anti-rabbit HRP-IG (Eurogentec) or StrepMAB classic (IBA GmbH) against the N-terminal StrepII-tag.
FMN fluorescence. To establish FMN content of RNCs and released constructs, FMN titration or TCA precipitation was performed as described in (44). To deter-mine the MG nature of RNCs of F44Y protein and of released protein, binding of FMN 
to these molecules was followed in time. All flavin fluorescence experiments were measured on a Cary Eclipse spectrophotometer (Varian) at 25 °C.
Samples for FMN titration contained 0.5 μM of either RNC or released protein produced in vivo in buffer I. Samples were titrated with a FMN solution of 5 μM to de-
termine their cofactor-binding capacity using flavin fluorescence. Excitation was at 450 nm, with emission recorded between 500 and 600 nm. For each titration point 
the average of five scans was taken. Excitation and emission slits were set to a band-width of 5 nm and PMT voltage was set to 900 V.Samples for TCA precipitation contained 50 nM of RNC or released protein pro-duced in vivo in buffer I. To establish the total amount of FMN bound to protein, the samples were precipitated by adding 3 % (w/v) TCA. Precipitate was spun down for 10 min at 21,000 g at 4 °C and supernatant was carefully pipetted off to mea-
sure its flavin fluorescence. A 50 nM solution of FMN in 3 % (w/v) TCA in buffer I was used as reference. Excitation was at 450 nm, with emission recorded between 
500 and 600 nm. Each sample was scanned five times and the average was used for calculations. Excitation and emission slits were set to a bandwidth of 10 or 20 nm, respectively. PMT voltage was set to 970 V.
To determine the rate of FMN binding to C69A and F44Y variants of apoflavo-doxin, E. coli ribosomes (NEB), RNC or released protein, samples were made of each with protein concentrations ranging from 50 to 147 nM. Samples were measured in 
stirred fluorescence cuvettes for five minutes before and after adding FMN to a final concentration of 24 nM. Excitation was at 450 nm and emission was monitored at 540 nm. Excitation and emission slits were set to bandwidths of 10 and 20 nm, re-spectively, and PMT voltage was 970 V. The averaging time of the measurement was 
0.1 s. The time between addition of FMN and the start of fluorescence detection was approximately 2 s. Buffers used in these experiments were 10 mM KPPi, pH 6.0; 100 
mM KPPi pH 6.0; buffer I or buffer I with a final concentration of 290 mM NaCl. The 
latter buffer has an ionic strength equal to that of 100 mM KPPi, pH 6.0.
RESULTS
Dependence of apoflavodoxin’s off-pathway MG on ionic strength and tem-
perature. Decreasing salt concentration is a well-known manner to destabilize fold-
ed proteins (48). Using this approach, in F44Y apoflavodoxin samples we can shift 
the equilibrium between natively folded protein and MG to the latter species (39). Fluorescence anisotropy shows that lowering ionic strength from 100 to 10 mM 
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KPPi (i.e., 345 to 75 mM equivalent NaCl units) at 25 °C forces F44Y apoprotein from 
native apoflavodoxin to MG (Fig. 2A). The MG state is characterized by fluorescence 
anisotropy that is higher than of native apoflavodoxin. In contrast, at high salt con-
centrations, like for example 100 mM KPPi, F44Y apoflavodoxin is predominantly in 
its native state. For C69A apoflavodoxin, which is similar to wild-type apoflavodoxin (49,50), no salt-dependent switch between folding states is observed (Fig. 2A), as its 
native state is considerably more stable than native F44Y apoflavodoxin (39).
The formation of the off-pathway MG not only depends on ionic strength but also on temperature. To follow the temperature-dependent existence of this MG we add-ed the extrinsic dye ThT. This reporter molecule is commonly employed to follow 
amyloid fibril formation, as it has a high affinity for β-sheets. Upon binding to fibril-
lar structures, ThT shows a fluorescence increase at 480 nm upon excitation at 450 
nm. Binding of ThT and subsequent fluorescence increase is not only restricted to 
fibrillar structures, but can also occur due to the presence of non β-sheet cavities, 
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Figure 2 Effects of ionic strength or temperature on F44Y apoflavodoxin. A, ionic strength 
dependency of fluorescence anisotropy of F44Y (closed red circles) and C69A apoflavodoxin 
(open red circles) (graph adapted from (39)). Upon decreasing ionic strength F44Y apofla-
vodoxin forms a MG, which is characterized by fluorescence anisotropy that is higher than 
of native apoflavodoxin. Expected anisotropy of F44Y apoflavodoxin in Buffer I is shown as a blue circle. B, temperature-dependence of ThT binding to F44Y apoflavodoxin, as followed 
by fluorescence emission at 485 nm. Protein is in 10 (red) or 100 mM (blue) KPPi, pH 6.0. 
ThT binding to the MG of F44Y apoflavodoxin increases ThT fluorescence. Due to unfolding 
of the MG with increasing temperature, ThT releases and its fluorescence decreases. Protein 
concentration is 3.3 μM and the heating rate is 1 °C/min.
93
The ribosome restrains molten globule formation in stalled nascent flavodoxin such as may form in MGs (25). Another extrinsic dye commonly used to probe MGs 
is 1-anilino-8-naphthalene sulfonate (ANS), however, in the case of F44Y apoflavo-
doxin, its fluorescence does not follow the unfolding of the MG, whereas ThT fluores-cence does (data not shown).
Fig. 2B shows how temperature affects F44Y apoflavodoxin at high and low ion-
ic strengths (i.e., 345 and 75 mM equivalent NaCl units, respectively). Temperature 
was raised from 15 to 45 °C, upon which F44Y apoflavodoxin unfolds (39). Tempera-ture was not raised further to avoid formation of aggregates, which would lead to a 
rise in ThT fluorescence. For protein at low ionic strength and low temperature, ThT 
fluorescence is high (Fig. 2B), because F44Y apoflavodoxin is predominantly in the 
MG state. Upon increasing temperature, ThT fluorescence decreases non-coopera-tively, because the MG unfolds gradually and binding of ThT diminishes. This grad-
ual, non-cooperative unfolding is a typical feature of apoflavodoxin’s MG (35,37). 
Tryptophan fluorescence shows that the thermal unfolding transition of native F44Y 
apoflavodoxin in 100 mM KPPi ranges from about 20 to 40 °C, with a thermal mid-
point of 32.9 ± 0.3 °C (39). Above approximately 40 °C, ThT fluorescence of protein at low and high salt concentrations is similar, because at both conditions the protein 
is now unfolded. At high salt concentration a slight hump in ThT fluorescence is observed in the thermal unfolding transition of native protein (Fig. 2B). This hump 
arises because the MG state of F44Y apoflavodoxin populates. At the thermal mid-
point of native apoflavodoxin (i.e., 32.9 ± 0.3 °C) ThT fluorescence due to MG popu-lation is low, because the MG is gradually unfolded.
Fig. 2B implies that at low salt concentration the MG of F44Y apoflavodoxin is 
maximally populated at about 15 °C. This corroborates our previous findings that 
the off-pathway MG of F44Y apoflavodoxin is structured in the absence of denatur-ant (35,40).
FMN binding rate as a tool to reveal the presence of apoflavodoxin’s MG. 
FMN is essential for flavodoxin’s role in electron transport. This cofactor binds to 
native apoflavodoxin through a very specific combination and geometry of aromatic 
and hydrogen bond interactions (41,45). In native apoflavodoxin the flavin-bind-
ing site is flexible, whereas upon cofactor incorporation it becomes rather rigid 
(45,51,52). Cofactor binding not only influences the binding pocket itself but also 
affects residues far away, resulting in picomolar binding affinity of FMN (45). As a 
consequence, flavodoxin is thermodynamically very stable and has to first release 
FMN before it can unfold (41,45). Accordingly, FMN binding to native apoflavodoxin 
is the last step during folding of flavodoxin. FMN neither acts as a nucleation site for 
folding nor does it interact with folding intermediates of apoflavodoxin, including the discussed off-pathway MG (41).
Binding of FMN to native apoflavodoxin can be followed by FMN fluorescence, 
as FMN incorporation into native apoflavodoxin severely quenches its fluorescence. We demonstrate this phenomenon in Fig. 3A, which shows the time-dependent de-
crease of FMN fluorescence upon cofactor binding to C69A apoflavodoxin in 100 and 10 mM KPPi at 25 °C. The rates of FMN binding at both salt concentrations are iden-
tical, because C69A apoflavodoxin is natively folded under these circumstances (39).
In contrast to C69A apoflavodoxin, the rates of FMN binding to F44Y apoflavo-doxin in 100 and 10 mM KPPi differ drastically (Fig. 3B). This dissimilarity arises 
because F44Y apoflavodoxin in 100 mM KPPi is natively folded, whereas in 10 mM 
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Figure 3 The rate with which FMN binds to apoflavodoxin depends on the presence of molten 
globular protein and thus on the salt concentration. To follow quenching of flavin fluores-
cence, FMN is added to protein at 25 °C. Shown are normalized FMN fluorescence traces. A, 
C69A apoflavodoxin in 100 (blue) and 10 (red) mM KPPi, pH 6.0. C69A protein is natively fold-ed under both conditions and thus binds FMN with the same rate. Concentrations for protein and FMN are 140 and 25 nM, respectively. B, F44Y apoflavodoxin in 100 (blue) and 10 (red) mM KPPi, pH 6.0. In 100 mM KPPi, F44Y protein is natively folded, whereas in 10 mM KPPi the F44Y variant pre-dominantly populates the MG state, which delays FMN binding as the MG 
needs to unfold before native apoflavodoxin can form. Concentrations for F44Y apoflavodoxin and FMN are 71 and 25 nM, respectively. C, F44Y apoflavodoxin in 100 mM KPPi (blue) and in buffer I containing 290 mM NaCl (orange). Protein is natively folded under these conditions 
and thus binds FMN with similar rate. F44Y apoflavodoxin in buffer I (green) populates the 
MG state, thereby delaying FMN binding. Concentrations of F44Y apoflavodoxin and FMN are 62 and 25 nM respectively.
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The ribosome restrains molten globule formation in stalled nascent flavodoxin KPPi the protein extensively populates the off-pathway MG. As this MG needs to un-
fold before productive folding can take place, FMN binding is delayed significantly 
when compared to F44Y apoflavodoxin in 100 mM KPPi and C69A apoflavodoxin in 10 or 100 mM KPPi, respectively. Thus, ascertaining the rate of FMN binding to 
apoflavodoxin as a function of ionic strength is a suitable tool to detect the presence 
of apoflavodoxin’s off-pathway MG.
To preserve ribosomal integrity during purification of RNCs we use buffer I (50 mM HEPES-KOH, 100 mM potassium acetate, 15 mM magnesium acetate, 1 mM dithiothreitol (DTT), pH 7.4), which contains magnesium to hold the two ribosomal subunits together. At the ionic strength of buffer I, which is similar to that of the 
cellular environment, the MG state of F44Y apoflavodoxin populates (Fig. 2A). We 
therefore assessed the rate of FMN binding to F44Y apoflavodoxin in buffer I (Fig. 
3C). When compared to F44Y apoflavodoxin in 100 mM KPPi, the FMN binding rate 
is considerably reduced in buffer I, indicating the presence of significant amounts 
of MG. To confirm that ionic strength also affects the equilibrium between MG and 
native apoflavodoxin in buffer I, 290 mM NaCl was added to buffer I, which would approximate the ionic strength of 100 mM KPPi. Indeed, the FMN binding rate in-creases upon addition of salt to buffer I and becomes comparable to the rate found 
for native apoflavodoxin.
Production and purification of RNCs of F44Y flavodoxin in vivo. To assess 
whether MGs form during translation we produced RNCs of C69A and F44Y flavo-doxin in E. coli (called C69ARNC and F44YRNC, respectively), using the construct of Fig. 
1C. Production at 37 °C and purification of C69ARNC have been described elsewhere (44). In case of F44YRNC we use the same procedure, except that now RNCs are in-duced in E. coli at either 37 or 15 °C. Lowering temperature to 15 °C maximizes 
population of the MG state of F44Y apoflavodoxin, whereas at 37 °C the protein is unfolded (Fig. 2B).
While the SecM sequence allows for relatively tight stalling (46), some release of nascent chains happens during their production in E. coli, as we observed pre-
viously for RNCs of C69A flavodoxin (44). This release is most probably due to the physical force that is exerted as soon as the nascent chain folds (53,54). Binding of 
FMN to natively folded nascent chains does not dissociate nascent flavodoxin from the ribosome (44). To separate released protein (called C69AP or F44YP) from RNCs (i.e., C69ARNC or F44YRNC), we utilize size-exclusion chromatography. The absorbance 
ratio A260/A280 enables distinction between RNCs and released flavodoxin, as this 
ratio is ~2 for RNCs, while A260/A280 is <1 for released protein. The RNCs elute in the void volume of the Superdex75 column, whereas released protein elutes later. Fig. 4A illustrates this separation of C69ARNC and C69AP through size exclusion. A 
similar distribution is observed for the F44Y flavodoxin variant grown at 37 °C (Fig. 4B), showing that also in case of this protein variant release of nascent chains hap-pens. However, an additional third elution peak is now present. This extra peak aris-es from the protein fragment consisting of the triple StrepII-tag and Smt3-domain (Fig. 4B,C), which we refer to as Smt3-fragment. The identity of the 18-kDa fragment 
is confirmed by Western blot probed with antibodies against StrepII-tag (Fig. 4D). Because the remaining C-terminal fragments do not contain a StrepII-tag anymore, 
they are not present after the purification step using a Strep-Tactin column. We pre-viously observed the same degradation product for C-terminally shortened nascent 
chains of C69A flavodoxin. These shortened proteins are less stable relative to the 
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Figure 4 Comparison of re-lease and degradation of 
C69A and F44Y flavodoxin nascent chains produced in 
E. coli under several growth conditions. Shown are Super-
dex75 elution profiles, with absorbance at 260 (red), 280 (blue) and 450 nm (green). All absorbance traces are normalized relative to the maximum absorbance at 260 nm of the respective RNCs. Absorbance at 450 nm tracks FMN incorporation. Elution volumes are normalized to the total column volume Vt. All constructs are induced for 2.5 h in E. coli Δtig::kan in minimal medium at either 37 °C (A, B) or 15 °C (C). A, use 
of C69A flavodoxin construct produces C69ARNC and C69AP. 
B, use of F44Y flavodoxin construct produces F44YRNC and F44YP. Proteolytic deg-radation of F44Y protein con-struct results in the presence of the fragment triple StrepII-tag - Smt3 (labelled Smt3). 
C, use of F44Y flavodoxin construct at 15 °C produces F44YRNC and F44YP with the same degradation pattern (i.e., Smt3) as observed in (B). D, Western blot of the fractions labelled F44YP and Smt3 probed with antibod-ies against the N-terminal StrepII-tag. 
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The ribosome restrains molten globule formation in stalled nascent flavodoxin full-length C69A protein (44), and thus Fig. 4B,C indicates decreased stability of also F44YRNC and/or F44YP show decreased stability when produced at 15 or 37 °C. Whether intracellular degradation of the F44Y construct occurs while it is bound to the ribosome and/or while it has been released is unknown. We can only distinguish between both species after their separation using size exclusion chromatography. As by then degradation has already happened, we are unable to determine which species degraded and formed the observed Smt3-fragment.
Production of the F44Y flavodoxin construct at 15 °C does not alter the elution peak arising from the Smt3-fragment (Fig. 4C). Thus, a temperature change of 37 to 15 °C has no effect on the amount of in vivo proteolytic degradation of F44YRNC and/or F44YP, suggesting that the respective proteolytic susceptibility of nascent chain and released protein is similar at both temperatures. The ratio between F44YP and F44YRNC is calculated taking into account the differences in extinction coefficients at 280 nm of RNCs and released protein. At both temperatures the ratio is around 70, which is comparable to the ratio we have found previously for a C-terminally short-
ened nascent chain of C69A flavodoxin (44).
All purified F44YP contains FMN. In a previous study we showed that when 
FMN binds to a released, C-terminally shortened C69A flavodoxin construct this con-struct is protected against intracellular proteolysis, due to the increased thermody-
namic stability conferred by incorporated FMN (44). As a consequence, all of these released constructs were saturated with FMN, because the unstable apo forms are proteolytically degraded in E. coli (causing the appearance of the Smt3-fragment). In contrast, for C69AP, which is full-length protein construct, the FMN content var-ies between 40 to 100 %, depending on the E. coli batch used for purification (44). Due to its increased thermodynamic stability compared to C-terminally shortened constructs, the apo-form of C69AP is not proteolytically degraded. To verify in the current study whether the elution peak labelled F44YP arises from protein saturated 
with cofactor, we titrated this fraction with FMN (Fig. 5A). Due to quenching of FMN 
fluorescence upon cofactor binding to apoprotein, the slope of fluorescence data arising from FMN bound to protein is less steep than the slope resulting from free FMN. This characteristic is widely used to demonstrate FMN binding (42,43,45). Fig. 
5A reveals similar slopes for FMN fluorescence titration data of buffer and F44YP. This observation shows that F44YP binds no additional FMN.To determine the ratio of FMN to apoprotein, we added trichloroacetic acid (TCA) to F44YP. This dissociates the cofactor from the protein and after centrifugation we 
measured FMN fluorescence of the supernatant. This experiment demonstrates 
equimolar presence of FMN and apoprotein (Fig. 5B). Full saturation of F44YP with FMN was seen independent of production temperature (i.e., 15 or 37 °C). Finally, we 
followed FMN fluorescence in time upon addition of the cofactor to F44YP (Fig. 5C). If the sample would contain any F44YP in its apo-form, one should detect a decrease 
in FMN fluorescence upon FMN binding. However, no such decrease was observed and thus no cofactor binding happened.
In conclusion, binding of FMN protects destabilized apoflavodoxin variants against the action of intracellular proteases, and thus all F44YP we purify contains FMN.
F44YRNC
 isolated from E. coli is saturated with FMN. To determine the extent of cofactor incorporation into F44YRNC we performed a titration of the purified nascent 
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Chapter 4protein with FMN. Fig. 5A shows that no added FMN binds to these RNCs. TCA precip-
itation of RNCs shows that this observation arises because RNCs of F44Y flavodoxin contain FMN (Fig. 5B), regardless of whether they are produced by E. coli at 15 or 
37 °C. Following FMN fluorescence in time upon addition of the cofactor to F44YRNC 
(Fig. 5C) shows only a marginal decrease in FMN fluorescence, which corresponds to maximally 5 % of F44YRNC being in the apo-form. In contrast to the observed nearly full saturation of F44YRNC with FMN, we previously demonstrated that C69ARNC is 
purified from E. coli as apoprotein. Observation of an altering slope in FMN fluores-cence titration data shows that C69ARNC binds FMN (Fig. 5A). This difference in FMN occupation of F44YRNC and C69ARNC, and the observation that F44YP is fully saturated with FMN, suggests that when the apo form of F44Y protein is present in E. coli, it is not as stable in the cellular environment of E. coli as C69A apoprotein is. Therefore, 
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Figure 5 RNCs of F44Y flavodoxin construct and released protein construct isolated from E. 
coli are saturated with FMN. A, titration of buffer I, F44YP, F44YRNC, and C69ARNC with FMN. 
Observation of an altering slope in FMN fluorescence titration data reveals cofactor binding, as is the case for C69ARNC. F44YP and F44YRNC show no change in slope of FMN fluorescence ti-
tration data. All fluorescence is normalized to the fluorescence of the end-point of the titrated 
buffer sample. Concentration of protein and RNC is 0.5 μM. Data of C69ARNC are adapted from (44). B, fluorescence of FMN in supernatants of F44YP (green) and F44YRNC (red) after TCA 
precipitation. The average fluorescence of TCA samples of four purifications is shown, togeth-er with the corresponding standard deviation. Before addition of TCA, concentration of F44YP and F44YRNC was 50 nM. Fluorescence is normalized to fluorescence of buffer I containing 50 nM FMN (blue).
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only the holo-forms of RNCs and released F44Y protein are purified.
The domains of F44YP do not affect MG formation of apoflavodoxin. To assess 
whether the triple Strep-tag, the Smt3-domain, the linker and the SecM sequence 
(Fig. 1C) influence MG formation of F44Y apoflavodoxin, we removed FMN from pu-
rified F44YP according to a previously published procedure (44). Subsequently, the FMN binding trace of this refolded apo-F44YP was measured in various buffers (Fig. 5D). Comparison of the refolded apo-F44YP traces with those of F44Y apoflavodoxin (Fig. 3C) shows that for both proteins a change in ionic strength has a similar effect on FMN binding. Increasing KPPi concentration from 10 to 100 mM, or addition of 290 mM NaCl to buffer I, leads to an increase in FMN binding rate. This observation 
is due to increased population of the native state of apoflavodoxin. Upon addition of salt (buffer I with 290 mM NaCl) the FMN binding rate of apo-F44YP is similar to the 
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C, FMN binding traces of F44YP and F44YRNC isolated from E. coli. FMN fluorescence is normal-ized. F44YP, F44YRNC, and FMN concentrations are 50, 50 and 25 nM, respectively. D, the triple 
Strep-tag, Smt3-domain, the linker and the SecM sequence of the construct used for RNC pro-
duction do not influence the formation of the off-pathway MG of apoflavodoxin. Shown are FMN binding traces of apo-F44YP in 100 mM KPPi (blue), 10 mM KPPi (red), Buffer I (green) and Buffer I + 290 mM NaCl (purple). F44YP and FMN concentrations are 147 and 25 nM, respectively.
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Chapter 4rate observed for apo-F44YP in 100 mM KPPi, as both proteins are natively folded. Thus, presence of the triple Strep-tag, the Smt3-domain, the linker and the SecM se-
quence of the construct used for RNC production do not influence formation of the 
off-pathway MG of apoflavodoxin or impair FMN binding.
The ribosome forces entirely synthesized and fully exposed F44Y apoflavo-
doxin towards the native state. Because no apo-F44YRNC could be obtained from 
E. coli due to proteolytic degradation, we adopted an in vitro transcription/trans-lation approach to generate nascent F44Y constructs in their apo form. We used a highly pure in vitro protein synthesis kit (PURExpress® Δ (aa, tRNA), New England Biolabs) to preclude presence of FMN in the translation reaction. We avoided usage of E. coli extracts for in vitro protein synthesis, as FMN is difficult to remove from 
these extracts. The highly purified in vitro protein synthesis kit does not contain chaperones that interact with nascent chains, such as Trigger Factor and DnaK. In 
vitro protein synthesis yields a very low percentage of stalled ribosomes, as can be inferred from Fig. 6A. Shown is a Coomassie stained gel of a sample from an in vitro 
translation reaction before and after purification with Strep-Tactin column chroma-
tography. The gel of the sample before purification shows protein bands originating from ribosomal proteins. Also bands arising from non-ribosomal components of the 
in vitro translation kit, like aminoacyl-tRNA synthases, can be seen. These non-ribo-somal components can be removed by Strep-Tactin column chromatography. In Fig. 6A the position of the band corresponding to F44Y protein construct is indicated. 
The identity of this band is verified by Western blots probed with antibodies against 
flavodoxin and StrepII-tag (Fig. 6B). Before purification of the in vitro translation mixture this band is barely visible, as most ribosomes are devoid of stalled nascent 
chains. After Strep-Tactin chromatography purification the intensity of this band is comparable to those of ribosomal proteins, because in stalled RNCs, all proteins are 
present in equimolar quantities.
In contrast, F44Y flavodoxin nascent chains produced in E. coli are released from 
the ribosome in considerable quantities, as described above (Fig. 4B, C). Interest-ingly, the amount of F44YP produced in vitro is very small, because, as mentioned, 
Fig. 6A shows that the Coomassie stained bands of F44Y flavodoxin RNCs are all of comparable intensities. In case of nascent chain release, the released construct 
would have been purified together with the remaining RNCs by Strep-Tactin chro-
matography. Essentially, F44Y flavodoxin construct would be overproduced and 
would therefore no longer be equimolar to ribosomal proteins, which is clearly not the case (Fig. 6A).As discussed, determination of the FMN binding rate enables detection of the 
presence of apoflavodoxin’s MG. This methodology is thus suitable to investigate 
formation of molten globular nascent apoflavodoxin, provided that ribosomes 
themselves do not bind FMN. To check the latter, FMN was added to purified E. coli 
ribosomes and its fluorescence followed in time. As can be inferred from Fig. 6C, 
FMN does not associate with ribosomes, since no change in flavin fluorescence is observed.We assessed the rate of FMN binding to F44YRNC in buffer I and in this buffer with 290 mM NaCl. Fig. 6D shows that this increase in salt concentration does not affect the rate of FMN binding to F44YRNC. In contrast, such salt concentration change of 
buffer I considerably increases the rate of FMN binding to F44Y apoflavodoxin (Fig. 3C) and to the apo-form of F44YP (Fig. 5D), as F44Y apoflavodoxin switches from MG 
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Figure 6 Apoflavodoxin in F44YRNC is natively folded at low and high salt concentrations. A, Coomassie-stained gels of samples taken from an in vitro translation reaction of F44Y flavo-
doxin construct before (1) and after (2) purification with Strep-Tactin affinity chromatog-
raphy. An arrow labels the position of F44Y flavodoxin construct and red boxes enclose the bands of the non-ribosomal components of the in vitro translation reaction. B, Western blots 
of sample (2), probed with antibodies against flavodoxin (αFLD) or N-terminal StrepII-tag 
(αStrep), respectively. C, FMN fluorescence shows that ribosomes do not bind FMN. Con-centrations of ribosomes and FMN are 50 and 25 nM, respectively. D, FMN binding traces of F44YRNC in buffer I (blue) and in this buffer with 290 mM NaCl (red). Concentrations of F44YRNC and FMN are 50 and 25 nM, respectively.
to native protein. Because F44YRNC binds FMN rapidly at both salt concentrations, 
apoflavodoxin in F44YRNC must be natively folded under both conditions. We note that another implication of this observation is that the sample of F44YRNC cannot 
contain released F44Y flavodoxin construct, because if this would be the case the mentioned increase in salt concentration would lead to a change in FMN binding rate. Such a change is not seen in Fig. 6D thereby corroborating the above-men-
tioned equimolar presence of nascent chain and ribosomal proteins. At low ionic 
strength, F44Y apoflavodoxin and the apo-form of F44YP are molten globular, but, 
remarkably, apoflavodoxin in F44YRNC is natively folded. Apparently, the ribosome 
modulates flavodoxin folding and forces F44Y apoflavodoxin that is entirely synthe-
sized and exposed outside the ribosome, to which it is stalled by an artificial linker 
containing the SecM sequence, towards the native state. To our knowledge, this is 
the first time the effect of the ribosome on formation of MGs during protein synthe-sis has been determined.
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DISCUSSION
Determination of the rate of flavin binding is an innovative approach that makes 
it possible to investigate the presence of MGs during translation of flavin binding proteins. Using this methodology we demonstrated that the ribosome forces na-
scent, fully exposed, F44Y apoflavodoxin towards the native state. Confinement of MG formation during translation is an important observation that emphasizes dif-ferences between folding in vivo and in vitro.Due to the presence of ribosomal RNA surrounding the end of the exit tunnel, this part of the ribosome area has a considerable negative surface charge (55). Though some proteins only seem to randomly interact with the ribosomal surface (56), oth-ers interact to such an extent that local motions of compact domains are constrained (57) or folding/unfolding transitions are slowed down (58). These interactions like-ly arise due to attraction of positively charged residues and simultaneous repulsion of negatively charged residues of the nascent chain by the negatively charged ribo-
somal outer surface. Because the population of natively folded apoflavodoxin within F44YRNC at low salt concentration (i.e., in buffer I) is higher than is the case for F44Y 
apoflavodoxin in buffer I, the ribosome restrains formation of the off-pathway MG. Upon release of the nascent chain this effect is negated, as F44YP, a construct which was stalled to the ribosome before its release due to physical exertion, can form the MG state upon lowering ionic strength (Fig. 5D). It is tempting to speculate that the ribosome potentially mimics the effects of high ionic strength, thereby forcing mol-
ten globular apoflavodoxin to the native state. Native apoflavodoxin has a net charge of -13 at neutral pH (59). Possibly, the conformational space of unfolded nascent 
apoflavodoxin is restricted due to electrostatic repulsion of the nascent chain by the ribosomal surface, leading to entropic stabilization of native protein at physiological ionic strength.
We note that the RNC construct we use creates a somewhat artificial situation 
compared to translation of solely the flavodoxin gene. Due to presence of the SecM 
sequence and attached linker (Fig. 1C), RNCs are produced with the entire flavo-doxin domain exposed outside the ribosome. In contrast, when a ribosome reaches the stop codon and terminates the nascent chain during translation of solely the 
flavodoxin domain, approximately 30 to 40 residues of the protein are still buried in the exit tunnel. These residues need to traverse this tunnel before full-length protein emerges from the ribosome. We showed based on investigating C-terminally short-
ened flavodoxin RNCs that exposure of the five C-terminal residues of flavodoxin is essential for the nascent chain to be able to attain its native fold (44). Thus, while the 
30 to 40 C-terminal residues of flavodoxin are inside the exit tunnel, the part of the protein that is already outside the exit tunnel is unable to fold natively.
It would be interesting to verify whether our finding that the ribosome forces 
flavodoxin towards the native state also applies to the folding of flavodoxin-like domains within multi-domain proteins like cytochrome P450 reductase and nitric oxide synthase (60,61). As each domain of such a protein is translated the nascent chain remains tethered to the ribosome, thus providing the ribosome ample oppor-
tunity to influence the folding of an already translated flavodoxin-like domain.
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Folding of proteins with a flavodoxin-like architecture
The flavodoxin-like fold is a protein-architecture that can be traced back to the uni-
versal ancestor of the three kingdoms of life. Many proteins share this α-β parallel topology and hence it is highly relevant to illuminate how they fold. Here, we review 
experiments and simulations concerning the folding of flavodoxins and CheY-like 
proteins, which share the flavodoxin-like fold. These polypeptides tend to temporar-ily misfold during unassisted folding to their functionally active forms. This suscep-
tibility to frustration is caused by the more rapid formation of an α-helix compared 
to a β-sheet, particularly when a parallel β-sheet is involved. As a result, flavodox-in-like proteins form intermediates that are off-pathway to native protein and sev-eral of these species are molten globules. Experiments suggest that the off-pathway 
species are of helical nature and that flavodoxin-like proteins have a non-conserved 
transition state that determines the rate of productive folding. Folding of flavodoxin from Azotobacter vinelandii has been investigated extensively, enabling a schematic 
construction of its folding energy landscape. It is the only flavodoxin-like protein of which cotranslational folding has been probed. New insights that emphasize dif-ferences between in vivo and in vitro folding energy landscapes are emerging: the 
ribosome modulates molten globule formation in nascent apoflavodoxin and forces this polypeptide towards the native state.
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INTRODUCTION: FOLDING OF Α-Β PARALLEL PROTEINS, WITH A FOCUS ON 
THE FLAVODOXIN-LIKE FOLD
Protein structures are classified into topologies according to the relationship be-
tween sequential ordering of secondary structure elements and their spatial orga-
nization. Proteins that share the α-β parallel topology are characterised by a central 
parallel β-sheet surrounded by α-helices on both sides. This topology is a common 
structural design in nature. Various functionally and sequentially unrelated proteins with such a topology temporarily misfold during unassisted in vitro folding to their native state, yielding off-pathway folding intermediates. These species have been ob-
served for α-β parallel proteins with for example TIM barrel, α/β hydrolase, P-loop 
containing nucleoside triphosphate hydrolase, or flavodoxin-like folds (1-10).
In this review we discuss the folding of proteins with a flavodoxin-like fold (Fig. 
1A), which includes the families of flavodoxin- and CheY-related proteins, according 
to Structural Classification of Proteins (SCOP) in the Protein Data Bank (PDB). Be-
sides other flavodoxins, we particularly focus on how flavodoxin from A. vinelandii (Fig. 1B) folds, as its folding behaviour is one of the best characterised to date. We also evaluate folding of the following CheY-related proteins: the bacterial response regulator CheY (Fig. 1C), the sporulation response regulator Spo0F, and the N-termi-nal receiver domain of nitrogen regulator protein NtrC (NT-NtrC).
FLAVODOXINS: FUNCTION, EVOLUTION AND CATEGORIZATION
Flavodoxins are monomeric, single domain flavoproteins that are involved in electron transfer between various physiological redox partners. To shuttle elec-
trons, flavodoxins contain a non-covalently bound flavin mononucleotide (FMN). 
Phylogenomic analysis shows that flavodoxin is evolutionary one of the earliest pro-teins, just as ferredoxin is. Both proteins are rather promiscuous in their choice of redox partners and evolved in the anaerobic environment, preceding the advent of oxygenic photosynthesis (11). Before O2 levels rose, ferredoxin was the obligatory redox protein. Once O2 started to form, and bioavailability of iron became limiting, there was an intense selective pressure to replace oxidant-sensitive, iron-dependent 
proteins by oxidant-resistant, iron-free iso-functional counterparts. As flavodoxin 
satisfies both requirements, it temporarily took over ferrodoxin’s role (11,12).
The flavodoxin-like fold represents an architecture that can be traced back to the universal ancestor of all three kingdoms of life (11). Despite its ancient origin and low susceptibility to O2, flavodoxin itself has been lost in most eukaryotic lineages, including the entire plant and animal kingdom (12). Cyanobacteria and algae thriv-
ing in iron-deficient oceanic environments usually contain the flavodoxin gene. It is 
assumed that plants evolved from macro-algae that already lacked flavodoxin, be-cause they thrived in an iron-rich, freshwater habitat with no need to back up ferre-
doxin functions and therefore no selective pressure to keep the flavodoxin gene (11). Flavodoxin is not found in mitochondria, though it is present in alphaproteobacte-
ria, the suspected original endosymbiont. When both flavodoxin and ferredoxin are present in the same genome, like in many prokaryotes and algae, stress conditions 
such as iron starvation induce flavodoxin expression. Because electron transfer is 
essential for survival, flavodoxin largely replaces the roles of ferredoxin under these 
circumstances (11). Though flavodoxin is not found in the higher kingdoms of life, it has become incorporated in important multi-domain enzymes such as cytochrome 
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Chapter 5P450 reductase (13) and nitric oxide synthase (14) (Figs. 1D,E).Depending on methods used to determine evolution of protein architectures, the 
flavodoxin-like fold (c.23) is the sixth fold that arose (15,16). Interestingly, six out of 
the nine most ancient folds belong to the α/β class of proteins and more than half 
of the studied molecular fossils contain cofactors. Indeed, a flavodoxin made of only “early” amino acid residues is a functional protein with effective electron transfer 
capacity (17). Homology exists between the flavodoxin-like fold and the (β/α)8-bar-rel fold (c.1 or TIM-barrel) (18), which is considered to be the second oldest protein 
fold (16). The flavodoxin-like fold is one of two preferred folds that bind FMN, and the other is the TIM-barrel (19).Flavodoxins are categorized as short- or long-chain ones, depending on the pres-
ence of an insertion of about 20 amino acid residues in the last (i.e., fifth) β-strand (Figs. 1A, 2). The function of this loop has not yet been determined, though it is suspected to be involved in binding of partner proteins (20). The loop also seems 
to increase the binding affinity of FMN (20) and it is speculated that it is involved in formation of folding intermediates (21). Phylogenetic analyses suggests that 
short-chain flavodoxins derived from long-chain ones (22), although resolving this issue is complicated by several horizontal gene-transfer events between organisms 
(12). Only short-chain flavodoxins are found in firmicutes (Gram-positive bacteria), 
whereas cyanobacteria and algae exclusively synthesize long-chain flavodoxins (23). 
Gram-negative bacteria can contain flavodoxins from either category and may even contain both short- and long-chain ones. In Escherichia coli, for example, there are 
four genes predicted to code for flavodoxins. Two of these proteins belong to the long-chain category (i.e., FldA and FldB) and the other to the short-chain one (i.e., 
MioC and YqcA) (24).
Figure 2 Three-dimensional structures of long- and short-
chain flavodoxins. Shown are a long-chain protein from A. vine-
landii (blue, PDB entry 1YOB) and a short-chain one from D. vul-
garis (cyan, PDB entry 1J8Q). The loop shown on the left divides the 
fifth β-strand of the long-chain 
flavodoxin into β5a and β5b. FMN is shown in stick representation.
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Because the flavodoxin-like fold is widespread in the protein universe, illumina-
tion of its folding is highly relevant. Folding of flavodoxins from Anabaena, A. vine-
landii, Desulfovibrio desulfuricans, D. vulgaris, and Helicobacter pylori has been inves-tigated with differing levels of depth. Of these proteins, the ones from Desulfovibrio 
are short-chain flavodoxins.
ENERGY LANDSCAPES OF PROTEIN FOLDING AND ROLE OF INTERMEDIATESHow are proteins able to form a wide variety of three-dimensional structures 
from differing amino acid sequences? How can similar sequences fold to disparate 
structures? Two principles are essential for solving these challenges (25-29): Anfin-
sen’s thermodynamic hypothesis and Levinthal’s paradox. The thermodynamic hy-pothesis states that, at least for small globular proteins, the native structure is only 
determined by its amino acid sequence (25). In the protein’s relevant physiological 
environment the native structure is a unique, stable conformation at the kinetically accessible minimum of free energy. Levinthal calculated the time it would take for a 100-residue protein to randomly search all possible conformations and found that this would last longer than the lifetime of the universe (30,31). Paradoxically, most small proteins fold to their native structure within micro- to milli-seconds, and even folding of large multi-domain proteins rarely exceeds folding times of minutes (32). This issue can be resolved if the conformational search is not random, but involves 
intermediates in which local interactions form that direct the subsequent folding of the polypeptide chain and thereby accelerate the folding reaction (30,31). Both 
Anfinsen’s thermodynamic hypothesis and Levinthal’s paradox are integrated in the funnel-like energy landscape for protein folding (26,33).All possible conformations of a single polypeptide can be visualized forming a folding funnel (26,33). This funnel depicts the free energy of folding as a function of conformational entropy. The rim of the funnel is the starting area for folding (i.e., the 
unfolded state), which is not just one defined protein structure. Instead, the unfold-ed state comprises a conformational ensemble of rapidly interconverting unfolded structures, which is characterized by large entropy. Starting from the unfolded state, the peptide chain searches for the native state, which is the lowest point in the fold-ing energy landscape, as the idealized, smooth funnel of Fig. 3A shows (25). A myri-ad of interactions is involved in folding an unfolded protein, such as establishment of hydrophobic contacts, van der Waals interactions and formation of intra-molecular electrostatic connections and hydrogen bonds. Lowering of the chain entropy also 
plays a role. Proteins appear to firstly develop secondary structures in the chain (such as turns and helices), which may interact transiently, followed by growth into more global structures (29).
Formation of intermediates gives rise to a rugged folding surface, reflecting the presence of local energetic minima (Fig. 3B). Most intermediates are transient and 
only few of them have sufficient stability to be detectable. These species can be ei-ther on- or off-pathway to the native structure. On-pathway ones pre-dominantly contain native-like interactions in their structured parts. In contrast, off-pathway 
species have significant non-native, misfolded structure and are trapped in the cor-responding energetic minima. To return to the productive folding ensemble, these 
trapped species have to overcome significant energy barriers, which can be achieved by their (partial) unfolding. Intermediates that are off-pathway to the productive folding route can be visualized as residing in a “moated” landscape (Fig. 3C). Folding 
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Figure 3 Energy surfaces of protein folding. Free energies are shown vertically and reaction coordinates horizontally. Unfolded protein structures reside at the rim of each folding funnel. 
N indicates native protein and Ioff signifies off-pathway folding intermediate. A, Example of a smooth energy landscape, through which a polypeptide chain is effectively funnelled to its native structure. B, In a rugged folding funnel a protein can form intermediates on its way to the native state. C, In a moated folding funnel a protein can become kinetically trapped in a trench, resulting in formation of an off-pathway intermediate. D, Example of a folding funnel that is rugged and contains a moat, i.e., it contains on- and off-pathway intermediates. E, Sim-
plified alternative energy landscape of a protein that can temporarily form an off-pathway intermediate.
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Folding of proteins with a flavodoxin-like architectureof certain proteins involves both on- and off-pathway species, because the corre-sponding energy landscape is complex (Fig. 3D). It is rugged and contains a moat. Figure 3D suggests that both intermediates are on direct routes to the native state, as they reside within the same funnel. To better visualise the distinct character of both species, Fig. 3E positions the off-pathway intermediate on the bottom of a sep-arate trough that is connected to an on-pathway funnel.
MOLTEN GLOBULAR FOLDING INTERMEDIATES
An important folding intermediate is the molten globule (MG), which was first 
described for the protein α-lactalbumin (34-36). MGs are characterized by a sub-stantial amount of secondary structure, yet without the tertiary side-chain packing of natively folded protein. Furthermore, MGs are relatively compact (typical radius increase compared to native protein of about 10 to 30 %), possess a loosely packed hydrophobic core and expose hydrophobic patches to the solvent (36,37). MGs are 
prone to aggregation and consequently are implicated in various diseases (38). In 
vitro, several proteins form MGs under mildly alkaline or acidic conditions, includ-
ing α-lactalbumin, apomyoglobin and cytochrome c (34,35,39-44). These MGs all contain native-like secondary structure and packing, causing them to be on-path-way to the native state. In contrast, off-pathway MGs contain non-native second-ary structure and/or packing. Nowadays, many proteins are thought to fold via MGs (1,45-47). For example, MG species are necessary during insertion of proteins into membranes or during translocation (48-50). Such insertions often happen cotrans-lationally, i.e., while the ribosome synthesizes the polypeptide concerned. Proteins can fold cotranslationally and sample intermediate folding states (51-57), which might include MGs.
EXPLORATION OF THE FOLDING OF FLAVODOXIN FROM A. VINELANDII
We first consider the folding of flavodoxin from A. vinelandii. This bacterium con-
tains three flavodoxins, of which the long-chain flavodoxin II is most abundant under 
nitrogen fixating conditions (58). Folding of both the apo- and the holo-form of this 179-residue protein has been probed by using guanidinium hydrochloride (GuHCl) 
as denaturant. A wide variety of techniques were used, including (time-resolved) 
fluorescence, far-UV circular dichroism (CD), nuclear magnetic resonance (NMR) spectroscopy, hydrogen/deuterium exchange, electron paramagnetic resonance 
spectroscopy, (single-molecule) Förster resonance energy transfer, stopped-flow, paramagnetic relaxation, and FMN binding kinetics (5,59-79). These experiments 
show that apoflavodoxin folds autonomously and spontaneously to its native state 
(5) and that the subsequent binding of FMN is the last step in folding of flavodoxin (65). The three-dimensional structures of both native proteins are nearly identical, 
except for considerable flexibility in the flavin-binding region of apoflavodoxin (61). 
This flexibility is probably required for apoflavodoxin to capture FMN out of solu-
tion. After binding FMN with nanomolar affinity, the protein relaxes to an energet-
ically even more favourable state with picomolar binding affinity (74). As a result, 
many amino acid residues dispersed throughout the structure of flavodoxin become 
stabilized against unfolding (62,74). The stability of flavodoxin is so high that FMN 
needs to be released first before global unfolding of the protein can occur (65). Char-
acterisation of how flavodoxin kinetically folds in vitro shows that two parallel fold-
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ing routes are accessible to apoflavodoxin molecules with all prolyl peptide bonds 
in their native trans configuration (5,65). These routes, of which one is on- and the other off-pathway, are visualized in the energy landscape of Fig. 4. This landscape depicts a funnel to the native state and a trough in which a misfolded intermediate temporarily resides. Folding in the funnel and trough are described by schemes A and B, respectively:
FMN
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U N
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(Holo)   Scheme A
MG
off
FMN
FMN
I
on
U* N
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N
(Holo) Scheme B
Scheme A represents the approximately 10 % of unfolded molecules (U; rim of the funnel towards native protein) that directly follow the productive folding route 
to native apoflavodoxin (Apo; bottom of funnel). On this path, intermediate Ion is an obligatory, high-energy on-pathway species that rapidly converts to native apo-
flavodoxin (5). Ion resides in a moat in the funnel towards native protein. Due to its instability, Ion is not observed during denaturant-dependent equilibrium folding of the protein. This productive folding of 10 % of unfolded molecules happens on the 
microsecond timescale. Subsequently, flavodoxin (Holo; not depicted in Fig. 4) forms 
upon binding of FMN to native apoflavodoxin. Around 90 % of unfolded molecules (U*; the outer edge of the off-pathway trough) misfold within milliseconds and form the off-pathway intermediate MGoff (scheme B). This relatively stable species is also 
detected during denaturant-dependent equilibrium folding and is molten globular. MGoff is positioned at the bottom of the off-pathway trough. Thermal unfolding of 
apoflavodoxin at equilibrium also proceeds through formation of a MG-like interme-diate (61). MGoff needs to unfold significantly (i.e., to U*), which lasts about a second, before folding to the native state takes place. This productive folding occurs within microseconds and again involves Ion (5,65). Thus, all folding apoflavodoxin mole-cules, whether they reside on productive or non-productive pathways, ultimately pass through Ion before reaching the native state.
Native apoflavodoxin occasionally forms partially unfolded forms (PUFs). Four 
PUFs have been identified, which unfold subglobally in a cooperative manner (66). In PUF1 part of the long loop is unfolded and in PUF2 another part of this loop is unfolded. In PUF3 mainly the 24 N-terminal residues are unfolded. In PUF4 the core of the protein is unfolded, except for helix α4. Both PUF1 and PUF2 are unfolding 
excursions that start from native apoflavodoxin but do not continue to the unfolded state, and do not reside on the productive folding route. PUF4 is an unfolding excur-sion of MGoff and PUF3 likely is as well (66,72). PUF1 to PUF3 represent misfolded 
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Folding of proteins with a flavodoxin-like architectureconformations. All PUFs are off the productive folding route and demonstrate that 
the energy landscape of apoflavodoxin folding is even more rugged than depicted in Fig. 4.
Unfolded apoflavodoxin is not a featureless statistical coil, but instead contains four transiently ordered regions (67). Three of these regions are α-helices, whereas the fourth adopts non-native structure that is neither α-helix nor β-strand (Fig. 5) 
(67). During folding, these structured elements interact and subsequently form the ordered core of MGoff (67,70). This propensity to interact is visualized in Fig. 4 and in scheme B by U*. Non-native docking of the α-helices in MGoff prevents formation 
of the parallel β-sheet of native apoflavodoxin (67,70-72). Thus, the source for MGoff formation is situated in the unfolded state. The off-pathway intermediate has a dras-tically different architecture compared with native protein: it is largely α-helical and 
contains no β-sheet (69) and is slightly expanded compared to native apoflavodoxin 
(59). This α-helical MG acts as a trap and needs to unfold significantly in order to 
embark on a route to native α-β parallel protein.
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Figure 4 Schematic folding energy landscape of A. vinelandii apoflavodoxin. The left funnel shows the on-pathway route to native protein (N), on which an on-pathway intermediate 
(Ion) resides. The trough on the right displays formation of apoflavodoxin’s off-pathway MG (MGoff). This molten globular species folds gradually, as exemplified by the presence of shal-
low moats. For simplicity’s sake, the rugged character of MGoff folding, as evidenced by the detection of partially unfolded forms PUF3 and PUF4 (66), is not depicted in the MGoff trough. Unfolding excursions PUF1 and PUF2 that start from native protein are also omitted. Only 
native apoflavodoxin binds FMN, which leads to considerable stabilisation of the protein and deepening of the corresponding funnel (not shown). In reality, the ratio of the circumferences 
of the rims of the on- and off-pathway funnels is about 1 to 9. This ratio reflects that 10 % 
of unfolded molecules directly follow the productive folding route to native apoflavodoxin, whereas 90 % of unfolded molecules misfold and temporarily form MGoff (5). Apoflavodoxin is in 100 mM potassium pyrophosphate, pH 6.0, at 25 °C.
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While formation of native apoflavodoxin is highly cooperative (5,61,64,78), con-version of unfolded protein into MGoff is a non-cooperative, gradual process that 
simultaneously involves separate regions within apoflavodoxin (70,78). This sug-gests an energy landscape of MG folding with many barriers (visualised by shallow moats in the off-pathway trough of Fig. 4). In vitro, folding of the C-terminal part of MGoff precedes folding of the N-terminal part and this intermediate gradually com-pacts due to progressive extension of its ordered core (76,78). This non-cooperative folding happens because helices involve relatively short-range interactions and the folding of one helix does not need to affect the folding of other helices (70). Indeed, thermodynamically derived phase diagrams indicate that the transition from an un-folded species to a MG is a gradual, second-order-like process (80,81). Ultimately, 
after folding, the helical off-pathway MG of apoflavodoxin is almost entirely struc-tured (70,78).
FOLDING OF OTHER FLAVODOXINS
Anabaena flavodoxin. In native apoflavodoxin from Anabaena PCC 7119 the 
cofactor-binding site is flexible and FMN binds preferentially to native apo-pro-tein (82-84). Full release of cofactor happens upon unfolding of this 169-residue 
long-chain flavodoxin (85). Both urea- and GuHCl-dependent equilibrium folding of 
apoflavodoxin are two-state (83,85,86). During kinetic folding an intermediate tran-siently accumulates, whose unfolding is rate-limiting (3). Whether this off-pathway intermediate is a MG is unknown. Phi-value analysis of mutations (87) revealed that the transition state that separates unfolded and native apo-protein is diffuse, and various interactions seem to be similarly important for rate-limiting barrier cross-
ing (88). The folding nucleus appears to be formed by the packing of helices α3, α4, 
and α5 onto strands β3 and β4.
In an apoflavodoxin variant whose stability has been reduced by excision of the 
Figure 5 Model of the off-pathway MG of A. vinelandii flavodoxin, in which the four, transiently structured regions detected in unfolded protein are highlighted. Helical parts also pres-ent in native protein are coloured green and regions of the unfolded 
protein that adopt α-helical struc-ture not found in native protein are coloured blue; the orange element 
is structured, yet is neither α-helix 
nor β-strand in unfolded protein. These regions dock non-natively 
and form the core of apoflavodox-
in’s MG (67,69,70,72). The cartoon shows the structural elements of the off-pathway MG, but their rela-tive positioning is unknown.
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Folding of proteins with a flavodoxin-like architectureC-terminal helix, the resulting protein fragment adopts a molten globular conforma-tion at pH 7 (89,90). Its far-UV CD spectrum resembles the one of full-length, molten 
globular apoflavodoxin at acidic pH (86). The structure of this MG is homogeneously weakened compared to the one of full-length native protein (90). The MG can be stabilized by increasing the helical propensity of helical regions of full-length native 
apoflavodoxin, suggesting preservation of helices in this MG (90).Thermal unfolding of Anabaena apoflavodoxin at equilibrium follows a three-state mechanism in which an intermediate, with spectroscopic properties of a MG, populates (85,91,92). A low-resolution structure of this species has been inferred from Phi-value analysis (92). Large parts of the intermediate seem to have na-tive-like topology, with somewhat weakened native interactions, but a 40-residue region is unfolded (85,91,92). The thermal intermediate neither resembles the MG that accumulates at low pH, nor the transition state for productive folding, nor the MG fragment. Whether this species is similar to the transient intermediate observed 
during kinetic folding of apoflavodoxin is unknown (93).
Apoflavodoxin variant F98N, in which the substitution of phenylalanine to aspar-agine destabilizes native protein, exhibits spectroscopic properties at 25 °C similar 
to those of the thermal intermediate of wild-type protein (93). For F98N apoflavo-
doxin the MG is the only species that populates significantly at 25 °C. The solution structure of this MG, which is less compact than native protein (94), comprises all 5 
α-helices and β-strands 1 to 4 and 5a of native apoflavodoxin as well as their pack-
ing. Strand β4 and helices α4 and α5 are shorter than in native protein (93). The loop 
that splits the fifth β-strand of apoflavodoxin into β5a and β5b is unstructured, just like the FMN binding loops encompassing residues 57 – 63 and 90 – 100 (92,93). These three segments are in contact in native protein and form a distinct region. 
Whether the thermal intermediate is on- or off-pathway to native apoflavodoxin has not been probed.
H. pylori flavodoxin. This 164-residue protein is essential to H. pylori, the bac-
terium responsible for gastric ulcers. Hence, this long-chain flavodoxin is a target 
for drug discovery (95-97). Again, FMN only binds to native apoflavodoxin, which strongly stabilises the protein (98), thereby enabling it to be functional between pH 
2 and 10 (99). Apoflavodoxin (100) and flavodoxin (97) are structurally similar, but 
in apo-protein the loops binding the isoalloxazine are flexible (100). This flavodoxin strongly resembles A. vinelandii and Anabaena flavodoxins, but its FMN binding site 
is more accessible (97,100). As a result, inhibitors can bind specifically to H. pylori 
flavodoxin and thereby disrupt its electron transfer function (96,101).The folding characteristics of H. pylori (apo)flavodoxin have been studied by thermal unfolding and by lowering pH (98,99,102). Both methods result in forma-tion of intermediates, yet with very different features. Thermal unfolding of (apo)
flavodoxin involves two equilibrium intermediates (102). One species is similar to the thermal intermediate observed for Anabaena apoflavodoxin. Compared to native protein, this species has a slight increase in solvent-exposure of tryptophans and preserves most of the secondary structure of the native protein (around 80 % of na-tive helix content). The other intermediate more closely resembles unfolded protein and has lost the tertiary contacts of native protein and a large part of its secondary structure, but at least one of its two tryptophans is partially buried (102).
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Chapter 5Under strongly acidic conditions, H. pylori apoflavodoxin forms a MG that is slightly expanded compared to native protein. It has high helical content, displays exposed hydrophobic patches, and is devoid of, or maybe has very weakened, ter-tiary native interactions (98). This MG is structurally different from the two thermal 
intermediates identified at neutral pH (99,102). Whereas under acidic conditions the MG of H. pylori apoflavodoxin is soluble and monomeric (98), the MG of Anabae-
na apoflavodoxin aggregates massively (86). For H. pylori apoflavodoxin at neutral pH, the ensemble of molecules comprises native protein, the MG discovered by acid unfolding and the two intermediates revealed by thermal unfolding of the protein (99). The latter three species are present at relatively low mole fractions, with the MG state hardly populated at all (99). As no studies are reported of the folding ki-netics of H. pylori flavodoxin, the on- or off-pathway nature of its intermediates is 
unidentified.
D. desulfuricans flavodoxin. This 148-residue protein is a short-chain flavodox-in and is very sensitive to buffer and ionic strength conditions (103). A single folding study of D. desulfuricans (apo)flavodoxin from ATTC strain 27774 has been report-
ed, which suggests that during its GuHCl-dependent equilibrium folding an inter-mediate populates. This species has a more solvent exposed tryptophan than native protein and judged by far-UV CD ellipticity at 220 nm it has native-like secondary 
structure (104). Folding of apoflavodoxin from D. desulfuricans strain ATTC 29577 
(75 % sequence identity with ATTC 27774 protein) has been studied more exten-
sively. This protein unfolds in a two-state fashion in denaturant-dependent equilib-rium folding (105) and possibly populates intermediate states at low concentrations of denaturant (106). Thermal unfolding of apo- and holo-protein shows formation 
of an equilibrium intermediate. This species has native-like CD signal at 222 nm and 
reduced fluorescence compared to native protein and resembles the thermal inter-mediate of Anabaena apoflavodoxin (107), suggesting that it is a MG. Kinetic folding of D. desulfuricans apoflavodoxin studied by stopped-flow involves an intermediate 
that forms during the mixing dead-time. This ‘burst-phase’ species has a significant amount of secondary structure and appears to be off-pathway to the native state (105,108,109). However, kinetic analyses that conclusively verify the role of this in-termediate still need to be done.For Y98A and W60A variants of D. desulfuricans flavodoxin the apo-protein first 
has to fold to its native state before it can bind FMN (108). For wild-type flavodoxin (ATTC strains 27774 and 29577) it was suggested that FMN binding has no effect on 
its GuHCl-dependent equilibrium folding (104,105). However, FMN speeds up the folding of this protein (105). The researchers involved handled the resulting ther-
modynamic conflict by assuming that unfolded wild-type protein binds FMN with 
nanomolar affinity (104,105), which is a remarkable assumption. Indeed, with urea, 
FMN dissociates prior to protein unfolding and urea-unfolded apoflavodoxin does not interact with FMN (106).Phi-value analysis revealed that the transition state for productive folding is dif-fuse and involves partially formed interactions throughout the polypeptide (109), as observed for Anabaena apoflavodoxin (88). In the transition state most β-strands on 
both sides of β-strand 3 must align properly with native-like interactions before final 
folding to native apoflavodoxin can occur (109).
123
Folding of proteins with a flavodoxin-like architectureCoarse-grained simulations can provide information about early folding events 
and intermediates. In such simulations of apoflavodoxin folding (109), interactions 
are represented by a Gō-like potential, in which only residue pairs that are in contact in the native state experience a pairwise attractive force. This procedure ignores non-native interactions, and thus is intrinsically limited, but can show frustration of 
another variety, called ‘topological frustration’. Topological frustration arises when native interactions form in the incorrect order or when competing folding pathways are present. The simulations suggest two competing folding nuclei at opposite sides 
of the central β-strand 3 of apoflavodoxin (centred on β-strands 1 and 4, respec-
tively). The β-strand pair that interacts first among the five strands leads to domi-nance of the corresponding nucleation site and causes early misfolding (109). This topological frustration may contribute to temporary formation of an off-pathway species. It is unknown whether the in vitro kinetic intermediate contains the β-sheet 
structure identified for the in silico folding species. Neither is it known whether this kinetic intermediate is a MG.
D. vulgaris (Hildenborough) flavodoxin. This 148-residue, short-chain fla-
vodoxin strongly resembles flavodoxin from D. desulfuricans (110,111). During its unfolding, dissociation into apo-protein and FMN is the rate-determining step and in unfolded protein FMN is fully dissociated (112). Binding of FMN is the last step 
during folding. The fluorescence changes observed during urea-dependent equilib-
rium folding of apo- and holo-protein fit two-state models, but involvement of inter-
mediates cannot be excluded as only one spectroscopic technique was used (112). 
No kinetic folding data have been reported of this flavodoxin.
Table 1 Folding of flavodoxin-like proteinsn.d.: not determined. *: derived from simulation.
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Table 1 summarises the folding of flavodoxins and shows that these proteins tend to form off-pathway intermediates during their unassisted folding in vitro to their functionally active forms. Several of these species are MGs.
FOLDING OF PROTEINS THAT SHARE THE FLAVODOXIN-LIKE FOLD: THE 
CHEY-LIKE SUPERFAMILY
CheY. Considerable effort has been put into elucidating the folding of CheY from E. coli, which is a 129-residue, single-domain, response regulator involved in chemotaxis. CheY becomes activated upon phosphorylation of D57 and has in-trinsic auto-dephosphorylation capacity. Its temperature-dependent folding pro-ceeds through a highly populated intermediate state, which is a MG dimer (113). 
Urea-dependent equilibrium folding of CheY monitored by fluorescence and far-UV 
CD fits a two-state model. However, ANS binding suggests that a MG-like folding state populates (113). Characterisation of the folding of the F14N/V83T variant of CheY by NMR spectroscopy also shows involvement of a MG, which can associate 
to a dimeric MG (114). It has been proposed that the monomeric MG can sequen-
tially unfold into another intermediate I*, in which the first half of the polypeptide chain remains non-native and collapsed, and the second half is unfolded (114). In contrast, native protein unfolds highly cooperatively (114). Unfolded F14N/V83T protein in 5 M urea has residual structure (115). Hα NMR chemical shift values indi-cate that two segments of unfolded CheY form helices. The 70 N-terminal residues of unfolded CheY have restricted mobility compared to the rest of the polypeptide. This collapsed region is stabilized by non-local interactions (115). It is tempting to 
speculate that formation of structured sequence segments in unfolded CheY leads to establishment of I*.To characterize the transition state on the productive pathway to native protein, 
use was made of Phi-value analysis. This procedure identified two folding subdo-mains: an N-terminal one that is highly structured in the transition state and an unstructured C-terminal one (116). Formation of the 70-residue N-terminal subdo-
main is rate limiting and serves as the nucleus for subsequent condensation of the C-terminal subdomain (116,117). Intermediate I* resembles this transition state (114).Upon folding, CheY collapses to a burst-phase intermediate that possesses sig-
nificant stability and secondary structure (117,118). Analysis of the folding kinetics 
suggests that all five helices of CheY are formed in this sub-millisecond species (118). The far-UV CD spectrum of this intermediate resembles that of the native state. How-ever, the packing of aromatic side chains might not be identical (9). Neither can it be 
excluded that this species lacks a β-sheet. CheY folds through two parallel pathways, 
which are defined by the state of isomerization of a proline in the active site, which is cis in native protein. Proline isomerization in the highly structured burst-phase species differs between both pathways. However, formation of this intermediate is 
not a consequence of proline isomerization (9). The most likely folding model places the burst-phase species off-pathway to the native state. Each intermediate has to at least partially unfold before productive folding occurs. The extent of secondary structure formation and side-chain packing in these off-pathway intermediates are consistent with a MG-like state (9).Coarse-grained simulations were used to further explore CheY folding. In these 
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Folding of proteins with a flavodoxin-like architecturesimulations the protein is represented as a string of C
α
 beads that interact via a Gō-like potential. One simulation shows formation of a misfolded intermediate, which 
has all five helices present in native CheY, but lacks its central β-parallel sheet. This misfolded species has to at least partially unfold before the native state is reached 
(119). More recent “flavoured” Gō-model simulations, in which the interaction en-ergies of side-chain native contacts were scaled according to their abundance in the PDB, also show the existence of a frustrated state. This topologically frustrated spe-
cies is a consequence of competition for native van der Waals contacts between the N- and C-terminal subdomains of CheY, leading to premature docking of these do-
mains (120). Secondary structure elements α2, β3, α3 and β4 of native protein are in-volved in formation of this intermediate (9,120). It unfolds before productive folding in the N-subdomain occurs, leading to native protein. The experimentally observed, off-pathway intermediate seems consistent with early topological frustration during folding of CheY (9,120).An alternative source for frustration during protein folding that leads to off-path-
way species could be the formation of an unproductive local-in-sequence cluster of side chains of isoleucine, leucine, and valine (ILV) (9,121,122). CheY has two ILV 
clusters, one on either side of the central β-sheet, each serving to fuse the surface 
helices to each other and to the β-sheet. The smaller cluster contains 10 side chains 
and primarily links α2-β3-α 3-β4 on one face of the parallel β-sheet of native CheY; the 
larger cluster contains 15 side chains and links the β-sheet to α1 and α5 (122,123). The smaller cluster seems crucial to the off-pathway reaction (9).Aspects of the models for premature docking of subdomains and for formation of an unproductive ILV cluster appear to describe the folding of CheY. The subdo-
main model fulfils the requirement for an intact N-terminal domain to access the native conformation. The ILV-cluster model captures best the initial formation of an off-pathway intermediate (122). The events that lead to this frustrated species comprise accumulation of substructures favoured by low-contact-order nonpolar interactions in the polypeptide. This leads to burial of surface areas, maximization of participation of aliphatic side chains in one of the two ILV clusters, and reduction in chain entropy penalty. Ultimately, CheY arrives in the lowest free energy minimum of its energy landscape of folding, which is the native state (122).
Spo0F and NT-NtrC. A combined experimental and simulation analysis was done on the folding of Spo0F from Salmonella typhimurium and NT-NtrC from Bacillus 
subtilis, which are 124-residue response-regulator proteins that have low sequence similarity (123). Both proteins are allosterically activated through phosphorylation 
of D54. “Flavoured” Gō-model-like simulations show that in the productive folding transition state for non-phosphorylated Spo0F and phosphorylated NT-NtrC the N-terminal subdomain is partially structured whereas the C-terminal one is not, just as observed for CheY (123). A similar result was obtained for non-phosphorylat-ed NT-NtrC using a topology-based, coarse grained approach based on a variational model of protein folding, which shows that the N-terminal half of the protein appears to fold earlier than the C-terminal half (124). This folding scenario was also derived by using a coarse-grained, structure-based Hamiltonian model (125). Remarkably, for phosphorylated NT-NtrC the latter two simulations suggest that the C-terminal 
half of the protein folds first (124,125), contradicting the simulations of (123).
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Chapter 5Kinetic folding experiments show that both Spo0F and NT-NtrC fold via parallel pathways through highly structured sub-millisecond intermediates before access-ing their cis prolyl peptide bond-containing native conformations. Global analysis of the data favours an off-pathway folding mechanism for both proteins (123). Se-
quence-sensitive Gō-model simulations suggest that frustration in the folding of 
Spo0F leads to the appearance of an off-pathway species, reflecting competition for intra-subdomain van der Waals contacts between its N- and C-terminal subdomains. 
Secondary structure elements α3, β4, α4 and β5 of native protein (i.e., the C-subdo-
main of Spo0F) are involved in formation of this frustrated state. Local-in-sequence clusters of side chains of ILV stabilize the intermediate. Comparable observations were made for CheY folding. In case of NT-NtrC, the simulations fail to detect an off-pathway species. Experimental kinetic folding data show that the free-energy landscapes for folding of NT-NtrC and Spo0F are in many ways similar to the one of CheY (9,123).
Table 1 shows that off-pathway intermediate formation is characteristic for 
the folding of CheY-like proteins. Just as for flavodoxins, differences in the stabili-ty of these intermediates, and hence in their populations, may be explained by se-
quence-specific interactions within these species.
FLAVODOXIN-LIKE PROTEINS TEND TO TEMPORARILY MISFOLD DURING 
UNASSISTED FOLDING IN VITRO AND HAVE NON-CONSERVED TRANSITION 
STATES OF FOLDINGFlavodoxin-like proteins are susceptible to frustration in the early stages of fold-
ing, because an α-helix forms much more quickly than a parallel β-sheet. α-Helix formation is rapid due to the highly local character of interactions that produce this secondary structure. In contrast, many intervening residues separate the amino ac-
ids that constitute the strands of a parallel β-sheet and thus its formation is rela-
tively slow. Since in Gō-like simulations only residue pairs that are in contact in the 
native state experience attractive forces, application of this model to flavodoxin-like proteins should produce comparably structured off-pathway intermediates. Howev-er, we note that slightly differing simulations, including those in which heterogene-
ity of the native contact energies is added to incorporate sequence effects, produce markedly dissimilar intermediates. For D. desulfuricans apoflavodoxin the misfolded 
species contains β-sheet structure (109). For CheY the off-pathway intermediate is 
reported to be helical, lacking the central parallel β-sheet of native protein (119). 
However, other simulations show that secondary structure elements α2, β3, α3 and β4 of native CheY seem to be involved in formation of this species (9,120). For Spo0F, simulations demonstrate that formation of this intermediate engages secondary 
structure elements α3, β4, α4 and β5 of native protein. Apparently, variations in se-
quence seem to modulate formation of these folding intermediates (122,123).It is important to experimentally characterize the structural features of the dis-cussed off-pathway intermediates in order to verify whether theory correctly pre-
dicts their conformations. In addition, characterization of the unfolded states of fla-vodoxin-like proteins is essential to comprehend how these misfolded species form, as residual structure in unfolded protein facilitates formation of folding intermedi-ates. For A. vinelandii flavodoxin (67,70-72) and CheY (115) the unfolded protein has 
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Folding of proteins with a flavodoxin-like architecturebeen experimentally probed at the residue level. Transiently ordered regions exist 
in both unfolded proteins and largely comprise α-helical structures. Besides native 
also non-native α-helical structure may develop (Fig. 5). Gō-like simulations cannot 
predict such non-native structure. In flavodoxin-like proteins, hydrophobic inter-
actions of side chains pack α-helices onto the parallel β-sheet. This typical feature 
probably contributes to the observed misfolding, as upon folding the α-helices fold 
first and can subsequently dock onto one another through hydrophobic interactions. 
This docking prevents formation of the parallel β-sheet and the resulting misfold-ed intermediate needs to unfold considerably before folding to native protein can take place, explaining why this species is off-pathway, as experimentally shown for 
A. vinelandii flavodoxin (67,70-72,76,78). Indeed, this off-pathway species is largely 
α-helical (69). The off-pathway intermediate of CheY also appears to be helical, as all 
five native α-helices are formed and as stabilization of any of its α-helices slows re-folding at low denaturant concentrations (118). Experiments thus strongly suggest 
that the off-pathway intermediate of flavodoxin-like proteins is of helical nature. Future experimental efforts, using for example Fourier transform infrared spectros-copy, should reveal whether the misfolded species of D. desulfuricans apoflavodoxin 
and Spo0F really contain β-sheet structure, as simulations seem to suggest.Current knowledge about the kinetics and energetics of protein folding largely stems from in vitro studies and from simulations. These studies revealed that the 
topology of a native protein influences the rate with which the native state is formed 
in vitro. This implies that the transition state that determines the rate of folding re-sembles the native state of a protein. Interactions involving a few key residues force a folding protein to adopt a rudimentary native-like architecture. Once the correct topology has been achieved, the native structure will then almost invariably be gen-
erated during the final stages of folding (126-130). Phi-value analysis shows that the productive folding transition state of CheY is polarized with a structured N-terminal subdomain and an unstructured C-terminal one (116). Simulations reveal transition states for non-phosphorylated Spo0F and phosphorylated NT-NtrC similar to the one of CheY (123). This indicates that the N-subdomain serves as the folding nucleus for these proteins. In contrast, the transition states of Anabaena and D. desulfuricans 
apoflavodoxins are diffuse with partial formation of many inter-residue interactions 
(88,109). Thus, the productive folding transition state of a flavodoxin-like protein seems to differ from one protein to another. Apparently, both chain topology and 
amino acid sequence contribute to defining the structure of this transition state and 
the folding energy landscapes of flavodoxin-like proteins.
In summary, flavodoxin-like proteins tend to temporarily misfold during their unassisted folding in vitro and have a non-conserved transition state that deter-mines their rate of productive folding
PROTEIN FOLDING IN VIVOWhile most protein folding experiments have been done in vitro (Fig. 6A), the circumstances under which folding occurs in the cellular environment differ dra-matically (Fig. 6B).Firstly, the conditions under which most folding landscapes are probed in vitro are physiologically speaking irrelevant. Illustrative in this regard is the use of high concentrations of GuHCl or urea (although data can be extrapolated to zero molar 
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denaturant). More gentle techniques to study protein folding are alteration of pH or temperature. Yet, even results obtained by these methods need to be carefully con-sidered before they can be judged to be physiologically relevant. For example, how pertinent are folding intermediates found at pH 4, such as MGs, when the cytoplas-mic environment is buffered at approximately pH 7 (131)? Concerning proteins that 
originate from endothermic organisms: how significant are folding intermediates found at 20 or 50 °C? Ultimately, existence of folding intermediates in vitro does not 
necessarily imply occurrence of the same or similar species and their consequences 
in vivo.
Secondly, compared to most in vitro folding experiments, the cellular environ-ment is immensely crowded (Fig. 6B), with estimations of the concentration of pro-teins and other macromolecules ranging up to 300 - 400 g/L (132). This crowding 
can lead to a significant excluded volume effect, which in turn can influence the type and amount of interactions a polypeptide can form (133,134). However, folding in 
vitro is typically done using dilute buffers with micro-molar protein concentrations (Fig. 6A). For A. vinelandii apoflavodoxin, conditions that mimic macromolecular crowding inside cells lead to compaction of unfolded protein and slight stabilization of native protein (59). Crowding causes severe aggregation of its off-pathway MG (59). In case of H. pylori apoflavodoxin, crowding slightly stabilizes both native and 
molten globular protein, but does not significantly stabilize the native state relative to its MG (99). Remarkably, crowding increases the midpoint of thermal unfolding 
Figure 6 Comparing protein folding in vitro and in vivo. A, Folding in vitro involves the entire 
polypeptide sequence (i.e., full-length protein (black)) in a dilute environment of interactors (red), the majority of which is similar in physical properties like size, charge and hydro-phobicity. B, Folding in vivo starts during translation of the nascent chain (black) by the ribosome (beige). Chaperones like Trigger factor (green) and DnaK/DnaJ (blue) can interact with the nascent chain, whereas chaperones like GroEL/GroES (purple) act on the released polypeptide. The cellular environment is crowded with many macromolecules (various colours), which span the entire range of physical properties.
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of apoflavodoxin from D. desulfuricans by up to 20 °C (103). In contrast to other 
apoflavodoxins, the stability of this protein is very sensitive to buffer composition. Its thermal midpoint of unfolding can decrease as much as 25 °C upon changing from phosphate to HEPES buffer (103). Crowding makes the ensemble of unfolded conformations of D. desulfuricans apoflavodoxin less expanded, resulting in a folding funnel that apparently is smoother and narrower (135). Upon changing the crowd-ing agent the folding mechanism of this protein seems to be modulated differently, and folding routes experiencing topological frustrations might be either enhanced 
or relieved (136). The influence of crowding on the folding CheY-like proteins has 
not been reported. For various other proteins the effects of artificial crowders, such as Ficoll, glycerol, dextrans and others, and occasionally of similar kinds of crowders put together, have also been probed (for an extensive review see (137)). However, these crowders differ from those in a cell, in which they span broad spectra of size, 
hydrophobicity and charge, and are present simultaneously. Artificial crowders thus possess shortcomings and their usefulness in predicting effects of crowding in vivo is contested (138).Thirdly, a major difference between folding in vitro and in vivo is the circum-stance under which a protein is introduced in either environment. During in vitro folding a full-length polypeptide, or sometimes fragments of it, is studied (Fig. 6A). 
The protein is chemically or thermally unfolded and subsequently it can in principle sample all of its folding states while progressing to the native state. In vivo, however, a polypeptide can start to fold as soon as it becomes produced by the ribosome (Fig. 6B).
Ribosomes play a crucial role as a central hub in coordinating protein quality control (139,140). They sense the nature of the emerging polypeptide, recruit pro-
tein folding and translocation factors, and integrate mRNA and nascent chain quality control. Ribosomes can control the cellular abundance of proteins at the translation-
al level and thus are a significant constituent of protein homeostasis (139,141-144). In growing cells, most ribosomes are active in translation and contain an emerging polypeptide. Whereas ribosomal structures have been elucidated in atomic detail (see e.g. (145-149)), relatively little is known about the conformational events poly-peptide chains undergo while they are produced.Upon addition of amino acid residues, the growing nascent chain gradually emerges from the ribosomal exit tunnel. This tunnel is between 80 and 100 Å long and 10 to 20 Å wide (150). Depending on nascent chain conformation, the exit tun-
nel can hold between 30 (extended) to 70 (α-helical) amino acid residues. Folding or misfolding of the nascent chain may already start in the exit tunnel (151-154) and in most cases commences while the nascent chain gradually emerges from it (51-53,55,155-163). As synthesis of the nascent chain is orders of magnitude slower than it takes a protein to fold (i.e., seconds versus micro- to milliseconds), nascent chains can already sample parts of their conformational space before the next amino acid residue is added. This phenomenon, in combination with gradual emergence of the polypeptide from the exit tunnel, might impose conformational constraints on the folding energy landscape of the protein involved. Folding during synthesis on the ribosome leads to constant remodelling of the folding energy landscape as translation proceeds. Matters are complicated even further by the various manners 
in which translational speed can be influenced. A well-known one is the effect of codon usage (164). The resulting ribosome pausing affects cotranslational folding 
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(165-168). Folding of the mRNA sequence that is being translated also influences translation velocity (169).The ribosome itself can also modulate protein folding, for example through in-teraction of the nascent chain with the exit tunnel or, upon its emergence from the tunnel, with the ribosomal surface (57,170,171). Nascent chains can adopt distinct 
conformations within this tunnel. Formation of α-helices, α- and β-hairpins and even 
native structure for some small proteins (< 10 kDa), but also non-native conforma-tion, can occur near the tunnel exit, where the tunnel widens to form a vestibule (57,172-174). The tunnel prevents proper tertiary folding of larger protein domains and precludes the C-terminal residues of the nascent chain from participating in 
long-range interactions (175). As a consequence, productive folding can occur only after a complete protein or a domain has come out of the ribosome (176). Once a na-
scent chain emerges it’s folding can be influenced by transient electrostatic interac-tions with the ribosomal surface. As the exterior of the ribosome consists for a large part of rRNA, it is negatively charged in many areas. Negative charge also surrounds the exit tunnel, thereby providing an environment that is very different from the 
cytoplasm (177). This charge may influence protein folding, as it attracts positively charged residues of the nascent chain and repels negatively charged ones (170). It also restricts the dynamics of nascent chains according to their charge (177). Due to these electrostatic interactions, nascent chains may be protected from misfolding or aggregation.Methodologies like epitope recognition, enzymatic activity, cofactor binding, 
NMR and fluorescence spectroscopy indicate structural ordering and acquisition of activity of polypeptides once they arrive outside the exit tunnel (51-53,55,155-163). 
Cotranslational folding has been observed for all α (51), all β (53,55,159,162) and 
α/β proteins (54,178,179). Various nascent chains form native- or non-native-like 
intermediates (51-53,55,159,180-182). In the next section we discuss the only fla-vodoxin-like protein where cotranslational folding has been probed: A. vinelandii 
flavodoxin.Lastly, upon emergence from the exit tunnel, cellular proteins can start to inter-
act with the nascent chain and affect it’s folding (Fig. 6B). Some of the first proteins that meet the nascent chain are processing proteins such as peptide deformylase, which removes the formyl moiety from the N-terminal formyl-methionine. Another processing protein is methionine aminopeptidase, which hydrolyses the N-termi-nal methionine for more than 50 % of nascent chains (183). Other processes that 
can happen during translation include nascent chain modification through glyco-
sylation, phosphorylation, etcetera’s, and/or translocation of the nascent chain into membranes, like the endoplasmic reticulum or the plasma membrane. Chaperone proteins that hover at the exit tunnel facilitate nascent chain folding just outside this tunnel (184,185). They prevent protein aggregation and/or stimulate folding towards the native state. Chaperones often interact with co-chaperones (186). After release of a protein from the ribosome, its folding may also be affected by chaper-
ones. Because chaperones can be purified, their individual effects on protein folding can be studied with relative ease in vitro. As a cell contains many different chap-erones, with estimations ranging to hundreds for eukaryotic cells (187), the total effect of the chaperone network on protein folding cannot be determined in a test 
tube. To date, no study of the influences of chaperones on the folding of flavodox-in-like proteins has been reported.
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Folding of proteins with a flavodoxin-like architectureThese differences between in vitro and in vivo protein folding show that a de-
mand exists to obtain a molecular description of how flavodoxin-like proteins fold 
in a cell. In the following, as a first step towards this goal, we discuss the cotransla-
tional folding of flavodoxin.
THE RIBOSOME AFFECTS FLAVODOXIN FOLDINGVarious strategies exist to study folding of a protein while it emerges from the ribosome. To characterize nascent chain folding of A. vinelandii flavodoxin, the approach we followed is to produce, purify and characterize stably arrested ribo-some-nascent chain complexes (RNCs). RNCs consist of the entire 70S ribosome with a polypeptide that is stalled through tight interaction with the exit tunnel. Pro-duction of these RNCs happens in E. coli (179) or by using an in vitro protein synthe-
sis kit (188). To achieve translational stalling, a sequence derived from E. coli SecM (Secretion Monitor protein) is attached to the C-terminus of the translating nascent protein (189,190). In addition, the construct used contains a linker that connects 
SecM and flavodoxin and spans the length of the exit tunnel, thereby entirely ex-
posing the flavodoxin polypeptide outside the ribosome (179,188). Use is made of 
constructs that lack zero, five or ten amino acid residues at the C-terminus of stalled 
flavodoxin. This procedure allows mimicking of late stages during protein transla-tion and enables one to obtain “snapshots” of cotranslational protein folding. Due 
to physical forces on the nascent chain (191,192), the flavodoxin construct is some-times released from the RNC (179). Comparison of released protein and RNCs allows 
assessment of the influence the ribosome has on apoflavodoxin folding.
FMN only binds to the flavin-binding site of full-length, isolated A. vinelandii apo-
flavodoxin when the protein is natively folded (65). We addressed cofactor binding 
to nascent flavodoxin and showed that FMN does not bind to apoflavodoxin during translation (179). The cofactor can only bind to the protein once it is entirely syn-
thesized and exposed outside the ribosome, because then apoflavodoxin becomes 
natively folded (Fig. 7A). Even when incomplete apoflavodoxin that lacks only its 5 C-terminal residues emerges from the ribosomal exit tunnel it cannot incorpo-rate FMN, because it forms a non-native intermediate, the conformation of which is presently unknown. In contrast, the corresponding released, shortened protein product does bind the cofactor (Fig. 7B). These differences in FMN binding capaci-
ties show that the ribosome affects nascent flavodoxin folding and cofactor binding. As a result, binding of cofactor to released full-length protein is the last step in the 
production of this flavoprotein in the cell (Figs. 7A,B) (179). The longer the chain 
of nascent apoflavodoxin is, the more stabilized the protein becomes and the less prone apo-protein is to intracellular proteolytic degradation. Upon incorporation of FMN the corresponding holo-proteins become protected against degradation (Figs. 7A,B) (179).
To further understanding of flavodoxin folding in vivo, we investigated whether 
the ribosome modulates formation of apoflavodoxin’s off-pathway MG (188). To this end, the F44Y mutation was introduced into an RNC construct that exposes the en-
tire nascent chain outside the exit tunnel. Full-length, isolated F44Y apoflavodoxin switches from natively folded to off-pathway MG upon decreasing ionic strength to physiological values (69), thereby avoiding the use of denaturant, which could ad-versely affect ribosomal integrity. The F44Y mutation introduces an extra oxygen 
atom into a hydrophobic pocket of native apoflavodoxin, causing considerable de-
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stabilization (69,72). It was verified that the SecM sequence, the linker and other 
components of the RNC construct do not influence formation of the off-pathway MG 
of F44Y apoflavodoxin or impair FMN binding. In addition, it has been shown that FMN does not associate with ribosomes (188). As the off-pathway MG needs to un-
fold before native apoflavodoxin can form, the rate of cofactor binding is delayed compared to the situation where only natively folded apo-protein is present. Thus, ascertaining the rate of FMN binding as a function of ionic strength is a suitable tool 
to detect the presence of apoflavodoxin’s off-pathway MG on the ribosome (188). 
Because F44Y apoflavodoxin RNCs bind FMN rapidly at both physiological and at high salt concentration, the fully exposed polypeptide must be natively folded un-der both conditions. Therefore, the ribosome modulates MG formation and forces 
nascent apoflavodoxin towards the native state (Fig. 7C) (188). This confinement of MG formation is an important observation that emphasizes differences between folding energy landscapes in vivo and in vitro. Possibly, electrostatic repulsion of the 
nascent chain (apoflavodoxin has a net charge of -13 at neutral pH) by the negatively charged ribosomal surface restricts the conformational space of unfolded protein, leading to entropic stabilization of native protein at physiological ionic strength (188). When release of the nascent chain occurs at physiological ionic strength, 
released F44Y apoflavodoxin construct predominantly forms the off-pathway MG, which is unstable and thus susceptible to intracellular proteolytic degradation (Fig. 
7C) (188). Because molten globular F44Y apoflavodoxin is in equilibrium with na-
tive protein, binding of FMN withdraws this latter state from the equilibrium and protects the protein against the action of proteases (Fig. 7C).
FUTURE PERSPECTIVES
Our understanding of the folding of isolated flavodoxin-like proteins in a test 
tube, including the influence of macromolecular crowding, has increased consider-
ably during the past decades. Also, the first facets of cotranslational folding of flavo-
doxin have been illuminated. Various aspects of the folding of flavodoxin-like pro-
teins still require clarification, some of which are highlighted below.Experimental determination of folding landscapes is a challenge and therefore relatively little experimental knowledge exists about them (29). Developments in 
biophysical techniques, including single-molecule ones, need to be applied to deter-
mine, refine and compare folding energy landscapes of various flavodoxin-like pro-teins and obtain more insight into off-pathway intermediate formation. For example, 
it is currently unknown when off-pathway intermediates of flavodoxin-like proteins 
unfold and embark on productive folding routes, which specific intramolecular in-teractions need to be disrupted. Mechanical unfolding and refolding by using optical tweezers may provide insight into this issue and can also be applied to further our understanding of the cotranslational folding of these proteins (170).Separate domains of multi-domain proteins are expected to fold independently of each other during translation (181). It would be interesting to verify whether the 
ribosome also forces the folding of a flavodoxin-like domain within multi-domain proteins, like cytochrome P450 reductase and nitric-oxide synthase (Figs. 1D,E), to-
wards the native state. When a flavodoxin-like domain is non-C-terminally located, it is tethered to the ribosome during further translation of the multi-domain pro-tein involved. Thus, once this domain emerges from the exit tunnel, the ribosome 
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has ample opportunity to influence its folding. If the ribosome pushes the flavodox-in-like domain towards the native state it should be able to bind FMN, as demon-strated for A. vinelandii apoflavodoxin (179). Cotranslational incorporation of flavin would impede proteolytic degradation of nascent multi-domain chains that contain 
a flavodoxin-like domain, due to increased stability conferred by cofactor binding. 
This could increase protein production efficiency (179). For several flavoproteins 
involved in diseases, a beneficial effect is observed upon supplementing the respec-
tive flavin (193).
While at equilibrium the ribosome restrains off-pathway MG formation in stalled 
RNC complexes that expose the entire F44Y flavodoxin protein outside the exit tun-
nel, comparable confinement may not happen during translation. For example, na-
scent flavodoxin that lacks five C-terminal amino acid residues adopts a non-native structure (179). It would be fascinating to elucidate how non-native interactions evolve during translation. Recently, by exploiting a reconstituted in vitro translation 
system combined with labelling of nascent chains at defined positions with bright 
fluorophores, nascent protein folding could be monitored in real-time by Förster resonance energy transfer (57). Application of this methodology can shed light onto 
folding of flavodoxin-like protein during translation and reveal whether temporary misfolding and formation of MGs occurs.
Isolated, full-length flavodoxin-like proteins tend to form off-pathway interme-diates during folding in vitro. While this observation does not signify that they also 
form misfolded species cotranslationally, once released from the restraining influ-ence of the ribosome these proteins may temporarily adopt misfolded structures 
in the cellular environment. Nevertheless, many flavodoxin-like proteins can be overexpressed in their native form, suggesting involvement of chaperones. Hence, a 
strong demand exists to clarify the influences chaperones, like Trigger factor, DnaK/
DnaJ and GroEL/GroES, have on the folding of flavodoxin-like proteins.
The ultimate challenge is to resolve the folding of flavodoxin-like proteins in 
vivo. Though progress has been made in characterising protein conformations at the atomic level in the crowded milieu of live cells (194-197), structural resolution of how proteins attain their native architecture in such an environment is still a formi-
dable challenge. Surprises are likely to emerge about the folding of flavodoxin-like proteins in a living cell.
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Discussion
This thesis explores the influence the ribosome has on cotranslational folding of fla-
vodoxin and on formation of apoflavodoxin’s off-pathway molten globule (MGoff), a folding state that has been extensively characterized in vitro (1-9). Using the experi-ments described in the previous chapters, we gained important insights into folding 
of apoflavodoxin and its MG.
In Chapter 2 we show that the model (scheme 1) used to describe the equilibri-
um folding of apoflavodoxin in vitro (9-11) requires revision.
MG
off
N
(Apo)
N
(Holo)
FMN
FMN    Scheme 1
Besides MGoff another MG exists, namely one that is on-pathway to native pro-tein and likely has a high degree of native structure. Two possible folding models can describe the folding through MGon: a linear one (scheme 2) or a triangular one (scheme 3).
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Under physiological conditions in vitro both MGs coexist for the F44Y variant of 
apoflavodoxin, indicating that they should also be concurrently present in the cel-lular environment. Due to cellular factors such as chaperones or macromolecular crowding these MGs might display different behaviour in vivo compared to in vitro. Preliminary experiments, not reported in this thesis, show that prokaryotic chap-erone Trigger factor as well as eukaryotic chaperone Hsp90 seem to interact with 
F44Y apoflavodoxin at physiological ionic strength (i.e., when both MGs are pres-ent). We could not yet determine whether these chaperones have a preference for a 
specific MG or interact with both of them. F44Y apoflavodoxin is thus an interesting candidate to study the effect of chaperones on MG formation in vitro and in vivo.
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Another reason why F44Y apoflavodoxin is an interesting candidate for future chaperone research in vitro is its propensity to aggregate at biologically relevant 
protein concentrations (12). Upon overproduction of this flavodoxin variant in E. 
coli, significant amounts of this protein end up in the insoluble cellular fraction. 
Also, F44Y apoflavodoxin has decreased global stability compared to C69A protein and thus is more susceptible to degradation by proteases (4). Both properties make F44Y a suitable protein for studying the effects of chaperones, especially in combi-
nation with C69A apoflavodoxin as a stable and non-aggregating control.
In Chapters 3 and 4 we investigate cotranslational folding of C-terminally short-
ened apoflavodoxin constructs and of F44Y apoflavodoxin, respectively. It has previ-
ously been demonstrated that FMN binding is the last step during flavodoxin folding 
in vitro (13). In Chapter 3 we show that the ribosome affects apoflavodoxin folding 
and thus prevents FMN binding to apoflavodoxin during translation. Consequently, 
binding of cofactor to released protein is the last step in production of this flavopro-tein in vivo (14). In the case of stalled ribosomes, FMN binding can also occur when the completely synthesized nascent chain is fully exposed outside the exit tunnel. We show that in this situation binding of FMN stabilizes the fully exposed nascent chain 
of apoflavodoxin against proteolytic degradation. We demonstrate that at physio-logical ionic strength the ribosome restrains formation of the off-pathway MG in F44Y RNCs by forcing the nascent chain towards the native state. This phenomenon 
is most likely caused by restriction of apoflavodoxin’s conformational space due to electrostatic repulsion by the highly negatively charged ribosomal surface (Chapter 
4).
Though the ribosome restrains formation of the off-pathway MG of F44Y apofla-vodoxin, it is still interesting to investigate the effect of chaperones, like for example Trigger factor, on the folding of this nascent protein. Trigger factor has been shown to possess a “holdase” functionality (15), which essentially keeps the protein in an 
unfolded state. Would this also be the case for F44Y apoflavodoxin, even though the ribosome forces the nascent chain towards the native state?
In Chapter 3 we illustrate that in E. coli production of FMN lags well behind pro-
duction of nascent chains and/or released apoflavodoxin. As a result, in case of de-
stabilized protein such as F44Y apoflavodoxin, large amounts of this protein end up in cellular aggregates or become degraded by intracellular proteases, before F44Y 
protein can incorporate the stability-enhancing FMN. Thus, compared to C69A flavo-
doxin, less soluble F44Y flavodoxin can be purified from E. coli. Yet, still a significant amount of F44Y holo-protein is obtained from E. coli, as intracellular binding of FMN 
to native F44Y apoflavodoxin stabilizes the protein against both processes. FMN acts 
like a chemical chaperone, which protects apoflavodoxin against degradation and aggregation. It does not, however, act as a chaperone in the sense that it affects fold-ing, as FMN binds only to natively folded apo-protein.
This latter finding may have implications for large-scale production of flavopro-
teins. It is well known that flavin incorporation stabilizes flavoproteins. As flavin production lags behind protein production, higher protein yields may thus occur in E. coli strains that have a high flavin production capability. Most research on in-
creasing flavin production has been done using Bacillus subtilis, as it is one of the 
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organisms for biological production of riboflavin on an industrial scale (16,17). By expressing part of the B. subtilis rib operon the production of flavin in E. coli could 
be increased 3.6 fold (18). Increasing production of the enzymes riboflavin kinase 
and FAD synthase could boost conversion of riboflavin to respectively FMN and FAD. 
Would expression of unstable flavoproteins in such a strain increase their yield? Or 
would induction of the flavin operon before induction of protein expression also be a way to increase protein yield?
As discussed, Chapter 4 reports that in case of F44Y apoflavodoxin the ribosome seems to force full-length nascent chain to the native state. However, this observa-tion is based on ascertaining the rate by which FMN binds to the nascent chain. As 
Chapter 2 shows, determination of this rate cannot distinguish between the pres-
ence of the on-pathway MG or natively folded apoflavodoxin. Whether both folding species exist on the ribosome is still unknown. While distinguishing between both 
folding states is difficult, NMR spectroscopy might be able to do so in future exper-iments. MGs have a reduced NMR signal compared to natively folded protein due to exchange between different conformations on the micro- to millisecond timescale. 
While the experiments of Chapters 3 and 4 increase our knowledge about the effect the ribosome has on protein folding, they still do not fully probe protein fold-
ing in a cell. The construct used for production of RNCs creates a somewhat artificial 
situation compared to translation of solely the flavodoxin gene. During the latter situation, translation termination and concurrent release of nascent chains occurs while approximately 30 to 40 C-terminal amino acids are still buried in the exit tun-nel. These residues need to traverse this tunnel before full-length protein emerges from the ribosome. Situations like in Chapters 3 and 4 where protein is stalled to 
the ribosome with the entire flavodoxin domain exposed outside the exit tunnel do 
not occur during translation of solely the flavodoxin gene. Despite these restrictions, 
demonstration of for example the importance of the five C-terminal amino acids for 
cofactor binding to apoflavodoxin remains valid. Binding of FMN to translating apo-
flavodoxin can thus only occur after the entire nascent chain has traversed the exit tunnel and the protein has obtained its native fold, as shown in Chapter 3.With regard to the non-observed formation of the off-pathway MG during trans-
lation of the flavodoxin gene (Chapter 4) we have additional circumstantial evi-
dence from previous work. Using fluorescence resonance energy transfer (FRET), it was discovered that folding of the C-terminal part of the off-pathway MG precedes folding of its N-terminal part (7). As cotranslational folding proceeds from the N- to 
the C-terminus, misfolding of apoflavodoxin’s nascent chain may possibly be pre-vented before the entire protein is exposed outside the ribosome. Nevertheless, it is unknown where in the C-terminal part the folding of the off-pathway MG starts, thus 
it cannot be ruled out that this species may form during translation of the apoflavo-
doxin gene. Still, the influence of the ribosomal surface on apoflavodoxin’s confor-mational space would be in effect, thereby potentially restraining formation of the off-pathway MG.
In Chapter 5, the folding of proteins with a flavodoxin-like fold, including fla-vodoxin- and CheY-related protein families, is reviewed. These proteins form mis-
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Chapter 6folded intermediates, and several of these species are molten globular. Experiments suggest that these off-pathway intermediates are of helical nature. It would be in-teresting to investigate whether the ribosome also restrains the formation of fold-
ing intermediates of flavodoxins other than the one from A. vinelandii and of CheY, Spo0F and NtrC.
Phylogenetic analysis shows that all flavodoxins studied concerning their folding belong to different classes of bacteria, with A. vinelandii belonging to the gammapro-teobacteria, D. desulfuricans to the deltaproteobacteria, H. pylori to the epsilonpro-teobacteria and Anabaena to the cyanobacteria (19). These classes occupy distinct 
environmental niches, as exemplified by the case of H. pylori, which can survive in 
the acidic environment of the stomach. The question arises whether the minor dif-ferences in folding behaviour between the various proteins as discussed in Chapter 
5 is due to adaption to these environmental niches. It might thus be appealing to in-
vestigate whether flavodoxins from the same bacterial class fold in similar ways. Un-
til now no flavodoxin from an algal species has been studied for its folding behaviour. 
As one of the few eukaryotic classes that retain the flavodoxin protein, studying the 
folding of algal flavodoxin may give us insights into the evolution of this protein in 
eukaryotes and bacteria. Additionally one can query whether all flavodoxins fold in the same manner cotranslationally, in other words does the ribosome negate the differences in folding behaviour found in vitro? Does the ribosome restrain forma-
tion of the MGs of other flavodoxins, as it does for A. vinelandii flavodoxin? Or does adaptation to different environmental niches also lead to different cotranslational folding behaviour? And even if the ribosome does restrain MG formation for other 
flavodoxins, upon release from the ribosome, F44Y apoflavodoxin reverts back into MG (Chapter 4). Thus, while the ribosome may temporarily restrict MG formation 
of apoflavodoxin, without sufficient intracellular cofactor, the produced protein may relapse into the MG state. 
Though our studies revealed the first glimpses of translation and folding of fla-vodoxin, and much still needs to be disclosed, they offer insight into nascent chain 
folding of multi-domain proteins that contain a domain with a flavodoxin-like to-pology. This architecture is part of several important multi-domain proteins, such as cytochrome P450 reductase and nitric oxide synthase (20,21). Translation of the C-terminal domains of such proteins continues when their N-terminal domains have 
already fully emerged from the ribosomal exit tunnel. Our findings imply that an 
N-terminal domain with a flavodoxin-like topology can already fold in a multi-do-main protein while translation of the other domains still takes place. As proteins 
with a flavodoxin-like topology seem to fold via involvement of off-pathway MGs 
(22), the same may hold true for flavodoxin-like domains in multi-domain proteins. Hence, if this domain is N-terminally located, the ribosome may force this domain to-wards the native state, just as is the case for A. vinelandii flavodoxin (Chapter 4), and 
thereby protect the nascent chain against degradation or aggregation. Subsequent 
binding of FMN to an N-terminally located flavodoxin-like domain even further sta-bilizes the nascent chain (Chapter 3). It would be interesting to determine whether there is a correlation between positioning of cofactor-binding domains in multi-do-main proteins and their stability during synthesis. If they predominantly locate in the N-terminal part of multi-domain proteins this protection against degradation and aggregation may be an important factor during cotranslational folding of these 
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Discussionproteins. One such example is the group of P450 fusion proteins, in which the N-ter-
minal domain is in all but one case either a heme-binding P450 or a flavin-binding domain (23).
The field of cotranslational folding develops quickly, with new techniques fa-cilitating breakthroughs. In a recent pioneering study, cotranslational folding has 
been studied in real time by incorporating fluorescent dyes in the nascent chain and following the resulting FRET signal during in vitro translation (24). It would be an exciting perspective to compare the results presented in this thesis with cotransla-
tional folding of flavodoxin in real time, particularly in perspective of the meticulous probing by FRET of the in vitro folding of dye-labelled flavodoxin (7-9).Another, less complicated, approach to study cotranslational folding is following proteolytic degradation of RNCs as a function of urea concentration (25). This could 
be a relatively quick method to further our understanding of the folding of apo-
flavodoxin with differing nascent chain lengths. Besides the -5 and -10 constructs reported in Chapter 3, we have a library of further shortened nascent flavodoxin constructs, which are interesting candidates to investigate. While the proteolytic 
degradation technique cannot provide the time-resolution of for example real-time 
FRET, it would allow for a first selection of potentially interesting constructs con-cerning their folding, before further in depth investigations.
In vitro investigations of full-length, isolated proteins are important to improve 
our understanding of their folding, which is of benefit for example in industrial 
settings where purified proteins are used. A strong desire exists to investigate the conformational events a protein undergoes while it folds in a cell, events that have hardly been probed to date. This thesis shows that differences exist between protein folding in vitro and in vivo, for example because the ribosome can affect this process. Exploration of polypeptide folding on the ribosome, and how this process is assisted by chaperones, contributes to a molecular description of protein folding in the cell. Cotranslational folding is suspected to be critical for many newly synthesized poly-peptides in order to prevent inter- or intra-molecular misfolding and aggregation (26,27). Increasing our knowledge of nascent chain folding is relevant to compre-hend aspects of the molecular basis for folding defects. These defects underlie pro-tein malfunction and protein homeostasis (28) failures that can ultimately manifest themself as a wide variety of diseases (29-33).
One of the findings in this thesis that has potential applications is the role of FMN 
as a chemical chaperone. As humans lack the ability to synthesize riboflavin, which is the precursor to FMN and FAD, this cofactor must either be obtained through the diet or through uptake from synthesis by the gut microbiome (34,35). In human cells, 
riboflavin is then converted into FMN and FAD by respectively riboflavin kinase and 
FAD synthase (36). In the endocrine disorders hypothyroidism and adrenal insuffi-
ciency, this conversion is impaired (36). Many flavoproteins are essential proteins in cells and are amongst others involved in the biosynthesis of coenzymes, such as 
folate, coenzyme A and pyridoxal 5′-phosphate (PLP), and of various steroid-derived 
hormones (37). About two-thirds of all human flavoproteins may have mutations that are associated with diseases (37) and for several of these mutations it is known 
that they decrease cofactor affinity (38), such as for methylenetetrahydrofolate re-
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ductase (39). In some cases of reduced cofactor affinity, supplementation of flavin 
upon onset of disease has already been shown to have a beneficial effect (38,40).
Binding of their respective flavin may not only stabilize a flavoprotein, but may 
also lead to dimerization to functionally active protein (41). Proteins that bind flavins 
covalently may require posttranslational modifications to complete the flavinyla-tion, such as is the case for succinate dehydrogenase (42,43). Flavins can therefore act in many different ways to increase stability and activity of their binding partners, 
though the exact timing of cofactor binding is unknown for most flavoproteins (i.e. whether this happens co- or post-translationally). This thesis shows that the phar-
macological chaperone function of flavins may already operate at the cotranslation-al level, as binding of FMN stabilizes a nascent chain and thereby protects it from 
degradation. Increasing the amount of available flavin is therefore a valid strategy to 
ameliorate diseases caused by inefficient cofactor binding of flavoproteins. Besides dietary supplementation, cofactor levels may be augmented by increasing the levels 
of riboflavin kinase and/or FAD synthase or by finding ways to boost synthesis by 
the gut microbiome. Cotranslational flavin binding is thus the first step for produc-
tion of a stable and active protein and it may well be a general mechanism for flavo-proteins to increase their stability during synthesis.
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ENGLISH SUMMARY
During and after their translation by the ribosome, folding of polypeptides to biologically active proteins is of vital importance for all living organisms. Gaining 
knowledge about nascent chain folding is required to enhance our understanding of protein folding in the cell. This in turn allows us to obtain insights into factors responsible for protein misfolding, aggregation, and, potentially, for numerous dev-astating pathologies.
In Chapter 1 the model protein flavodoxin is introduced. Also theories about protein folding are presented, which led to the concept of the “folding energy land-scape”. Flavodoxin folds via a misfolded off-pathway intermediate, which is molten globular and forms extensively during its refolding in vitro.
In Chapter 2 we show that flavodoxin also populates an on-pathway molten 
globule during its folding. In the F44Y variant of apoflavodoxin, lowering the ionic strength induces the off-pathway molten globule state. By adding the cofactor FMN, we could follow aspects of the folding of this protein, as off-pathway molten glob-
ular flavodoxin first has to unfold and subsequently refold before FMN can bind. Thus, presence of the off-pathway molten globule retards FMN binding. We deter-mined the presence of the off-pathway molten globule at decreasing ionic strengths 
with cofactor binding kinetics and polarized time-resolved tryptophan fluorescence spectroscopy. Comparison of both data sets revealed the presence of another, con-currently present molten globule. This species is most likely on-pathway to native 
protein. To our knowledge this is the first time that two concurrent molten globules have been discovered that reside on folding routes of decidedly different nature (i.e., on- and off-pathway ones).
While much work has been done on the folding of flavodoxin in vitro, the next step is to elucidate how this protein folds in vivo. In Chapter 3 the first insights 
into cotranslational flavodoxin folding are presented. By using ribosomal nascent 
chains (RNCs) we could determine that when flavodoxin is fully exposed outside the 
ribosome it can bind its cofactor. However, while its five C-terminal amino acids are 
still sequestered in the ribosomal exit tunnel, the protein is in a non-native state and 
cannot bind FMN. Thus the last step in production of this flavoprotein in vivo is the binding of cofactor.
Chapter 4 reveals the influence of the ribosome on formation of the off-pathway 
molten globule of flavodoxin. By using RNCs of the F44Y variant of apoflavodoxin, we proved that the ribosome restrains formation of this molten globule. This discovery 
was possible by exploiting the findings of Chapter 2 and Chapter 3, namely that co-factor binding kinetics slow down when off-pathway molten globule is present and 
that a fully exposed, natively folded flavodoxin nascent chain binds FMN. For F44Y RNCs no retardation in FMN binding occurs, whereas cofactor binding slows down 
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in case of isolated, full-length F44Y in the molten globule state. Thus the ribosome 
restrains formation of molten globules in stalled nascent flavodoxin. This is possibly due to electrostatic repulsion of the nascent chain by the ribosomal surface, as both are negatively charged, leading to entropic stabilization of native protein at physio-logical ionic strength.
In Chapter 5 we review experiments and simulations concerning the folding of 
flavodoxins and CheY-like proteins, which share the flavodoxin-like fold. These pro-teins form intermediates that are off-pathway to native protein and several of these species are molten globules. This susceptibility to frustration is caused by the more 
rapid formation of an α-helix compared to a β-sheet, particularly when a parallel 
β-sheet is involved. The experimentally characterized off-pathway intermediates 
seem to be of α-helical nature. We discuss the probing of the cotranslational folding 
of flavodoxin as a first step towards a molecular description of how flavodoxin-like proteins fold in vivo.
Finally, Chapter 6 touches upon the implications of our findings and possible 
applications in biotechnology, health and disease. A finding that has potential appli-cation is the role FMN has as a chemical chaperone. This chemical chaperone can al-ready work at the cotranslational level, as binding of FMN stabilizes a nascent chain and thereby protects the nascent chain against degradation.
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NEDERLANDSE SAMENVATTING
Vouwing van polypeptides tot biologisch actieve eiwitten is van groot belang voor alle levende organismen. Dit vouwingsproces gebeurt tijdens en na het maken van de polypeptide keten door ribosomen (dit proces heet translatie). Inzicht ver-krijgen in de vouwing van eiwitten tijdens translatie van belang voor het begrijpen van eiwitvouwing in de cel. Deze kennis helpt ons om meer te weten te komen over de verschillende factoren die verantwoordelijk zijn voor het verkeerd vouwen van eiwitten en de vaak daarbij voorkomende aggregatie verschijnselen. Deze factoren zijn potentieel betrokken bij verscheidene ziektebeelden, zoals Alzheimer en Par-kinson.In Hoofdstuk 1 wordt het model-eiwit flavodoxine geïntroduceerd, alsmede de eiwitvouwing theorie van de “vouwings-trechter” (folding funnel). Flavodoxine vou-wt via een tussen vorm die verkeerd gevouwen is, een zogenaamde “off-pathway” intermediair. Deze intermediair vouwt als een “molten globule”, dat wil zeggen met secundaire structuur, maar zonder de pakking van een tertiaire structuur zoals in goed gevouwen globulaire eiwitten. Deze molten globule vormt in grote getale tij-
dens het hervouwen van flavodoxine in vitro.In Hoofdstuk 2 laten we zien dat flavodoxine ook via een “on-pathway” interme-diair vouwt en dat deze intermediair ook een molten globule is. In tegenstelling tot de off-pathway intermediair, is de on-pathway wel groten deels correct gevouwen. 
In de F44Y variant van apoflavodoxine kan de vorming van de off-pathway molten 
globule geïnduceerd worden door de zout sterkte (en daarmee de ionische sterk-
te) te verlagen. Door het toevoegen van de cofactor van  flavodoxine, FMN, konden we aspecten van de vouwing volgen. De off-pathway molten globule moet namelijk eerst ontvouwen en correct hervouwen voordat FMN kan binden. Als de off-pathway molten globule dus aanwezig is, wordt de binding van FMN vertraagd. We hebben de aanwezigheid van de off-pathway molten globule bij verschillende ion sterktes bep-
aald door middel van cofactor bindings-kinetiek en gepolariseerde tryptofaan flu-orescentie spectroscopie. Door beide data sets te vergelijken kon de aanwezigheid van een tweede molten globule worden aangetoond. Deze tweede intermediair is gelijktijdig met de off-pathway molten globule aanwezig en is hoogstwaarschijnlijk on-pathway. Voor zover wij weten is dit de eerste keer dat twee gelijktijdige mol-ten globules zijn aangetoond, die op verschillende vouwings-routes liggen (namelijk off-pathway en on-pathway).
Hoewel er al veel werk gedaan is op het gebeid van vouwing van flavodoxine 
in vitro, is het nog onbekend hoe dit eiwit vouwt in vivo. In Hoofdstuk 3 worden 
de eerste resultaten op het gebied van co-translationele vouwing van flavodoxine gepresenteerd. Door middel van “ribosomal nascent chains” (RNCs, eiwitketens die 
nog vast zitten aan het ribosoom) konden we bepalen dat flavodoxine zijn cofactor FMN kan binden als het helemaal te voor schijn is gekomen uit het ribosoom. Echter, wanneer zijn laatste vijf C-terminale aminozuur residuen nog in de exit tunnel van 
het ribosoome verblijven, kan flavodoxine niet vouwen naar zijn natieve toestand en 
kan FMN niet binden. De binding van FMN aan natief gevouwen flavodoxine is dus 
de laatste stap in de productie van dit flavo-eiwit.
Hoofdstuk 4 beschrijft de invloed van het ribosoom zien op de formatie van de 
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off-pathway molten globule van flavodoxine. Door gebruik te maken van RNCs van 
de F44Y variant van apoflavodoxine konden we aantonen dat het ribosoom deze formatie verhindert. Deze ontdekking werd mogelijk gemaakt door onze bevindin-gen uit Hoofdstuk 2 en Hoofdstuk 3, namelijk dat de kinetiek van cofactor binding vertraagd wordt wanneer de off-pathway molten globule aanwezig is en dat volle-
dig uit de exit tunnel gekomen flavodoxine natief vouwt en FMN kan binden. Voor F44Y RNCs zien we geen vertraging in de binding van FMN, terwijl dit wel het geval 
is voor losgelaten F44Y onder dezelfde omstandigheden. Zodoende beïnvloedt het 
ribosoom de formatie van molten globules in flavodoxine dat nog vast zit aan het 
ribosoom. Waarschijnlijk komt deze beïnvloeding door elektrostatische repulsie van 
het flavodoxine polypeptide door het oppervlak van het ribosoom, aangezien beide negatief geladen zijn. Dit zorgt voor stabilisatie van het natief gevouwen eiwit bij fysiologisch relevante ionische sterktes.In Hoofdstuk 5 bediscussiëren we experimenten en simulaties betreffende 
de vouwing van verschillende flavodoxines en CheY-eiwitten, die eenzelfde soort 
vouwing hebben als flavodoxine. Deze eiwitten vormen allen intermediairen die off-pathway zijn tot de natieve toestand en waarvan sommige gekarakteriseerd zijn als molten globule. Deze off-pathway intermediairen vormen vanwege de snellere 
vouwing van α-helixen ten opzichte van β-sheets, met name wanneer een parallelle 
β-sheet moet worden gevormd. De experimenteel gekarakteriseerde off-pathway in-
termediairen lijken allemaal alleen α-helices te hebben en geen β-structuren. Verder 
bespreken we de experimenten inzake de co-translationale vouwing van flavodox-
ine, welke een eerste stap zijn op weg naar een omschrijving van flavodoxine vou-wing in vivo.Ten slotte worden in Hoofdstuk 6 de implicaties van onze resultaten en mogeli-jke industriële of farmaceutische toepassingen besproken. Een mogelijke applicatie zou het gebruik van FMN als chemische “chaperone” zijn. Dit chemische chaperone zou al op het co-translationale niveau kunnen werken, aangezien binding van FMN 
het flavodoxine polypeptide stabiliseert en zodoende beschermt tegen degradatie. 
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